書籍詳細

白血病の疫学

P.17 掲載の参考文献

• 1) 厚生大臣官房統計情報部 (旧統計調査部) 編:人口動態統計 昭和22年〜昭和50年. 厚生統計協会, 東京, 1949-1977.

• 2) W. H. O. ;World Health Statistics Annual 1970. 1971, 1972 Geneve 1970-1972.

• 3) W. H. O.:World Health Statistics Reports Vol. 62 (7-8) , Vol. 27 (6-7) , Geneve, 1974.

• 4) Segi, M. and Kurihara, M.:Cancer mortality for selected sites in 24 countries No. 6 (1966-1967) , Japan Cancer Society, Tokyo, 1972.

• 5) 瀬木三雄:日本および諸国における白血病死亡の統計的観察. 癌の臨床, 3, 727-733, 1957.

• 6) Segi, M. et al.:Age-adjusted death rates for cancer for selected sites (A-Classification) in 43 countries in 1970-1972, Segi Institute of Cancer Epidemiology, Nagoya, 1975-1977・

• 7) Doll, R., Muir, C. and Waterhouse, J. (eds.) :Cancer Incidence in Five Continents Vol. II 1970 Springer-Verlag Berlin-Heidelberg-NewYork, 1971.

• 8) Waterhouse, J., Muir. C. Correa. P. and Powell. J. (eds.) :Cancer Incidence in Five Continent Vo. III IARC LYON. 1976.

• 9) 厚生大臣官房統計調査部編:疾病・傷害および死因統計分類提要. 昭和43年度版 第1〜3巻, 厚生統計協会, 1971.

• 10) Gunz. F. and Baike. A. G.:Leukemia (3rd edition) . Nankodo. Tokyo. 1974.

• 11) Burch. P. R. J.:The Biology of Cancer. A New Approach. MTP Press・1976・

• 12) Heath, C. W. and Hasterlik, R. J.:Leukemia among children in a suburban community Am. J. Aled. 34, 796-812, 1963.

• 13) Knox, G.:Epidemiology of childhood leukemia in Northunberland and Durham. Brit. J. Prev. Soc. Mod. 18, 17-24, 1964.

• 14) Ederer, F., Myers, M. H. and Mantel, N.:A Statistical problem in space and time, Do leukemia cases come in cluster? Biometrics 20, 626-638, 1964.

• 15) 小林博, 上村孝二:白血病の集中発生. 日本医事新報, 2251, 28-34, 1967,

• 16) 太田和雄:岐阜県白川町の白血病の cluster. 最新医学, 24, 2214-2218, 1909.

• 17) 大北 威:中国地方および長崎県の白血病多発. 最新医学, 24, 2222-2224, 1969,

• 18) 宇塚善郎:福島県霊山町の白血病集中発生. 最新医学, 24, 2224-2225, 1969.

• 19) 平山 雄:静岡県湯河原町の白血病集中発生. 最新医学, 24, 2225-2226, 1969.

• 20) 杢野寿一, 西山宏, 太田和雄:白血病多発地域と多発現象の考察. 最新医学, 2231-2238, 1969

• 21) 大谷元彦, 青木国雄:白血病 clustering の疫学モデルによる検討. 医学のあゆみ, 79, 685-686, 1971.

• 22) 青木国雄, 清水弘之, 黒石哲生:患者発生分布の分析法. 数理科学 161, 15-22, 1976.

• 23) Stewart, A. and Barber, R.:The Epidemiologial importance of childhood cancer. Brit. Med. Bull. 27. 64-70, 1971.

• 24) Kneale, G. W.:Excess sensitivity of preleukemics to pneumonia. A model situation for studying the interaction of infectius digeases with cancer. Brit. J. Prev. Soc. Med. 25, 152-159 1971.

• 25) 青木国雄:血液病の疫学. 臨床血液, 18, 555-563, 1977.

• 26) 平山雄:疫学における白血病モデル. 伊藤洋平, 編. 白血病. 231-256 講談社サイエンティフィク, 1974.

• 27) Lee. J. A. H.:Acute myeloid leukemia in adolescents. Brit. Med. J. 1, 988-992, 1961.

• 28) 西塚泰章, 志佐 瑞:白血病の成因. クリニカ, 3, 44-47, 1976.

• 29) 青木国雄, 清水弘之:再生不良性貧血の宿主要因, 日比野進他編, 再生不良性貧血III (再生不良性貧血班昭和49年度業績集) pp. 1-8, 1975.

• 30) 青木国雄, 清水弘之:白血病の疫学. クリニカ, 13, 37-43, 1976.

• 31) 青木国雄, 清水弘之, 黒石哲生, 小川浩:再生不良性貧血の宿主要因(第2報) , 日比野進他編, 再生不良性貧血IV. (再生不良性貧血班昭和50年度業績集) pp. 175-180, 1976.

• 32) Aoki, K., Cancer monitoring among industrial workers. Presented at the Seminar of Cancer Registries and Occupational Cancer. NCI of Japan, Tokyo, May 1975.

• 33) 北畠隆, 渡辺強, 中村実:本邦放射線技術者 1966〜1972年における死亡分析. 日医放誌, 34, 440-443, 1974.

• 34) 岩崎竜郎, 青木正和:レントゲン線高度被曝者からの悪性腫瘍の発生, 人工気胸療法実施例における肺がん発生状況, 厚生省がん研究助成"特殊環境における肺がんの早期発見に関する研究班"報告. 東京 (December 1972) .

• 35) 青木国雄, 大谷元彦, 清水弘之:各種薬剤と血液・造血器疾患死亡について. 日比野進他編, 再生不良性貧血III (再生不良性貧血班昭和49年度業績集) pp. 13-18. 1975.

• 36) 島正吾, 加藤保夫, 渡辺清博, 皿井進, 大谷元彦, 落合昭博, 栗田秀樹, 太田みどり, 村井佳幸:再生不良性貧血に関する産業別疫学調査. 日比野進他編, 再生不良性貧血III (再生不良性貧血班昭和49年度業績集) , pp. 19-32. 1975.

• 37) 平山雄:白血病の疫学. 中尾喜久, 編 白血病のすべて. p102-103, 南江堂 1972

• 38) 産業結核管理研究全国会議資料. 第2集〜第14集, 保健文化社 1964-1974

白血病と遺伝

P.31 掲載の参考文献

• 1) Guasch, J.:Heredite des leucemies. Sang, 25, 384-421, 1954.

• 2) Rigby, P. G., Rosenlof, R. C., Pratt, P. T.:Leukemia and lymphoma, JAMA, 197, 95-100, 1966.

• 3) Gunz, F. W., Veale, A. M. O.:Leukemia in close relatives-accident or predisposition? J. Nat. Cancer lnst., 42, 517-524, 1969.

• 4) MacMahon, B., Levy, M. A.:Prenatal origin of childhood leukemia-evidence from twins, New Engl. J. Med., 270, 1082-1085, 1964.
  pubmed

• 5) Jackson, E D., Norris, F. D., Klauber, M. R.:Childhood leukemia in California-born twins, Cancer, 23, 913-919, 1969.

• 6) Keith, L., Brown, E.:Epidemiologic study of leukemia in twins (1928-1969) , Acta Genet. Med. Gemellol., 20, 9-22, 1971
  pubmed

• 7) Miller, R. W.:Persons with exceptionally high risk of leukemia, Cancer Res. 27, 2420-2423, 1967.
  pubmed

• 8) Fraumeni, J. F.:Constitutional disorders on man predisposing to leukemia and lymphoma, Nat. Cancer Inst. Monogr., 32, 221-232, 1969

• 9) Gatti, R. A., Good, R. A.:Occurrence of malignacy in immunodeficiency diseases-a literature review, Cancer, 28, 89-98, 1971.

• 10) Kersey, J. H., Spector, B. D., Good, R. A:Primary immunodeficiency and malignancy, Birth Defects, 11, 289-298, 1975.
  pubmed

• 11) Kourilsky, F. M., Dausset, J., Feingold, N., Dupuy, J. M., Bernard, J.:Leukocyte groups and acute leukemia, J. Nat. Cancer Inst., 41, 81-87, 1968.
  pubmed

• 12) Regentine, G. N., Yankee, R. A., Gart, Z. Z. Nam, J., Trapani, R. J.:HL-A antigens and disease, acute lymphocytic leukemia, J. Clin. lnvest., 51, 2420-2428, 1972.

• 13) Sanderson, A. R., Mahour, G. H., Jaffe, N., Das, L.:Incidence of HL-A antigens in acute lymphocytic leukemia, Transplantation, 16, 672-674, 1973.

• 14) Dausset, J., Degos, L., Hors, J.:A review, the association of the HL-A antigens with diseses, Clin. lmmuno. Immunopath 3, 127-149, 1974.

• 15) Oliver, R. T. D., Pillai, A., Klouda, P. T., Lawler, S. D.:HLA liked resistance factors and survival in acute myelogenous leukemia, Cancer, 39, 2337-2341, 1977.

• 16) 栗田宗次:白血病の家族発生. 日血会誌, 31, 748-755, 1968.

• 17) 栗田宗次, 亀井良孝:家族性白血病の遺伝学的研究. 人類遺伝学雑誌, 14, 163-179, 1969.

• 18) Ardashnikov, S. N.:The genetics of leukemia in man, J. Hyg., 37, 286-302, 1937.

• 19) Gunz, F. W., Gunz, J. P, Veale, A. M. O., Chapman, C. J., Houston, I. B.:Familial leukaemia:a study of 909 families, Scand. J. Haemat., 15, 117-131, 1975.

• 20) Gordon, R. D.:Hereditary factors in human leukemia, a report of four cases of leukemia in a family, Australian Ann. Med., 12, 202-207, 1963.

• 21) Weiner, L.:A family with high incidence leukemia and unique Ph1 chromosome findings, Blood, 26, 871, 1965.

• 22) Lundmark, K. M., Thilen, A., Vahlquist, B.:Familial leukemia, three cases of acute leukaemia in four siblings, Acta Paediat. Scand., Suppl, 172, 200-205, 1967.

• 23) Ferguson, S. W., Lynn, T. N.:Familial leukemia;a report of 4 cases of acute leukemia in 4 consecutive generations, Southern. Med. J, 63, 1337-1340, 1970.
  pubmed

• 24) Undriz, E., Schnyder, F.:Vier Geschwister mit chronischer lymphatischer Leukamie in Wallis, Schweiz . med. Wschr., 101, 1779-1780, 1971.

• 25) Ghosh, H. L.:Familial leukaemia, Acta Haemat., 48, 98-103, 1972.

• 26) Larsen, W. E., Schimke, R. N:Familial acute myelogenous leukemia with associated C-monosomy in two affected members, Cancer, 38, 841-845, 1976.
  pubmed

• 27) Petzoldt, R., Hartwich, G., Demmler, K:Familiare-gehauftes Auftreten der chronischen lymphatischen Leukamie, Med. Klin., 71, 2123-2126, 1976.

• 28) McPhedran, P., Heath, C. W., Lee:J., Patterns of familial leukemia, ten cases of leukemia in two interrelated families, Cancer, 29, 403-407, 1969.

• 29) Imaizumi, Y., Shinozaki, N., Aoki, H.:Inbreeding in Japan:results of a nation-wide study, Jap. J. Human Genet., 20, 91-107, 1975.

• 30) 柳瀬敏幸:内科臨床遺伝学-易罹病性の遺伝的解析. 日内会誌, 59, 917-935, 1970.

• 31) Twomey, J. J, Levin, W. C., Melnick, M. B. . Trobaugh, F. E, Allgood, J. E., Allgood, J. W:Laboratory studies on a family with a father and son affected by acute leukemia, Blood, 29, 920-930, 1967.

• 32) Fraumeni, J. F., Vogel, C. L., DeVita. V. T. . Familial chronic lymphccytic leukemia, Ann. Intern. Med., 71, 279-284. 1969.
  pubmed

• 33) Snyder, A. L, Li, F. P., Henderson, E. S., Tadaro, G. J:Possible inherited leukemogenic factors in familial acute myelogenous leukemia, Lancet, 1, 586-589, 1970.

• 34) Potalsky, A. I., Heath C. W., Buckley, C. E., Rowland, D. T.:Lymphoreticular malignancies and immunologic abnormalities in a sibship, Am. J. Med., 50, 42-48, 1971.

• 35) Till, M. M., Jones, L. H., Pentycross, C. R., Hardisty, R. M., Lawler, S. D., Harrey, B. A. M., Soothill, J. F., :Leukaemia in children and their grandparents, studies of immune function in six families, Brit. J. Haemat., 29, 575-586, 1975.

• 36) Sutton, R. N. P., Bishun, N. P., Soothill, J. F., :Immunological and chromosomal studies in firstdegree relatives of children with acute lymphoblastic leukaemia, Brit. J. Haemat., 17, 113-119, 1969.

• 37) Chandra, R. K., :Serum immunoglobulin levels in children with acute lympoblastic leukemia and their mothers and sibs, Arch. Dis. Child., 47, 618-620, 1970.

• 38) Blattner, W. A., Strober W., Muchmore, A. V., Blaese, R. H., Broder, S., Fraumeni, J. F.:Familial chronic lymphocytic leukemia, immunologic and cellular characterization, Ann. lntern. Med., 84, 554-557, 1976.

• 39) Walker, F. A., Kurt, T. L.:Familial leukemia and dry cleaning, Ann. Intern. Med., 85, 404, 1976.

• 40) Kolmeier, K. H., Bayrd, E. D.:Familial leukemia, report of instance and review of the literature, Proc. Mayo Clin., 38, 523-531, 1963.

• 41) Jedlicka, V., Hermanska, Z., Smida, I., Kouba, A., Paramyeloblastic leukemia appearing simultaneously in two blood cousines after simultaneous contact with gammexan (hexachlorcyclohexane) , Acta Med. Scand., 166, 447-451, 1958.

• 42) 中山健太郎, 田中文男, 矢崎みどり:姉妹2名に発病した急性白血病. 臨床内科小児科, 11, 191-193, 1956.

• 43) 田坂英子, 宮崎澄雄:三人姉妹にみられた急性骨髄性白血病. 血液と脈管, 1, 1145-1154, 1970.

• 44) 脇坂行一, 米田道正:白血病統計. A, 臨床統計, 白血全書, 5, 596-634, 1962.

• 45) 脇坂行一:私信;宮田久寿:私信

• 46) Lilly, F., Boyse, E. A., Old. L. J.:Genetic basis of susceptibility to viral leukemogenesis, Lancet, 2, 1207-1209, 1964.

• 47) Lawler, S. D., Klouda, P. T., Smith, P. G., Till, M. M.:Survival and the HLA system in acute lymphblastic leukemia, Brit. Med. J., 23, 547-548, 1974.

• 48) Gatti, R. A., Good, R. A.:Occurrence of malignancy in immunodeficiency disease a literuture review, Cancer, 28, 89-98, 1971.
  pubmed

• 49) Page, A. R., Hansen, A. E., Good, R・A.:Occurrence of leukemia and lymphoma in patients with agammaglobulinernia, Blood, 21, 197-206, 1963.

• 50) Bensel, R. W., Stadlan, E. M., Krivit, W.:The development of malignancy in the course of the Aldrich svndrome, J. Pediat., 68, 761-767, 1966.

• 51) Cooper, M. D., Chase, H. P., Lowman, J, T., Krivit, W・・Good・R. A.:Wiskott-Aldrich syndrome, an immunologic deficiency disease involving the afferent limb of immunity, Am. J. Med., 44, 499-513, 1968.

• 52) Peterson, R. D., Cooper, M. D., Good, R. A.:Lymphoid tissue abnormalities associated with ataxiatelangiectasia, Am. J. Med., 41, 342-359, 1966.
  pubmed

• 53) Schroeder, T. M., Kurth, R.:Spontaneous chromosomal breakage and high incidence of leukemia in inherited disease, Blood, 37, 96-112, 1971・

• 54) Jackson, E. W., Turner, J. H., Klauber, M. R., Norris, F. D.:Down's syndrome:variation ofleukemia occurrence in institutionized population, J. Chron. Dis., 21, 247-253, 1968.

• 55) Fraumeni, J. F., M iller, R. W.:Cancer dauths in the newborn, Am. J. Dis. Child., 117・186-189, 1969.

• 56) Sasaki, M. S., Tonomura, A.:chrornosomal radiosensitivity in Down's syndrome, Jap. J. Human Genet., 14, 81-92, 1969.

• 57) Sutnick, A. I., London, W. T., Blumberg, B. S., Gerstley, B. J. S.:Susceptibility to leukemia:immunologic factors in Down's syndrome, J. Nat. Cancer Inst., 47, 923-933, 1971.
  pubmed

• 58) Agarwal, S. S., Blumberg, B. S., Gerstly, B. S. S., London, W. T,. Sutnick, A. I., Loeb, L. A.:DNA polymerase actirity as an index of lymphocyte stimulation, studies in Down's syndrome, J. Clin. Invest., 49, 161-169, 170.

• 59) Rosner, F., Lee, S. L.:Down' s syndrome and acute leukemia, myeloblastic or lymphoblastic? Am. J. Med., 53, 203-217, 1972.
  pubmed

• 60) Bloom, G. E., Warner, S., Gerald, P. S., Diamond, L. K.:chromosome abnormalities in constitutional aplastic anemia, New Engl. J. Med., 274, 8-14, 1966.
  pubmed

• 61) Dosik, H., Hsu, L. Y., Todaro, G. J., Lee, S. L., Kirschhorn, K., Selirio, E. S., Alter, A. A:Leukemia in Fanconi's anemia:cytogenetic and tumor virus susceptibility studies. Blood, 36, 341一352, 1970.

• 62) Schuler, D., Kiss, A., Fabian, F.:Chromosomal peculiarities and "in vitro" examinations in Fanconi's anemia, Humangenetik, 7, 314-322, 1969.
  pubmed

• 63) Sawitsky, A., Bloom, D., German, J.:Chromosomal breakage and acute leukemia in congenitul teleangiectatic erythema and stunted growth. Ann. Intern. Med., 65, 487-495, 1966.

• 64) Braun-Falco, O., Marghesu, S.:Bloom-Syndrom, Eine krankheit mit relative hoher Leukamie-Mobiditat, Munchener Med. Wochenschr., 111, 65-69, 1969.

• 65) 中村了正, 古川利温:白血病の1卵性双生児例. 臨床血液, 7, 8, 1966.

• 66) MacMahon, B., Levy, M. A.:Prenatal origin of childhood leukemia, evidence from twins, New Engl. J. Med., 270, 1082-1085, 1964.
  pubmed

• 67) Jackson, E. D., Norris, F. D., Klauber, M. R.:Childhood leukemia in Californiaborn twins, Cancer, 23. 913-919, 1969.

• 68) Tokuhata, G. K., Neely, C. L., Williams, D. L.:Chronic myelocytic leukemia in identical twins and a sibling, Blood, 31, 216-225, 1968.

• 69) Goh, K., Swisher, S. N., Herman, E. C.:Chronic myelocytic leukemia and identical twins, Arch. Intern. Med., 120, 214-219, 1967.
  pubmed

• 70) Bauke, J.:Chronic myelocytic leukemia, chromosome studies of a patient and his non-leukemic identical twin, Cancer, 24, 643-648, 1969.

• 71) Kosenow, W., Pfeiffer, R. A.:Chronischmyeloische Leukamia bei eineiigen Zwillingen, Deutsche Med. Wochenshr., 94, 1170-1176, 1969.

• 72) Keith, L., Brown, E.:Epidemiologic study of leukemia in twins (1928-1969) , Acta Genet. Med. Gemellol., 20, 9-22, 1971.
  pubmed

• 73) Falletta, J. M., Starling. K. A. Leukemia in twins, Pediatrics, 52, 846-849, 1973.
  pubmed

• 74) Levine, P. H., Herberman, R. B., Rosenberg, E. B., McClure, P. D., Roland, A., Pienta, R. J., Ting, R. C. Y.:Acute leukemia in identical twins:search for viral and leukemia-associated antigens, J. Nat. Cancer Inst., 49, 943-952, 1972.

放射線と人白血病

P.44 掲載の参考文献

• 1) von Jagie, N., et al.:Blutbefunde bei rontgenogen. Berl. klin. Wschr. 48, 1220-1222, 1911

• 2) Henshaw, P. S., and J. W. Hawkins:Incidence of leukemia in physicians. J. Nat. Cancer lnst. 4, 339-346, 1944.

• 3) March, H. C.:Leukemia in radiologists. Radiology 43, 275-278, 1944.

• 4) March, H. C.:Leukemia in radiologists in a 20 year period. Am. J. Med. Sci. 220, 282-286, 1950.

• 5) Ulrich, H.:The incidence of leukemia in radiologists. New:Eng. J. Med. 234, 45-46, 1946.
  pubmed

• 6) Dublin, L. I., and M. Spiegelman:The longevity and mortality of American physicians. 1938-194 2:A preliminary report. J. Am. Med. Ass. 134, 1211-1215, 1947.

• 7) Dublin, L. I., and M. Spiegelman:Mortality of medical specialists, 1938-1942. J. Am. Med. Ass. 137, 1519-1524, 1948.

• 8) Peller, S., and P. Pick:Leukemia and other malignant diseases in physicians. J. Am. Med. Ass. 147, 893-89 4, 1951.

• 9) Moloney, W. C.:Induction of leukemia in man by radiation. Radiation Biology and Cancer, Univ. of Texas Press, Austin, 310-321, 1959.

• 10) Court-Brown, W. M., and R. Doll:Expectation of life and mortality from cancer among British radiologists. Brit. med. J. ii, 181-187, 1958.

• 11) Cronkite, E. P., et al.:Radiation leukemogenesis:Amer. J. Med. 28, 673-682, 1960.
  pubmed

• 12) Lewis, E. B.:Leukemia, multiple myeloma, and aplastic anemia in American radiologists. Science 142, 1492-1494, 1963.
  pubmed

• 13) Warren, S.:Longevity and causes of death from irradiation in physicians. J. Am. Med. Ass. 162, 464-468, 1956.

• 14) Schwartz, E. E., and A. C. Upton:Factors influencing the incidence of leukemia; special consideration of the role of ionizing radiation. Blood 13, 845-864, 1958

• 15) 北畠隆・他:エックス線技師の死因および死亡率調査. 日医放会誌, 25, 213-223, 1965.

• 16) 粟冠正利:我が国のエックス線技師の死亡分析. 日医放会誌, 27, 611-613, 1967.

• 17) 北畠隆・他:本邦放射線技師1966〜1972年における死亡分析. 日医放会誌, 34, 440-443, 1974.

• 18) Miller, R. W.:The threshold for somatic radiation effects in man as known at present. ABCC TR O8-59, 1959.

• 19) Seltser, R., and P. E. Sartwell:The influence of occupational exposure to radiation on the mortality of american radiologis is and other medical specialists. Amer. J. Epid. 81, 2-22, 1965.

• 20) 北畠隆:本邦X線従業員の放射線障害の見積り. 日医放会誌, 24, 999-1006, 1964.

• 21) 北畠隆, 岡島俊三:往時における本邦のX線従業員の被曝線量の推定. 日医放会誌, 23, 1151-1158, 1964.

• 22) 後藤五郎:放射線による職業性慢性障害. 南江堂, 京都 1955.

• 23) 宮田久寿・他:放射線取扱者および放射線治療患者における白血病, 東日本. 日本血液学会雑誌, 31, 784-791 1968.

• 24) 脇坂行一, 刈米重夫:放射線取扱者および放射線治療患者における白血病, 西日本. 日本血液学会雑誌, 31, 792-804, 1968.

• 25) 日本造血器腫瘍登録委員会編:全国造血器腫瘍登録調査報告 第1報 (昭和47・48年症例) 1976.

• 26) 大北威:過去30年間の広島における原爆被爆者白血病の概要と現況. 広大原医研年報 17, 77-90, 1976.

• 27) 大北威・他:最近5年間の広島の被爆者白血病について. 長崎医会誌, 51, 171-174, 1976.

• 28) 渡辺漸, 横路謙次郎:原爆後遺症白血病 (特に広島例の病理) . 日本血液学全書. 第3巻, 721-743, 丸善, 東京 1964.

• 29) 朝長正允:原爆後遺症及び白血病 (広島及び長崎例の臨床) 日本血液学全書. 第3巻, 704-720, 丸善 東京 1964

• 30) 朝長正允・他:原爆被爆者の白血病の20年間のまとめ, 附:日本の白血病疫学の-断面. 九州血液研究同好会誌, 17, 375-395, 1967.

• 31) 石丸寅之助・他:広島・長崎のABCC基本サンプル中の原爆被爆者に発生した白血病. 広島医学, 24, 1009-1035, 1971.

• 32) Ichimaru, M. and T. Ishimaru:Leukemia and related disorders. J. Radiat. Res. 16 (Suppl.) , 89-96, 1975.

• 33) 市丸道人, 石丸寅之助・他:原爆被爆者における白血病の発生率. 広島・長崎 1950〜71年, 線量, 被爆後経過年数, 年令および病型別. 放影研業績報告書, 10-76, 1976.

• 34) Storer, J. B. et al.:The relative biological effectiveness of various ionizing radiations in mammalian systems. Rad. Res. 6, 188-288, 1957.

• 35) Vogel, H. H. and R. Zaldivar:Neutron-induced mammary neoplasms in the rat. Cancer Res. 32, 933-938, 1972.

• 36) Rossi, H. H. and A. M. Kellerer:Radiation carcinogenesis at low doses. Science 175, 200-202, 1972.

• 37) Shellabarger, C. J. et al.:Rat mammary carcinogenesis following neutron or X-radiation. In, Biological effects of neutron irradiation. pp. 391-401, International Atomic Energy Agency, Vienna, 1974
  pubmed

• 38) Mole, R. H.:Ionizing radiation as a carcinogen:Practical questions and academic pursuits. Brit. J. Radiol. 48, 157-169, l975.

• 39) Rossi, H. H. and C. W. Mays:Leukemia risk from neutrons. Health Phys. 34, 353-360, 1978.

• 40) Rossi, H. H. and A. M. Kellerer:The validity of risk estimates of leukemia incidence based on Japanese data. Rad. Res., 58, 131-140, 1974.

• 41) Court-Brown, W. M., and R. Doll:Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Brit. med. J. ii, 1327-1332, 1965.

• 42) Hempelmann, L. H.:Epidemiological studies of leukemia in persons exposed to ionizing radiation. Cancer Res. 20, 18-27, 1960.
  pubmed

• 43) Pifer, J. W., et al.:Neoplasms in children treated with X-rays for thymic enlargement. I. Neoplasms and mortality. J. Nat. Cancer Inst. 31, 1333-1356, 1963.
  pubmed

• 44) Toyooka, E. T. et al.:Neoplasms in children treated with X-rays for thymic enlargement. II. Tumor incidence as a function of radiation factors. J. Nat. Cancer Inst. 31, 1357-1377, 1963.
  pubmed

• 45) Toyooka, E. T., et al:Neoplasms in children treated with X-rays for thymic enlargement. III. Clinical description of cases. J. Nat. Cancer lnst. 31, 1379-1405, 1963.

• 46) Lewis, T. L. T.:Leukemia in childhood after antenatal exposure to x-rays. Brit. med. J. ii, 1551-1555, 1960.

• 47) Wells, J., and C. M. Steer:Relationship of leukemia in children to abdominal irradiation of mother during pregnancy. Am. J. Obstet. Gynec. 81, 1059-1063, 1961.

• 48) Court-Brown, W. M., et al.:Incidence of leukemia after exposure to diagnostic radiation inute ro. Br. med. J. ii, 1539-1545, 1960.

• 49) Diamond, E. L., et al.:The relationship of intrauterine radiation to subsequent mortality and deve-lopment of leukemia in children. Am. J. Epidemiol. 97, 283-313, 1973.

• 50) Stewart, A., et al:A survey of childhocd malignancies. Brit. med. J. i, 1495-1508, 1958.

• 51) Ford, D. D., et al.:Fetal exposure to diagnostic X-rays and leukemia and other malignant diseases in childhood. J. Nat. Cancer Inst. 22, 1093-11041959.
  pubmed

• 52) Kaplan, S.:An evaluation of the somatic and genetic hazards of the medical uses of radiation. Am. J. Roentgenol. 80, 696-706, 1958.

• 53) Graham, H. S., et al.:Preconception, intrauterine and postnatal irradiation as related to leukemia Nat. Cancer Inst. Monogr. 19, 347-371, 1966.

• 54) MacMahon, B.:Prenatal x-ray exposure and childhood cancer. J. Nat. Cancer Inst. 28, 1173-541191, 1962.

• 55) Polhemus, D. W., and R. Koch:Leukemia and medical radiation. Pediatrics 23, 453-461, 1959.

• 56) Murray, R., et al.:Leukemia in children exposed to ionizing radiation. New Eng. J. Med. 261, 585-589, 1959.
  pubmed

• 57) Stewart, A.:The carcinogenic effects of low level radiation. A re-appraisal of epidemiologists met-hods and observations. Health Physics 24, 223-240, 1973.

• 58) Smith, P. G., and R. Doll:Late effects of X irradiation in patients treated for metropathia haemorrhagica, Br. J. Radiol. 49, 224-232, 1976.

• 59) Brinkley, D., and J. L. Haybittle:The late effects of artificial menopause by X-radiation, Br. J. Radilol. 42, 519-521, 1969.

• 60) Alderson, M. R., and S. M. Jackson:Long term follow-up of patients with menorrhagia treated by irradiation. Br. J. Radiol. 44, 295-298, 1971.

• 61) Wagoner, J. K.:Leukemia and other malignancies following radiation therapy for gynecological disease. cited from Smith and Doll, and UNSCEAR 1972.

• 62) Hutchison, G. B.:Leukemia in patients with cancer of the cervix uteri treated with radiation. A report covering the first 5 years of an international study. J. Nat. Cancer Inst・40, 951-982, 1968・

• 63) 北畠隆:医用放射線による白血病発生の統計的研究. 日医放会誌, 26, 882-890, 1966.

• 64) 北畠隆:医用放射線と悪性リンパ腫発生に関する既往調査. 日医放会誌, 26, 891-893, 1966.

• 65) Pochin, E. E.:Long-term hazards of radioiodine treatment of thyroid carcinoma, pp. 293-304, in Thyroid Cancer, UICC Monograph Series, Vol. 12, C. Hedinger, ed., Springer-Verlag, Berlin, 1969.

• 66) Wald, N., et al.:Hematologic manifestations of radiation exposure in man. Progress in Hematology 3, 1-52, 1962.

• 67) 森武三郎:トロトラスト晩発障害の疫学的および病理学的研究. 放射線科学, 20, 82-86, 1977.

• 68) Doll, R.:Cancer following therapeutic external irradiation. Paper presented to the 10th International Cancer Congress in Houston, 1970.

• 69) Gibson, R. et al.:Irradiation in the epidemiology of leukemia among adults. J. Nat Cancer lnst. 48, 301-311, 1972.

• 70) Stewart A. et al.:Adult leukemias and diagnostic X rays. Brit. med. J. ii, 882-890, 1962.

• 71) Lewis, E. B.:Leukemia and ionizing radiation. Science 125, 965-972, 1957.
  pubmed

• 72) Brues, A. M.:Critique of the linear theory of carcinogenesis, Science 128, 693-699, 1958・

• 73) Kimball, A. W.:Evaluation of data relating human leukemia and ionizing radiation. J. Nat. Cancer Inst. 21, 383-391, 1958.
  pubmed

• 74) Ishimaru, T., et aL:Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950-30 September 1966, Rad. Res. 45, 216-233, 1971.

• 75) Court-Brown, W. M., and R. Doll:Radiation and leukemia. Lancet i, 162-163, 1958.

白血病とウイルス

P.61 掲載の参考文献

• 1) Virchow, R.:Weisses Blut. Froriep' s Natizen. 36, 151, 1945.

• 2) Gross, L.:Pathogenic properties and"vertical"transmission of the mouse leukemia agent. Proc. Soc. Exp. Biol. Med. 78, 342-348, 1951.
  pubmed

• 3) Ellermann, V. & Bang, O.:Experimentele Leukamie bei Huhnern. Zentralbl. Bakteriol Abt. I. Corig 46, 595, 1908.

• 4) 木村禧代二:Viruses&Cancer. Report of a WHO scientific group. No. 295, 1965.

• 5) Bernhard, W.:The detection and study of tumor viruses with the electron microscope. Cancer Res. 20, 712-727, 1960.
  pubmed

• 6) Suggestions for the classification of oncogenic RNA viruses. J. Natl. Cancer lnst. 37, 395・ 1966・

• 7) Rous, P.:Asarcoma of a fowl transmissible by an agent separable from the tumor cells. J. Exp. Med. 13, 397-411, 1911.

• 8) Zilber, L. A.:Some data on the interaction of Rous sarcoma virus with mammalian cells. Natl. Cancer. Inst. Monogr. No. 17, 261-275, 1964.

• 9) Rubin, H.:A virus in chick embryo which induced resistance in vitro to infection with Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 46, 1105-1119, 1960.

• 10) DeThe, G.:Localization and origin of the ATPase activity of avian myeloblastosis virus. A review. Natl. Cancer lnst. Monogr. No. 17, 651-671, 1964.

• 11) Kaplan, H. S. & Yaffe, D.:Accelerated development of strain AK/N mouse lymphoma by cell-free tissue and tumor extracts. Proc. Am. Assoc. Cancer Res. 3, 332, 1960.

• 12) Schoolman, H. M., Spurrier, W., Schwartz, S. O. & Szanto, P. B.:Studies in leukemia. VII. The induction of leukemia in Swiss mice by means of cell-free filtrates of leukemic mouse brain. Blood 12, 694-700, 1957.
  pubmed

• 13) 市川康夫:白血病ウイルス研究の現状. 医学のあゆみ 53, 191, 1965.

• 14) 螺良義彦:白血病ウイルス. 宮川他編:実験腫瘍学, p. 428, 朝倉書店, 東京, 1966.

• 15) 平木 潔:ウイルス性白血病の病型変異について. 癌の臨床, 8, 212, 1962.

• 16) 粟野亥佐武:癌ならびに白血病細胞の染色体とウイルス. 癌の臨床, 8, 191-224, 1962.

• 17) Rich, M. A. & Spiegler, R.:Virus leukemia in the mouse. Ann. Rev. Microbiol. 21, 529, 1967.

• 18) Moloney, J. B.:Biologlcal studies on a lymphoid leukemia virus extracted from sarcoma 37. J. Natl. Cancer Inst. 24, 933-951, 1960.

• 19) Graffi, A. et al.:Gehanftes Auftreten von Leukamien nach Injection von Sarkom-Filtration. Wien. Med. Wochenschr. 105, 61-64, 1955.
  pubmed

• 20) Friend, C.:Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J. Exp. Med. 105, 307, 1957.
  pubmed

• 21) 大星章一:癌とウィルス-フレンド白血病ウイルスを中心として. 治療 49, 503-511, 1967.

• 22) Rauscher, F. J.:A virus-induced disease of mice characterized by erythrocrytopoiesis and lymphoid leukemia. J. Natl. Cancer Inst. 29, 515-543, 1962.
  pubmed

• 23) Kuroki, T., Goto, M. & Sato, H.:Malignant transformation of hamster embryonic cells by 4-hydr-oxyaminoquinoline N-oxide in tissue cultare. Tohoku. J. Exp. Med. 91, 109-118, 1967.

• 24) Vogt, M. & Dulbeco, R.:Studies on cells rendered neoplastic by polyoma virus:The problem of the presence of virus related materials. Virology 16, 41-51, 1962.

• 25) 花房秀三郎:腫瘍を作る"かたわ"のウイルス. 科学 33, 569-574, 1963.

• 26) Hartby, J. W. & Rowe, W. P.:Production of altered cell foci in tissue culture by defective Moloney sarcoma virus. Proc. Natl. Acad. Sci. USA 55, 780-786, 1966.

• 27) 伊藤洋平:癌ウイルスの諸問題. 川喜田編, ウイルスの生物学 p. 203, 岩波書店, 東京, 1965.

• 28) Sjogren, H. O.:Transplantation methods as a tool for detection of tumor-specific antigens. Prog. Exp. Tumor Res. 6, 289, Karger Based, New York, 1965.

• 29) Black, P. H. et al.:A specific complement fixing antigen in SV40 tumor and transformed cells. Proc. Natl. Acad. Sci. USA 50, 1148-1156, 1963.
  pubmed

• 30) Pope, J. H. & Rowe, W. P.:Detection of specific antigen in SV40 transformed cells by immunofluorescence. J. Exp. Med. 120, 121-128, 1964.
  pubmed

• 31) Gerber, P.:Virogenic hamster tumor cells. Induction of virus synthesis. Science 145, 833, 1964.
  pubmed

• 32) Hanabusa, H. et al.:The defectiveness of Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 49, 572-580, 1963.

• 33) 山本 正:ウィルス癌に対する一考察. 医学のあゆみ53, 139-146, 1965.

• 34) Macpherson, I.:Malignant transformation and reversion in virus-infected cells. Recent Results . Cancer Res. VI, 1-8, 1966.

• 35) Sarma, P. S. et al.:Complement fixation test for the detection and assay of avian leukosis viruses. Natl. Cancer Inst. Monogr. No, 17, 481-494, 1964.

• 36) 武田勝男・他:発癌個体における自家免疫第一編, ML 発癌ラットの抗移植性. 最新医学, 20, 2526-2535, 1965.

• 37) Habei, K.:Immunological aspects of oncogenesis by polyoma virus. Conceptual Advances in Immunology and Oncology. p. 486, New York, 1963.

• 38) Old, L. J. & Boyse, E. A.:Antigens of tumors and leukemia induced by viruses. Fed. Proc. 24, 1009-1017, 1965.
  pubmed

• 39) 大星章一・他:Friend Virus 腫瘍に於ける移植抗原. 医学のあゆみ, 61, 424-431, 1966.

• 40) Sjogren, H. O. & Jonsson, N.:Resistance against isotranplantation of mouse tumors induced by Roussarcoma virus. Exp. Cell Res. 32, 618-621, 1963.

• 41) Henning, N.:Beobachtungen zur Pathogenese der akuten Myeloblastenleukamie. Dtsch. Arch. Klin. Med. 178, 538, 1936.

• 42) 坂本 陽:実験的白血病. 日小会誌 49, 736, 1943.

• 43) 坂本 陽:実験的細網肉腫. 血液学討議会報告第2輯 p. 45, 永井書店, 大阪, 1949.

• 44) Schwartz, O. S.:Induction of mouse leukemia by cell free filtrate of leukemia mouse and leukemic human brain. Proc. Internal. Soc. Hematol., Grune & Stratton, pp. 70, New York 1958.

• 45) Dmochowski, L.:Electronmicroscopy of human leukemia. 9th Annual Clinical Conference 1964.

• 46) Beard, J. W.:Oncogenic virus. p. 882, 2nd ed. Luduik Gross, Pergamon Press, Oxford, London 1970.

• 47) Braunsteiner, H.:On the occurrence of virus like bodies in human leukemia. Blood 15, 476-479, 1963.

• 48) Almeida, J. D.:Virus-like particles in blood of two acute leukemia patients. Science 142, 1487-1489, 1963.
  pubmed

• 49) Porter, G. H.:Association of electron-dense particles with human leukemia. J. Natl. Cancer Inst. 33, 547-556, 1964,
  pubmed

• 50) Dalton, A. J.:Studies on murine and human leukemia. Trans. Assoc. Am. Physicians. 77, 52-63, 1964.
  pubmed

• 51) Dmochowski, L. & Levy, B. M.:Viruses and their relationship to animal and human tumors. Tex. Rep. Biol. Med. 23, 539-561, 1965.

• 52) Burger, C. L.:Virus-like particles in human leukemic plasma. Proc. Soc. Exp. Biol. Med. 115, 151-156, 1964.
  pubmed

• 53) Smith, K. O.:Studies on human leukemia. II. Stucture and quantitation of myxovirus-like particles associated with human leukemia. J. Natl. Caner lnst. 33, 557-570, 1964.

• 54) Rauscher, F. J.:Survey of viral oncology with particular reference to lymphoma. Cancer Res. 22, (part 1) , 1176-1184, 1966.

• 55) Fink. M. A.:Application of immunofluorescence to the study of human leukemia. J. Natl. Cancer Inst. 33, 581-588, 1964.

• 56) Dmochowski, L.:Electron microscope studies of leukemia in animals and man. First International Symposium on Tumour Viruses. Nagoya, Japan, 1966"Nissha"Printing Co., (Y. Itoed.) Kyoto, p. 362-407, 1967.

• 57) Iwakata, S. &Grace, J. T.:Cultivation in vitro of myeloblasts from human leukemia. N. Y. State J. Med. 2279-2282, 1964.

• 58) Foley, G. E.:Continuous culture of human lymphoblasts from peripheral blood of a child with acute lekuemia. Cancer l8, 522-529, 1965.

• 59) Zeve, V. H.:Continuous cell culture from a patient with chronic myelogenous leukemia. II. Detection of herpes-like virus by electron microscopy. J. Natl. Cancer lnst. 37, 761-774, 1966.

• 60) Moore, G. E.:Leukocyte cultures of patients with leukemia and lymphomas. N. Y. State J. Med. 2757-2764, 1966.
  pubmed

• 61) Moore, G. E.:Culture of normal human leukocytes. JAMA 199, 519-524, 1967.
  pubmed

• 62) Osato, T. &Ito, Y.:Morphological alteration of human embryo celles in vitro by treatment with human leukemic culture fluid. Proc. Natl. Acad. Sci. USA 57, , 1076, 1967.

• 63) Kimura, I.:Transformation in vitro of human embryo cells by human leukemic culture fluid. II. Proc. Jap. Acad. 44, 95, 1968.

• 64) Kawamura, A. et al.:Seroepidemiological studies on nasopharyngeal carcinoma by fluorescent anti-body techniques with cultured Burkitt lymphoma cell Gann 61, 55, 1970.

• 65) Baltimor, D.:RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226, 1209, 1970.

• 66) Temin, H. M. & Mizutani, S.:RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226, 1211, 1970.
  pubmed

• 67) Gallo, R. C., Yang, S. S. & Ting, R. C.:RNA dependent DNA polymerase of human acute leukemia cells. Nature 228, 927, 1970.
  pubmed

• 68) Gallo, R. C.:Reverse transcriptase and neoplasia. Biomedicine 18, 446-452, 1973.
  pubmed

• 69) Gallo, R. C., Sarin, P. S., Sarngadhardn, M. G., Reit, M. S., Smith, R. G. &Bobrord, S. N.:Inmolecular studies in viral neoplasia, 25th Annual Symposium Fund Cancer Research at M. D. And-erson Hospital and Tumor Institute, Houston Texas. P. 477-494, Williams and Watikins Press, 19. 74.

• 70) Health, G. W. & Hasterlik, R. J.:Leukemia among children in suburban community. Am. J. Med. 24, 796, 1963.

• 71) Schwartz, O. S.:Leukemia cluster in Niles. III. JAMA 186, 106, 1963.

• 72) Dowsett, E. G.:Leukemia in Kingston, survey, 1958-1968:An epideminological study. Bt. J. Cancer 10, 16, 1966.

• 73) Yamada, K., Ota, K. & Mokuno, J.:Studies on epidemiology of leukemia in Tokai district in Japan statistical approaches to leukemia cluster. Acta Haem. Jap. 31, 756-764, 1968.

• 74) 平山 雄:白血病の疫学的研究-特に時期, 地域集積性とその意義について. 日血会誌, 31, 737-747, 1968.

• 75) 小林 博, 上村孝二, 小玉孝郎:わが国の白血病集中発生. 医学のあゆみ, 63, 130-131, 1957.

• 76) Aleksandrowicz, J.:Etiology of leukemia. Lancet ii, 438, 1966.

• 77) The lymphoreticular tumors in Africa:Symposium international union against cancer. Karger, Paris, 1964.

• 78) Burkitt, D.:A sarcoma involving the jaw in African children. Br. J. Surg. 46, 218-223, 1958.
  pubmed

• 79) Burkitt, D. & O'conor, G. T.:Malignant lymphoma in African children. I. A clinical syndrom. Cancer 14, 258-269, 1961.

• 80) Burkitt, D. &Wright, D. H.:Burkitt's lymphoma, E. & Livingstone. Edinbargh & London 1970.

• 81) O'conor, G. T.:Malignant lymphoma in African children. II. A pathological entity. Cancer l4. 270-283, 1961.

• 82) O'conor, G. T.:Significant aspects of childhood lymphoma in Africa. Cancer Res. 23, 1514-1517, 1963.
  pubmed

• 83) Oboshi, S., Ise, T. & Hanawa, Y.:A childhood lymphoma of jaw resembling Burkitt tumor:The first case in Japan. Gann 60, 347-349, 1969.
  pubmed

• 84) Epstein, M. A.:Lymphoblastic lylnphoma in bone-marrow of African green monkeys (Cercopithecusaethiops) inoculated with biopsy material from a child with Burkitt's lymphoma. Lancet ii, 288-290, 1964.

• 85) Epstein, M. A. et a1.:Virus particles in cultured lymphoblast from Burkitt's lymphoma. Lancet ii, 702-703, 1964.

• 86) Epstein, M. A. et al.:A second virus-carrying tissue culture strain (EB2) of lymphoblasts from Burkitt's lymphoma. Pathol. Biol. (paris) 12, 1233-1234, 1964.

• 87) Epstein, M. A. et al.:Studies with Burkitt's lymphoma. Methodological approaches to the study ofleukemias. Wistar Institute Symposium Monograph. No. 4, 69-82, 1966.

• 88) Stewart, S. E.:Burkitt tumor:Tissue culture, cytogenetic and virus studies. J. Natl. Cancer lnst. 34, 319-327, 1965.

• 89) Epstein, M. A.:Morphological and virological investigation on cultured Burkitt tumor lymphoblast (Strain Ra. ii) . J. Natl. Cancer lnst. 37, 547-559, 1966.

• 90) O'conor, G. T. & Rabson, A. S.:Herpes-like virus particles in an American lymphoma. Preliminary note. J. Aiatl. Cancer Inst. 35, 899-903, 1965.

• 91) 平木 潔:白血病の成因-とくにウイルスの関与について. 日血会誌, 36, 427-440, 1973.

• 92) Gallo, R. C. & Gallagher, R. E.:Are viruses concerned in the etiology of human leukemia?. Ser. Haematol. 7, 224-273, 1974.
  pubmed

白血病の細胞回転

P.76 掲載の参考文献

• 1) 木村禧代二, 今村一夫:単細胞オートラジオグラフィー. 日血全書, 6-II, 483-515, 1965.

• 2) Tayler, T. H., Woods, P. S., and Hughes, W. L.:The organization and duplication of chromosomes as revealed by autoradiographic studies using tritium labeled thymidine. Proc. Nat. Acad. Sci. 43, 122-128, 1957.

• 3) Hughus, W. L, Bond, V. P., Cronkite, E. P., Brecher, G., Paintar, R. B., Quesler, H. and Sherman, F. G.:Cellular proliferation in the mouse as revealed by autoradiograpy with tritiated thymidine. Proc. Not. Acad. Sci. 44, 476-483, 1958.

• 4) Rubini, J. R., Cronkite. E. P. Bond, V. P., and Fliedner, T. M.:The metabolism and fate of tritiated thymidine in man. J. Lab. Invest. 39, 909-918, 1960.

• 5) 小川一誠:3H-thymidine autoradiograpy法による急性白血病細胞の増殖に関する研究. 名古屋医学, 90, 91-105, 1967

• 6) Clarkson. B., Ohkita, T., Ota, K. and Fried, J.:Studies of cellular proliferation in bumau leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. J. Clin. Invest. 45, 506-529, 1967

• 7) 太田和雄:3H-サイミジンの血液学への応用. 日血会誌, 27, 693-704, 1964

• 8) Killman S. A.:Acute leukemia:The kinetics of leukemic blast cells in man, An analytical review. Ser. Haemat., 1 (3) , 38-102. 1968

• 9) Ohkita. T:Estimation of the size of non proliberating fraction of precursor cells in bone marrow of acute myelogenous leukemia. In Recent Advances in Acute Leukemia, ed. K. Yamada. PP. 93-97, 1966.

• 10) Clarkson B. D., Fried, J. and Ogawa. M.:Magnitude of proliferating fraction and rate of proliferation of populations of leukemic cells in man. in RRCR 17. Normal and Malignant Cells. ed. R. J. M. Fry et al, 75-185, Springer-Verlag, 1969.

• 11) Ogawa. M., Fried. J., Sakai. Y., Strife. A. and Clarkson B. D.:Studies of cellular proliferation in human leukemia IV. The proliferatire activity, generation time and emergence time of neutrophilic granulacytes in chronic granulocytic leukemia. Cancer 25, 1031-1049, 1970.

• 12) 村上厳:3H-thymidine autoradiograpy法による人白血球の回転に関する研究, (I) 好中球に関して. 日血会誌, 31, 270-287, 1968.

• 13) 小川一誠:細胞回転と癌化学療法. 癌と化学療法, 3, 23-30, 1976.

• 14) Clarkson, B. D., Todo, A., Ogawa, M., Gee, T and Fried, J.:Consideration of the cell cycle in chemotherapy of acute leukemia, in RRCR 36. Current concepts in the management of leukemia and lymphoma, ed. J. E. Ultman et al, P. 88-118, Springer-Verlag, 1971.

• 15) Stryckmans, P., Cronkite, E. P., Fache, J., Fliedner, T. M. and Ramos, J.:Deoxyribonucleic acid synthesis time of erythropoietic and granulopoietic cells in human beings. Nature 50, 717-718. 1966.

• 16) 村上厳, 小川一誠, 天羽弘行, 太田和雄:3H-thymidine autoradiograph法による人白血球の回転に関する研究, (III) -リンパ球, 形質細胞, 単球に関して-. 日血会誌, 32, 391-396, 1969.

• 17) 村上厳, 小川一誠, 天羽弘行, 太田和雄:3H-thymidine autoradiograpy法による人白血病の回転に関する研究, (II) -好酸球, 好塩基球に関して-. 日血会誌, 32, 384-390, 1969.

• 18) 小川一誠, 太田和雄:細胞回転の立場より見た白血病化学療法. 日本合同癌会議シンポジウム記録, 11-16, 1971.

• 19) 太田和雄:癌化学療法と癌細胞回転. 第17回日本医学会総会学術講演集 II, 1046-1050, 1967.

• 20) Todo, A.:Proliferation and differentiation of hematopoistic cells in hematologic disorders:Report III In vivo radioautographic study of leukemia including erythroleukemia. Act Haem. Jap. 31, 947-966. 1968.

• 21) Wagner, H. P., Cottier, H., and Cronkite. E. P.:Variability of proliferative patterns in acute lymphoid leukemia of children. Blood 39, 176-186. 1972.
  pubmed

• 22) Saunders, E. F., Lampkin, B. C., and Mauer, A. M.:Variation of proliferative activity in leukemic cell population of patients with acute leukemia. J. Clin. Invest 46, 1356-1363, 1967.
  pubmed

• 23) Clarkson, B. D., Sakai, Y., Kimura, T., Ohkita, T., and Fried, J.:Studies of cellular proliferation in human leukemia II. Variability in rates of growth and cellular differentiation in acute myelomonocytic leukemia and effects of treatment. In the Proliferation and spread of Neoplastic Cells, P. 295, Baltimore, Williams and Willkins 1968.

• 24) 御供泰治, 西田敬子, 太田和雄:細胞沈降分離装置およびその応用. 医学のあゆみ, 90, 439-440, 1974

• 25) 御供泰治, 高本滋, 太田和雄, 小川一誠, 亀井良孝, 後藤達彦:細胞沈降分離法を用いた白血病細胞回転に関する研究 (第一報) -AMLのAra-C治療中に於ける細胞回転-. 癌と化学療法, 3, 157-162, 1976.

• 26) 高本滋, 御供泰治, 太田和雄, 小川一誠, 亀井良孝, 尾山淳:細胞沈降分離法を用いた白血病細胞回転に関する研究 (第2報) -AMLのNCS単独およびAra-C併用治療中における細胞回転-. 癌と化学療法, 3, 119-126, 1976.

• 27) Skipper, H. E., Schabe, F. M., Mellett, L B., Montgomery, J. A., Willkaff, L. J. Lloyd, H. H. and Brockman, R. W., :Implications of biochemical, cytokinetic, pharmacologic and toxicologic relationship in the design of optimal therapeutic schedule. Cancer. Chemoth. Rep. 54, 431-450, 1970.

• 28) 下山正徳:抗白血病剤のcell-kill-kineticsの立場から抗白血病剤の投与はいかにあるべきか. 日血会志, 3, 33-40, 1976.

• 29) 下山正徳:制癌剤のcell-kill-kinaticsと至適投与法. 癌と化学療法, 3, 33-40, 1976.

• 30) Fried, J., Arlin, Z., Alikpala, A., Tan, T. C, and Clarkson, B. D.:Kinetic response of human leukemic and lymphoma cells in vitro to combination chemotherapy using flow microfluometry. Cancer Treat. Rept. 60, 1937-1946, 1976.

• 31) 太田和雄, 高本滋, 御供泰治:DNA瞬間自動測定装置. 癌と化学療法, 4, 179-185, 1977.
  Medical*Online

• 32) Saunders, E. F. and Mauer, A. M.:Reentry of non dividing leukemic cells into a proliferative phase in acute childhood leukemia. J. Clin. 1nvest, 48, 1299-1305, 1969.

• 33) Lamphin, B. C, Nagao, T. and Mauer, A. M.:Synchronization and recruitment in acute leukemia. J. Clin. Invest. 50, 2204-2214. 1971.

• 34) 吉川治哉, 竹山英夫, 永田紘一郎, 上田竜三, 石黒順造, 西脇洋, 神谷忠, 大野竜三, 今井邦之, 山田一正, 植谷忠昭:急性白血病細胞のDNA合成誘起に関する検討とその治療計画への応用. 臨床血液 16, 8-18, 1975.

• 35) 大野竜三, 山田一正:成人急性白血病の治療. 癌と化学療法, 2, 33-39, 1975.

白血病細胞の生化学的特性

P.96 掲載の参考文献

• 1) in "Recent Adv. in Haematology", edt. Hoffbrand, A. V., Brain, M. C. and Hirsh, J. No. 2. Churchill Livingstone, Edinburgh, 1977.

• 2) Nicolson, G. L.:Transmembrane control of the receptors on normal and tumor cells, I. Cytoplasmic influence over cell surface components. Biochim. Biophys. Acta, 457, 57-108, 1976.
  pubmed

• 3) Nicolson, G. L:Transmembrane control of the receptors on normal and tumor cells, II. Surface malignancy, Biochim. Biophys. Acta, 458, 1-72, 1976.
  pubmed

• 4) in"Cellular Membranes and Tumor Cell Behavior"Williams and Wilkins Co., Baltimore, 1975.

• 5) 井上正康, 山中直樹, 内海耕慥:癌細胞と細胞膜. 癌と化学療法, 3, 589-603, 1976.
  Medical*Online

• 6) 山中直樹, 加藤武俊, 太田和雄:細胞膜修飾による癌化学療法の効果増強. 癌と化学療法, 4 (Supplement) , 69-82, 1977.

• 7) 山中直樹, 小泉斤也, 太田和雄:細胞膜修飾と癌治療. 癌と化学療法, 5, 270-305, 1978.

• 8) Yamada, K. M., Yamada, S. S. and Pasten, I.:Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts. Proc. Natl. Acad. Sci., U. S. A., 73, 1217-1221, 1976.

• 9) Whittenberger, B. and Glaser, L.:Inhibition of DNA synthesis in cultures of 3T3 cells by isolated surface membranes. Proc. Natl. Acad. Sci., 74, 2251-2255, 1977.
  pubmed

• 10) Branton, D. and Deamer, D. W.:Membrane Structure, Protoplasmatologia, Springer-Verlag, Wien, New York, 1972.

• 11) Branton D.:Fracture faces of frozen membranes. Proc. Natl. Acad. Sci. U. S. A., 55, 1048-1056, 1966.
  pubmed

• 12) Deamer, D. W.:Fracture planes in an ice-bilayer model membrane system, Science, 158, 655--657, 1967.

• 13) Pinto Da Silva, P. G. and Branton, D.:Membrane splitting in freeze-etching, J. Cell Biol., 45, 598-605, 1970.

• 14) Deamer, D. W. and Yamanaka, N.:Freeze-etch images of sarcoplasmic reticulum and submitochondrial membranes, in "Biomembranes-architecture, biogenesis, bioenergetics and differentiation" edt. by Packer, L., Acad. Press, New York, 1974.

• 15) Yamanaka, N. and Deamer, D. W.:Protease digestion of membranes-ultrastructural and biochemical effects, Biochim. Biochys. Acta, 426, 132-147, 1976.
  pubmed

• 16) Packer, L., Mehard, C. W., Meissner, G., Zahler, W. L. and Fleischer, S.:The structural role of lipids in mitochondrial and sarcoplasmic reticulum membranes. Freeze-fracture electron microscopy studies. Biochim. Biophys. Acta, 363, 159-181, 1974.
  pubmed

• 17) Bretscher M. S.:Asymmetrical lipid bilayer structure for biological membranes, Nature New Biol., 236, 11-12, 1972.
  pubmed

• 18) Verkleij, A. J., Zwaal, R. F. A., Roelofsen, B., Comfurius, P., Kastelijn. in, D. and Van Deenen, L. L. M.:The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using Phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta, 323, 178-193, 1973.

• 19) Fisher, K. A.:Analysis of membrane halves:Cholesterol. Proc. Natl. Acad. Sci. U. S. A., 73, 173-177, 1976.
  pubmed

• 20) Demel, R. A., Jansen, J. W. C. M. ., Van Dijck, P. W. M. and Van Deener, L. L M., The preferential interaction if cholesterol with different classes of phospholipids. Biochim. Biophys. Acta, 465, 1-10, 1977.

• 21) Singer, S. J. and Nicolson, G. L.:The fluid mosaic model of the structure of cell membranes, Science 175, 720-731, 1972.
  pubmed

• 22) Hirano, H., Parkhouse, B., Nicolson, G. L., Lennox E. S. and Singer, S. J.:Distribution of saccharide residues on membrane fragments from a myeloma-cell homogenate:Its implications for membrane biogenesis. Proc. Natl. Acad. Sci. U. S. A, 69. 2945-2949, 1972,
  pubmed

• 23) Israelachvili, J. N.:Refinement of the fluid-mosaic model of membrane structure. Biochim. Biophys. Acta, 469, 221-225, 1977.
  pubmed

• 24) 箱守仙一郎:ガン細胞膜の糖質異常性と脱組織化. 蛋白質, 核酸, 酵素, 15, 397-402, 1970.

• 25) Hakomori, S., Gahmberg, C. G., Laine, R. A. and Yogeeswaran, G.:Organization and modification of membrane glycolipids and glycoproteins. in"Cellular Membranes and Tumor Cell Behavior"pp. 289-308, Williams and Wilkins Co., Baltimore, 1975.

• 26) Rapin, A. M. C. and Burger, M. M.:Tumor cell surfaces:General alterations detected by agglutinins, Adv. Cancer Res., 20, 1-91, 1974.

• 27) McCulloch, E. A. and Till, J. E.:Stem cells in normal early・haemopoiesis and certain clonal haemopathies, in"Recent Adv. Haematology"edt. by Hoffbrand, A. V., Brain, M. C. and Hirsh, J., No. 2. pp. 85-110, Churchill Livingstone, Edinburgh, 1977・

• 28) Wu, A. M. and Gallo, R. C.:Biochemical basis of leukaemia and lymphoma in man, in "Recent Adv. Haematology"edt. by Hoffbrand, A. V., Brain, M. C. and Hirsh, J., No. 2, pp. 289-324, Churchill Livingstone, Edinburgh, 1977.

• 29) Edelman, G. M., Yahara, I. and Wang, J. L.:Receptor mobility and receptor-cytoplasmic interactions in lymphocytes, Proc. Natl. Acad. Sci., U. S. A., 70, 1442-1446, 1973.

• 30) Schekman, R. and Singer, S. J.:Clustering and endocytosis of membrane receptors can be induced in mature erythrocytes of neonatal but adult humans, Proc. Natl. Acad. Sci. U. S. A, 73, 4075-4079, 1976.
  pubmed

• 31) Ben-Bassat, H., Polliak, A., Rosenbaum, S. M., Naparstek, E., Shouval, D. and Inbar, M.:Fluidity of membrane lipids and lateral mobility of concanavalin A receptors in the cell surface of normal lymphocytes and lymphocytes from patients with malignant lymphomas and leukemias, Cancer Res., 37, 1307-1312, 1977.
  pubmed

• 32) Zagyansky, Y., Benda, P. and Bisconte, J. C.:Restricted lateral diffusion of concanavalin Areceptors of different malignant cells of nervous system, FEBS Letters, 77, 206-208, 1977.

• 33) Kehry, M., Yguerabide, J. and Singer, S. J.:Fluidity in the membranes of adult and neonatalhuman erythrocytes, Science, 195, 486-487, 1977.
  pubmed

• 34) Hubbell, W. L. and McConnell, H. M.:Molecular motion in spin labeled phospholipids and membranes, J. Am. Chem. Soc., 93, 314-326, 1975.

• 35) Kury, P. G. and McConnell, H. M.:Regulation of membrane flexibility in human erythrocytes, Biochemistry, 14, 2798-2803, 1975.

• 36) Shinitzky, M., Dianoux, A. C., Gitler, C. and Weber, G.:Microviscosity and order in the hydrocarbon region of micelles and membranes determined with fluorescent probes. I. Synthetic micelles, Biochemistry, 10, 2106-2113, 1971.
  pubmed

• 37) Shinitzky, M. and Barenholz, Y.:Dynamics of the hydrocarbon layer in liposomes of lecithin andsphingomyelin containing dicetyl phosphate, J. Biol. Chem., 249, 2642-2657, 1974.

• 38) Inbar, M., Shinitzky, M. and Sachs, L.:Microviscosity in the surface membrane lipid layer ofintact normal lymphocytes and leukemic cells, FEBS Letters, 38, 268-270, 1974.

• 39) Barnett, R. E., Scott, R. E., Furcht, L. T. and Kersey, J. H.:Evidence that mitogenic lectins induce changes in lymphocyte membrane fluidity, Nature New Biol., 249, 465-466, 1974.

• 40) Inbar, M. and Shinitzky, M.:Decrease in microviscosity of lymphocyte surface membrane associated with stimulation induced by concanavalin A, Eur. J. Immunol., 5, 166-170, 1975.
  pubmed

• 41) Toyoshima, S. and Osawa, T.:Lectins from Wistaria fioribunda seeds and their effect of membrane fluidity of human peripheral lymphocytes, , J. Biol. Chem., 250, 1655-1660, 1975.
  pubmed

• 42) Collard, J. G., De Wildt, A., Oomen-Meulemans, E. P. M., Seekens, J. and Emmelot, P.:Increase in Huidity of membrane lipids in lymphocytes, fibroblasts and liver cells stimulated for growth, FEBS Letters, 77, 173-178, 1977.

• 43) Inbar, M, Yuli, I. and Raz, A:Contact-mediated changes in the fluidity of membrane lipids innormal and malignant transformed mammalian fibroblasts, Exp・Cell. Res., 105, 325-335, 1977.

• 44) Shinitzky, M. and Inbar, M.:Difference in microviscosity induced by different cholesterol levelsin the surface membrane lipid layer of normal lymphocytes and malignant lymphorma cells, J. Mol. Biol., 85, 603-615, 1974.

• 45) Inbar, M. and Shinitzky, M:Increase of cholesterol level in the surface membrane of lymphoma cell and its inhibitory effect of ascites tumor development, Proc. Nαオ膓. Acad. Sci. U. S. A., 71, 2128-2130, 1974.

• 46) Inbar, M. and Shinitzky, M.:Cholesterol as bioregulator in the development and inhibition of leukemia, Proct. Nat. Acad. Sci. U. S. A., 71, 4229-4231, 1974.

• 47) Van Blitterswijk, Emmelot, P. Hilkmann, H. A. H., Oomen-Meulemans, El. P. M. and Inbar, M.:Differences in lipid fluidity among isolated and membranes exfoliated from their cell

• 48) Inbar, M., Goldman, R., Inbar, L., Bursuker. I., Goldman, B., Akstein, E., Segel P., Ipp, E. and Ben-Bassat, I.:Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum conponents. Cancer Res., 37, 3037-3041, 1977.

• 49) Fucks, P., Parola, A., Robbins, P. W. and Blout, E. R.:Flourescence polarization and viscosities of membrane lipids of 3T3 cells, Proc. Nat. Sci. U. S. A., 72, 3351-3354, 1975.

• 50) Blecher, T. E. and Bisby, R. H.:Mononuclear cell-membrane "fluidity":a study in some haematological malignancies, Br. J. Cancer, 36, 763-769, 1977.
  pubmed

• 51) Nicolson, G. L, Robbins, J. C. and Winkelhake, J. L.:Tumor cell surfaces and metastasis:dynamic changes in neoplastic membrane structure and their relationship to tumor spread, in "Cellular Membranes and Tumor Cell Behavior", pp81-127, Williams and Wilkins Co., Baltimore, 1975

• 52) Pagano, R. E., Ozato, K. and Ruysschaert, J-M.:Intracellular distribution of lipophilic flourescent probes in mammalian cells, Biochim. Biophys. Acta, 465, 661-666, 1977.

• 53) Johnson, S. M. and Nicolau, C.:The distribution of 1, 6-diphenyl hexatriene flourescence in normal human lymphocytes, Biochem. Biophys. Res. Commun., 76, 869-874, 1977.

• 54) Johnson, S. M. and Kramers, M.:Membrane microviscosity differences in normal and leukaemic human lymphocytes, Biochem. Biophys. Res. Commun., 80, 451-457, 1978.
  pubmed

• 55) Inbar, M.:Fluidity of membrane lipids:a single cell analysis of mouse normal lymphocytes and amalignant lymphoma cells, FEBS Letters, 67, 180-185, 1976.

• 56) Bruck, A., Sahar, E., Agmon, E. and Shinitzky, M.:Flourescence polarization microscope for automatic screening of membrane fluidity of individual cells, Applied Optics, 16, 564-567, 1977.

• 57) Williams, L. T., Snyderman, R., Pike, M. C. and Lefkowitz, R. J.:Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. U. S. A., 74, 1204-1208, 1977.
  pubmed

• 58) Becker, E. L, Showell, H. J. Henson, P. M. and Hsu. L. S.:The ability of chemotactic factors to induce lysosomal enzyme release. I. The chracacteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J. Immunol., 112, 2047-2054, 1974.
  pubmed

• 59) Goetzl, E. J. and Austen, K. F.:Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic responsiveness, J. Clin. Invest., 53, 591-599, 1974.
  pubmed

• 60) Ryan, G. B., Borysenko, J. Z. and Karnovsky, M. J.:Factors affecting the redistribution of surface-bound concanavalin A on human polymorphonuclear leukocytes. J. Cell Biol., 62, 351-365, 1974.
  pubmed

• 61) Michell R. H.:Inositol phospholipids and cell surface receptor fuction, Biochim, Biophys. Acta, 415, 81-147, 1975.

• 62) Graham, R. C., Karnovsky, M. J., Shafer, A. W., Glass, E. A. and Karnovsky, M. L.:Metabolicand morphological observationson the effect of surface-active agents on leukocytes, J. Cell Biol, 32, 629-647, 1967.

• 63) Kakinuma, K.:Effects of fatty acids on the oxidative metabolism of leukocytes, Biochim. Biophys. Acta, 348, 76-85, 1974.
  pubmed

• 64) Romeo, D., Zabucchi, G. and Rossi, F.:Reversible metabolic stimulation of polymorphonuclear leukocytes and macrophages by concanavalin A. Nature New Biol., 243, 111-112, 1973.
  pubmed

• 65) Nakagawara, A., Takeshige, K. and Minakami, S.:Induction of a phagocytosis-like metabolic pattern in polymorphonuclear leukocytes by cytochalasin E. Exp. Cell Res., 87, 392-394, 1974.
  pubmed

• 66) 柿沼カツ子:白血球の食作用に併う代謝変化. 蛋白質, 核酸, 酵素, 21, 43-53, 1976.

• 67) Babior B. M., Kipnes, R. S. and Curnutte, J. T.:Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent, J. Clin. Invest., 52, 741-744, 1973・

• 68) Curnutte, J. T., Whitten, M. and Babior, B. M.:Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N. Engl. J. Med., 290, 593-597, 1974.

• 69) Johnston, R. B., Keele, B. B., Misra, H. P., Lehmeyer, J. E., Webb, L. S., Baehner, R. L. and Ra agopalan, K. V.:The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes, J. Clin. Invest., 55, 1357-1372, 1975.

• 70) McCord, J. M. and Fridovich, I.:Superoxide dismutase, An enzymic function for erythrocuprein (hemocuprein) , J. Biol. Chem., 244, 6049-6055, 1969.
  pubmed

• 71) Fridovich, I.:Superoxide dismutases, Adv. Enzymol., 41, 35-97, 1974・

• 72) Fridovich, I.:Superoxide dismutases, Annu. Rev. Biochem., 44, 147-159, 1975.
  pubmed

• 73) in "Biochemical and medical aspects of active oxygen", edt. Hayaishi, O. and Asada, K., Univ. Tokyo press, Tokyo, 1977.

• 74) in "Superoxide and superoxide dismutase" edt. Michelson, A. M., McCord, J. M. and Fridovich, I., Acad. Press, New York, 1977.

• 75) Goldstein, I. M., Cerqueira, M., Lind, S. and Kaplan, H. B.:Evidence that the superoxide-generating system of human leukocytes is associated with the cell surface, J. Clin. Invest., 59, 249-254, 1977.
  pubmed

• 76) Tsan, Min-Fu and McIntyre, P. A.:The requirement for membrane sialic acid in the stimulation of superoxide production during phagocytosis by human polymorphonuclear leukocytes, J. Exp. Med., 143, 1308-1316, 1976.

• 77) Najjar, V. A. and Nishioka, K.:Tuftsin:anatural phagocytosis stimulating peptide, Nature, 228, 672-673, 1970.

• 78) Constantopoulos, A. and Najjar, V. A.:The requirement for membrane sialic acid in the stimulation of phagocytosis by the natural tetrapeptide, Tufsin, J. Biol. Chem., 248, 3819-3822, 1973.

• 79) Erp. E. E. and Fahney, D.:Chromatographic characterization and opsonic activity of bovine erythrophilic and leukophilic gamma-globulins, Arch. Biochem. Biophys., 163, 1-7, 1975.

• 80) Yamanaka, N., Fukushima, M., Matsuoka, H., Nishida, K. and Ota, K.:Effects of Tuftsin on polymorphonuclear leukocyte metabolism, in Phagocytosis" edt. Kokubun, Y., Univ. Tokyo Press, pp. 93-100, 1979.

• 81) DeChatelet, L. R., McCall, C. E., McPail, L. C. and Johnston, R. B.:Superoxide dismutase activity in leukocytes:J. Clin. 1nvest., 53, 1197-1201, 1974.

• 82) Salin, M. L. and McCord, J. M.:Superoxide dismutases in polymorphonuclear leukocytes, J. Clin. lnvest., 54, 1005-1009, 1974.

• 83) Yamanaka, N., Ota, K. and Utsumi, K.:Changes in superoxide dismutase activities during development, aging and transformation. in "Biochemical and medical aspects of active oxygen" edt. Hayaishi, O. and Asada, K., pp. 183-190, Univ. Tokyo Press, 1977.

• 84) 山中直樹, 吉岡保, 内海耕造:老化と過酸化反応. 医学のあゆみ, 97, 573-580, 1976.

• 85) 山中直樹, 太田和雄:老化, 癌化および制癌, 特に Free radical 反応と関連して. 癌と化学療法, 4, 1-10, 1977.
  Medical*Online

• 86) 山中直樹, 太田和雄:癌と Free radicals. 最新医学, 33, 730-734, 1978.
  Medical*Online

• 87) de Duve, C., Pressmann, B. C., Ganetto, R., Wattiaux, R. and Appelmans, F.:Tissue fractionation studies. VI, Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem. J., 60, 604-617, 1955.

• 88) de Duve, C.:in"Tocopherol, Oxygen and Biomembranes"edt. C. de Duve and O. Hayaishi, pp. 351-361, Elsevier, Amsterdam. 1978.

• 89) 太田宏:白血球の代謝と酵素-最近の知見を中心に. 最新医学, 24, 764-778, 1968.

• 90) Kasukabe, T., Honma, Y. and Hozumi, M.:Induction of lysosomal enzyme activities with glucocorticoids during differentiation of cultured mouse myeloid lekemia cells, Gann, 68, 765-773, 1977.

• 91) Norwell, P. C. and Hucgerford, D. A.:Aminute chromosome in human chronic granulocytic leukemia, Science, 132, 1497, 1960.

• 92) Beutler, E., Collins, Z. and Irwin, L. E.:Value of genetic variants of glucose-6-phosphat dehy drogenase in tracing the origin of malignant tumors, N. Engl. J. Med. 276, 389-391, 1967.

• 93) 滝川清治:白血球の化学. 日本血液学全書, 2, pp. 69-98, 1963.

• 94) 高久史麿:白血球の細胞病理, 白血病のすべて. 中尾喜久編, pp. 122-134, 南江堂, 1972.

• 95) 日比野進:分担執筆, 内科学 (下巻) pp. 200 医学書院, 東京, 1957

• 96) 木村禧代二:急性白血病細胞に就て. 日本血液学全書, 5, pp. 158-197, 1962.

• 97) Katsunuma, S.:Intracellulare oxidation and indophenolblausynthetase, Gustav Fisher, Jena, 1924.

• 98) 勝沼精蔵:血液疾患の診断及び療法, (白血球方面) . 日内会誌, 23, 1-113, 1935.

• 99) Takaku, T.:personal communication

• 100) Yamanaka, N. and Deamer, D.:Superoxide dismutase activity in WI-38 cell cultures:effect of age, tripsinization and SV-40 transfomation. Physiol. Chem. Physics, 6, 95-106, 1974.

• 101) Dionisi, O., Galeotti. T., Terranova, T. and Azzi, A.:Superoxide radicals and hydrogen pero, xide formation in mitochondria from normal and neoplastic tissues. Biochim. Biophys. Acta, 403, 292-300, 1975.

• 102) Ts'o, P. O. P., Barrett, J. C., Caspary, W. J., Lesko, S. A. and Lorentzen, R. J.:The involve. ment of free radicals in chemical carcinogenesis, in"Free radicals in biology", edt. Pryor, W. A., Vol. III, pp. 251-303, Acad. Press, New York, 1977.

• 103) 山中直樹, 加藤武俊, 太田和雄:制がん剤の薬物代謝と副作用-特にBleomycinの作用機序と副作用について-. 癌と化学療法, 3, 1139-1146, 1976.
  Medical*Online

• 104) Yamanaka, N, Fukushima, M., Koizumi, K., Nishida, K., Kato, T. and Ota, K.:Enhancement of DNA chain breakage by bleomycin and biological free radical producing systems, in "Tocopherol, Oxygen and Biomembranes" edt. C. de Duve and O. Hayaishi, PP. 59-69. Elsevier, Amsterdam, 1978.

• 105) Yamanaka, N., Fukushima, M., Koizumi, K. and Ota, K.:Experimental results with the combination of bleomycin plus mitomycin C, Recent Results in Cancer Res., 63, 211-218, 1978.
  pubmed

• 106) 福島雅典, 太田和雄:クロマチン研究の最近の進歩と今後の展開. 癌と化学療法, 5, 879-892, 1978.
  Medical*Online

• 107) Kornberg, R. O.:Structure of Chromatin, Ann. Rev. Biochem., 46, 931-954, 1977.

• 108) Finch, J. T. and Klug, A.:Solenoidal Model for Superstructure in Chromatin, Proc. Natl. Acad. Sci U. S. A., 73, 1897-1901, 1976.
  pubmed

• 109) Bak, A. L, Zeuthen, J. and Crick, F. H. C.:Higher-Order Structure of Human Mitotic Chromosomes. Proc. Natl. Acad. Sci. U. S. A., 74, 1595-1599, 1977.

• 110) Barlogie, B., Hittelman, W., Spitzer, G., Trujillo, J. M., Hart, J. S., Smallwood, L. and Dre. winko, B.:Correlation of DNA Distribution Abnormalities with Cytogenetic Findings in Human Adult Leukemia and Lymphoma, Cancer Res., 37, 4400-4407, 1977.

• 111) Wallace, R. B., Dube, S. K. and Bonner, J.:Localization of the Globin Gene in the Template Active Fraction of Chromatin of Friend Leukemia Cells, Science, 198, 1166-1168, 1977.
  pubmed

• 112) Finch, J. T., Lutter, L. C., Rhodes, D., Brown, R. S., Rushton, B., Levitt, M. and Klug, A.:Structure of Nucleosome Core Particles of Chromatin. Nature, 269, 29-36, 1977.
  pubmed

• 113) Allfrey, V. G.:Post-Synthetic Modifications of Histone Structure. in Chromatin and Chromosome structure, eds・Li, H. J. and Eckhardt, R. E. Acad. Pren New York, pp. 167-191, 1977.

• 114) Horiuchi, K., Fujimoto, D. and Fukushima. M.:Enzymic Acetylation of Nucleosome, J. Bio. chem., 84, 1203-1207, 1978.

• 115) Marks, P. A. and Rifkind, R. A.:Erythroleukemic Differentiation, Ann. Rev. Biochem., 47, 419-448, 1978.
  pubmed

• 116) Reuben, R. C., Khanna, P L. Gazitt, Y., Breslow, R., Rifkind, R. A. and Marks, P. A.:Inducers of Erythroleukemic Differentiation. J Biol. Chem., 253, 4214-4218, 1978.
  pubmed

• 117) Candido, E. P. M., Reeves, R. and Davie, J. R.:Sodium Butyrate Inhibits Histone Deacetylation in Cultured Cells, Cell, 14, 105-113, 1978.

• 118) Sealy, L and Chalkley, R.:The Effect of Sodium Butyrate on Histone Modification, Cell, 14, 115-121, 1978.
  pubmed

• 119) Boffa, L. C., Vidali, G., Mann, R. S. and Allfrey, V. G.:Suppression of Histone Deacetylation in vivo and in vitro by Sodium Butyrate, , J. Biol. Chem. . 253, 3354-3356, 1978.

• 120) Fukushima, M., Yamanaka, N., Ota, K., Horiuchi, K. and Fujimoto, D.:Histone Acetyltransferase Activity in Normal Cell and Cancer Cell, Proc. Jap. Cancer Assoc., 37, Ann. Meeting. pp. 178, 1978.

• 121) Ruiz-Carrillo, A., Waugh, L. J. and Allfrey, V. G.:Selective Synthesis and Modification of Nuclear Proteins during Maturation of Avian Erythroid Cells, Arch. Biochem. Biophys., 174, 273-290, 1976.

• 122) Mukherjee, A. B. and Fabricant, J. D.:Possible Use of Histone Acetylation in Mixed Leukocyte Cultures to Assess Histocompatibility, Nature, 273, 467-469, 1978.
  pubmed

• 123) Hayaishi, O. and Ueda, K.:Poly (ADP-Ribose) and ADP-Ribosylation of Proteins, Ann. Rev. Biochem., 46, 95-116, 1977.
  pubmed

• 124) Okayama, H., Edson, C. M., Fukushima, M., Ueda, K. and Hayaishi, O.:Purification and Properties of Poly (Adenosine Diphosphate Ribose) Synthetase., J. Biol. Chem., 252, 7000-7005, 1977.
  pubmed

• 125) Edson, C. M., Okayama, II., Fukushima, M. and Hayaishi, O.:Histone is an Activator of Purified Poly (ADP-Ribose) Synthetase. not an Acceptor of Poly (ADP-Ribose) , Fed. Proc., 35, 1722, 1976.

• 126) Burzio, L., Reich, L. and Koide, S. S.:Poly (Adenosine Diphosphoribose) Synthetase Activity of Isolated Nuclei of Normal and Leukemic, Leukocytes, Proc. Soc. Exp. Biol. Med., 149, 933-938, 1975.

• 127) Caplan, A. H. and Rosenberg, N. I. J.:Interrelationship Between Poly (ADP-Ribrose) Synthesis, Intracellular NAD Levels, and Muscle or Cartilege Differentiation from Mesodermal Cell of Embryonic Chick Limb. Proc. Natl. Acad. Sci. U. S. A., 72, 1852-1857, 1975.

• 128) Pastl, E. and Swetly, P.:Expression of Poly (Adenosine Diphosphate-Ribose) Polymerase Activity in Erythroleukemic Mouse Cells during Cell Cycle and Erythropoietic Differentiation, J. Biol. Chem., 253, 4333-4340, 1978.

• 129) Rakienten, N, Gordon, B. S., Beaty A., Cooney, D. A., Davis, R. D. and Schein, P. S.:Pancreatic Islet Cell Tumors Produced by the Combined Action of Streptozotocin and Nicotinamide, Proc. Soc. Exp. Biol. Med., 137, 280-283, 1971.

• 130) Smulson, M., Schein, P. S., MuUins, D. W. Jr. and Sudhakar, S.:A Putative Role for Nicotinamide Adenine Dinucleotide Promoted Nuclear Protein Modification in the Antitumor Activity of N-Methyl-N-Nitrosourea, Cancer Res., 37, 3006-3017, 1977.

• 131) 山本正博, 高井義美:蛋白質のリン酸化による代謝調節と疾病. 代謝, 15, 551-564, 1978.

• 132) Collett, M. S. and Erikson, R. L.:Protein Kinase Activity Associated with the Avian SarcomaVirus Src Gene Product, Proc. Natl. Acad. Sci. U. S. A., 75, 2021-2024, 1978.

• 133) Koide, Y., Earp, H. S., Ong, S. H. and Steiner, A. L.:Alterations in the Intracellular Distribution of cGMP and Gnanylate Cyclase Activity during Rat Liver Regeneration. J. Biol. Chem. . 253, 4439-4445, 1978.
  pubmed

• 134) 日比野進:分担執筆, 内科学 (下巻) . pp. 157-224, 医学書院, 東京, 1957.

白血病と免疫

P.119 掲載の参考文献

• 1) Klein, G.:Experimental studies in tumor immunology. Fed. Proc., 28, 1793-1753, 1969.

• 2) Herberman, R. B.:Existence of tumor immunity in man. in Green, I., Cohen, S. and McCluskey (eds) :Mechanism of Tumor Immunity. J. Wiley & Sons, New York, 1977, pp. 175-191.

• 3) Leventhal, B. G., Mirro, J. J r. and Yabro, G. S. K.:Immune reactivity to tumor antigens in leukemia and lymphoma., Seminar Hematol., 15, 157-180, 1978.

• 4) Louie, S. and Schwartz, R. S.:Immunodeficiency and the pathogenesis of lymphoma and leukemia. Seminar Hematol., 15, 117-138, 1978.

• 5) Gooch, W. M, and Fernbach, D. J.:Immunoglobulin during the course of acute leukemia in children. Cancer, 28, 984-990, 1971.
  pubmed

• 6) Chandra, R. K.:Serum immunoglobulin levels in children with acute lymphoblastic leukemia and their mothers and sibs. Arch. Dis. Child., 47, 618-621, 1972.
  pubmed

• 7) McKelvey, E. and Carbone, P. P.:Serum immunoglobulin concentrations in acute leukemia during intensive chemotherapy. Cancer, 18, 1292-1297, 1965.
  pubmed

• 8) Dupuy, J. M., Kourilsky, F. M., Frandelizzi, D., Feingold, N., Jacquillat, C., Bernard, J. and Dausset, J.:Depression of immunologic reactivity of patients with acute leukemia. Cancer, 27, 323-331, 1971.

• 9) Santos, G. W., Mullins, G. M., Bias, W. B., Anderson, P. N., Graziano, K. D., Klein, D. L. and Burke, P. J.:Immunologic studies in acute leukemia. Natl. Cancer lnst. Monogr., 37, 69-75, 1973.

• 10) Hersh, E. M., Whitecar, J. P., McCredie, KB., Bodey, G. P. and Freireich, E. J.:Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. New Engl. J. Med., 285, 1211-1216, 1971.
  pubmed

• 11) Leventhal, B. G., Cohen, P. and Triem, S. C.:Effect of chemotherapy on the immune response in acute leukemia, Israel J. Med. Sci., 10, 866-887, 1974.

• 12) Sen, L. and Borella, L.:Expression of cell surface markers on T and B lymphocytes after longterm chemotherapy of acute leukemia. Cellmmunol., 9, 84-95, 1973.

• 13) Hersh, E. M. and Oppenheim, J. J.:Inhibition of in vitro lymphocyte transformation during chemotherapy in man. Cancer Res., 27, 98-109, 1967.
  pubmed

• 14) Char, D. H., Lepourhiet, A., Leventhal, B. G. and Herberman, R. B.:Cutaneous delayed hypersensitivity responses to tumor associated and other antigens in acute leukemia. Int. J. Cancer, 12, 409-419, 1973.

• 15) Cheema, A. R. and Hersh, E. M.:Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer, 28, 857-862, 1971.

• 16) Visa, D., Davies, D. A. L. and Harris, R.:Solubilization and partial purification of human leukaemia specific antigens. Nature, 227, 1249-1251, 1970.

• 17) Harris, R., Viza, D., Todd, R., Phillips, J., Sugar, R., Jennison, R. F., Marriott, G. and Gleeson, M. H.:Detection of human leukaemia-associated antigens in leukaemic serum and normal embryos. Nature, 233, 556-557, 1971.
  pubmed

• 18) Yata, J., Klein, G., Kobayashi, N., Furukawa, T., and Yanagisawa, M.:Human thymuslymphoid tissue antigen and its presence in leukaemia and lymphoma. Clin. Exp. Immunol., 7, 781-792, 1970.
  pubmed

• 19) Mann, D. L, Ulmer, C., Lepourheit, A., Leventhal, B. and Halterman, R.:Studies on the immunologic reactivity of sera from acute leukemia patients. Prog. Exp. Tumor Res., 19, 102-109, 1974.

• 20) Mohanakumar, T., Metzgar, R. S. and Miller, D. S.:Human leukemia cell antigens:Serologic characterization with xenoantisera. J. Natl. Cencer Inst., 52, 1435-1444, 1974.

• 21) Mann, D. L., Leventhal, B. and Halterman, R.:Human antisera detecting leukemia-associated antigens on autochthonous tumor cells. J. Natl. Cancer lnst., 54, 345-347, 1975.

• 22) Dore, J. F., Motta, R., Markoley, L, Hrsak, Colas de la Nove, H., Seman, G., de Vassal, F. and Mathe, G.:New antigens in leukemic cells and antibody in the serum of leukemic patients. Lancet, ii, 1396-1398, 1967.

• 23) Maruyama, K., Dmochowski, L., Bowen, J. M. and Hales, R. L.:Studies of human leukemia and lylnphoma cells by membrane immunofluorescence and mixed hemadsorption test. Texas Rep. Biol. Med., 26, 545-565, 1968.

• 24) Yoshida, T. O. and Imai, K.:Autoantibody to human leukemic cell membrane as detected by immune adherence. Rew. Eur. Etud. Clin. Biol., 15, 61-65, 1970.

• 25) Garret, T. A., Takahashi, T., Clarkson, B. D. and Old L. J.:Detection of antibody to autologous human leukemia cells by immune adherence assays. Proc. Natl. Acad. Sci., 74, 4587-4590, 1977.

• 26) Herberman, R. B.:Studies on the specificity of human cytotoxic antibody reactive with cultures of lymphoid cell. J. Natl. Cancer lnst., 42, 69-75, 1969.

• 27) Klein, G., Steiner, M., Wiener, F. and Klein, E.:Human leukemia-associated-antinuclear reactivity. Proc. Natl. Acad. Sci., 71, 685-689, 1974.
  pubmed

• 28) Gutterman, J. U., Rossen, R. D., Butler, W. T., McCredie, K. B., Bodey, G. P., Freireich, E. J. and Hersh, E. M.:Immunoglobulin on tumor cells and tumor induced lymphocyte blastogenesis in human acute leukemia. New. Engl. J. Med., 288, 169-173, 1973.
  pubmed

• 29) Metzgar, R. S., Mohana kumar, T. and Miller, D. S.:Membrane-bound immunoglobulins on human leukemic cells:Evidence for humoral immune responses of patients to leukemia-associated antigens. J. Clin. Invest., 56, 331-338, 1975.

• 30) Hersey, P., MacLennan, I. C. M., Campbell, A. C., Harris, R. and Freeman, C. B.:Cytotoxicity against human leukemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts. Clin. Exp. Immunol., 14, 159-166, 1973.

• 31) Oren, M. E. and Herberman, R. B.:Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumor cells. Clin. Exp. Immunol., 9, 45-56, 1971.
  pubmed

• 32) Gutterman, J. U, Hersh, E. M., Freireich, E. J., Rossen R. D., Butler, W. T., McCredie, K. B., Bodey, G. P., Rodriguez, V. and Mavligit, G. M.:Cell-mediated and humoral response to acute leukemia cells and soluble leukemia antigen-Relationship to immunocompetence and prognosis. Natl. Cancer. Inst. Monogr. 37, 153-156, 1973.
  pubmed

• 33) Santos, G. W., Mullins, G. M., Bias, W. B., Anderson, P. N., Graziano, K. D., Klein, D. L. and Burke, P. J.:Immunologic studies in acute leukemia. Natl. Cancer. Inst. Monogr., 37, 69-75, 1973.
  pubmed

• 34) Baker, M. A., Taub, R. N., Brown, S. M. and Ramachandar, K.:Delayed cutaneous hypersensitivity in leukemic patients to autologous blast cells. Brit. J. Hematol. 27, 627-633, 1974.

• 35) Hollinshead, A. C. and Herberman, R. B.:Identification and characterization:cell membrane antigens associated with the blast phase of human adult leukemia. Bibl. Haematol., 40, 339-348, 1975.
  pubmed

• 36) Ezaki, K, Kato, Y., Ohno, R., Kodera, Y. and Yamada, K.:Extraction and identification ofleukemia associated antigen. Acta Haematol. Jap., 41, 1163-1170, 1978.

• 37) Hiberg, R. W., Balcerzak, S. P. and LoBuglio, A. F.:Amigration inhibition-factor assay fortumor immunity in man. CeJ. lmmunol., 7, 152-158, 1973.

• 38) Anderson, P. N., Klein, D. L, Bias, W. B., Mullins, G. M., Burke, P. J. and Santos, G. W.:Cell-mediated immunological reactivity of patients and siblings to blast cells from adult acuteleukemias. Israel. J. Med. Sci., 10, 1033-1051, 1974.

• 39) Fridman, W. H. and Kourilsky, F. M.:Stimulation of lymphocytes by autologous leukemic cells in acute leukemia, Nature, 244, 277-279, 1969.

• 40) Viza, D. C., Bernard-Degani, O., Bernard, C. and Harris, R, :Leukemia antigens. Lancet, ii, 493-494, 1969.

• 41) Powles, R. L., Balchin, L. A., Fairley, G. H. and Alexander, P.:Recognition of leukemia cells as foreign before and after autoimmunization. Brit. Med. J., i, 486-489, 1971.
  pubmed

• 42) Leventhal, B. G., Halterman, R. H., Rosenberg, E. B. and Herberman, R. B.:Immune reactivity of leukemia patients to autologous blast cell. Cancer. Res., 32, 1820-1825, 1972.
  pubmed

• 43) 大野竜三, 森島泰雄, 加藤幸男, 杉浦さよ子, 竹山英夫, 若山喜久子, 上田龍三, 江崎幸治, 山田一正:リンパ球・自己白血病細胞混合培養法による急性白血病細胞の腫瘍特異抗原の検索. 日血会誌, 40, 177-182, 1977.

• 44) Kanner, S. P., Madiney, M. R. Jr. and Mangi, R. J.:Experience with a mixed lymphocyte-tumor reaction as a method of detecting antigenic differences between normal and neoplastic cells. J. Immunol., 105, 1052-1055, 1970.

• 45) Opelz, G., Kiuchi, M., Takasugi, M, and Terasaki, P, :Autologous stimulation of human lymphocyte subpopulation. J. Exp. Med., 142, 1327-1333, 1975.
  pubmed

• 46) Kuntz, M. M., Innes, J. B. and Weksler, M. E.:Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lympho-cytes. J. Exp. Med., 143, 1042-1054, 1976.

• 47) Rosenberg, E. B., Herberman, R. B., Levine, P. H., Halterman, R. H., McCoy, J. L. and Wunderlich, J. R.:Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int., J. Cancer, 9, 648-658, 1972.
  pubmed

• 48) Herberman, R. B., Rosenberg, E. B., Halterman, R. H., McCoy, J. L. and Leventhal, B. G.:Cellular immune reactions to human leukemia. Natl. Cancer. Inst. Monogr., 35, 259-266, 1972.
  pubmed

• 49) Eijsvoogel, V. P., Schellekens, P. Th. A, Du Bois, M. J. G. J. and Zeulmaker, W. P.:Human cytotoxic lymphocyte after allo-immunization in vitro. Transplant. Rev., 29, 125-145, 1976.

• 50) Zarling, J. M., Raich, P. C., McKeough, M. and Bach, F. H.:Generation of cytotoxic lymphocytesin vitro against autologous human leukemia cells. Nature, 262, 691-693, 1976.

• 51) Sondel, P. M., O'Brien, C., Porter, L., Schlossman, S. F. and Chess, L.:Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes. Requirement for a proliferative trigger in vitro. J. Immunol., 117, 2197-2203, 1976.
  pubmed

• 52) Hersh, E. M., Gutterman, J. U. and Mavligit, G. M.:Immunotherapy of leukemia. Med. Clin. North Amer., 60, 1019-1042, 1976.

• 53) 大野竜三, 小寺良尚, 江崎幸治, 横幕省三, 谷本光音, 山田一正:ヒトB細胞による細胞の autologous stimulation. 日血会誌, 42, 197, 1979.

• 54) 多田富雄:Suppressor Tcell. 代謝, 12 (臨時増刊) , 553-563, 1975.

• 55) Mathe, G., Amiel, J. L., Schwarzenberg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Hayat, M. and de Vassal, F.:Active immunotherapy for acute lymphoblastic leukemia. Lancet, 1, 697-699, 1969.
  pubmed

• 56) Hersh, E. M., Gutterman, J. U. and Mavligit, G. M.:Immunotherapy of leukemia. Med. Clin. North Amer., 60, 1019-1042, 1976.

• 57) Metzgar, R. S. and Mohanakumar T. ;Tumor-associated antigens of human leukemia cells. Seminar Hematolo., 15, 139-156, 1978.

• 58) 小寺良尚, 谷本光音, 小林政英, 江崎幸治, 大野竜三, 山田一正:人白血病関連抗原と免疫応答-in vitro sensitizationに対する検討-. 日血会誌, 42, 203, 1979.

• 59) Mathe, G., Pouillart, P. and Laperaque, F.:Active immunotherapy of L1210 leukemia applied after the graft of tumor cells. Brit. J. Cancer., 23, 814-824, 1969.

• 60) Mathe, G., Schwarzenberg, L, de Vassal, F.:Delgado, M., Immunotherapy for acute lymphoid leukemia. Lancet 1, 143-144 1976.
  pubmed

• 61) Mathe, G., de Vasaal, F., Delgado, M., Pouillart, P., Belpomme, D., Joseph, R, Schwarzenberg, J. L., Amiel, M., Schneider, A., Cattan, M., Musset, L. and Jasmin, C.:1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy. Cancer. Immunol. Immunother. 1, 77-86, 1976.

• 62) Aur, R. J. A.:Management of acute lymphocytic leukemia in children, in Cleton, F. J., Crowther D. and Malpas, J. S. (eds) :Advances in Acute Leukemia, American Elsevier, New York, 1974, pp. 95-113.

• 63) Medical Research Council:Treatment of acute lymphoblastic leukemia. Comparison of immuno-therapy (B. C. G.) , intermittent methotrexate and no therapy after a five-month intensive cytotoxic regimen (Concord trial) . Brit. Med. J., 4, 189-194, 1971.

• 64) Mackaness, G. B., Auclair, D. J. and Lagrange, P. H.:Immunopotentiation with BCG. I. Immune response to different strains and preparations. J. Natl. Cancer. Inst., 51, 1665-1667, 1965.

• 65) Heyn, R. M., Joo, P., Karon, M., Nesbit, M., Shore, N, Breslow, N., Weiner, J., Reed, A. and Hammond, D.:BCG in the treatment of acute lymphocytic leukemia. Blood, 46. 431-442, 1975.
  pubmed

• 66) Poplack, D. G., Graw, R. G., Pomeroy, T. C., Henderson, E. S. and Leventhal, B.:Chemotherapy versus chemotherapy and immunotherapy in childhood acute lymphatic leukemia. Proc. Amer. Assoc. Cancer Res., 16, 230, 1975.

• 67) Adrien, J. M. and the Europian Organization for Research on Treatment of Cancer Hemopathies Working Party:Immunotherapy versus chemotherapy as maintenance treatment of acute lymphoblastic leukemia. in Terry W. D. and Windhorst, D (eds) :immunotherapy of Cancer:Present status of Trials in Man. Raven Press, New York, 1977, pp. 471-482.

• 68) E. Kert, H., Jose, D. G. and Water K. D.:Intermittent chemotherapy and BCG in continuation therapy of children with acute lymphoblastic leukemia. Med Pediatr. Oncol. 3, 85-91, 1977.

• 69) 井沢 道, 桜井 実, 吉住 完, 多喜紀雄, 神谷 斉, 岩佐敏秋, 筒井 孟, 内田幸憲, 谷本康夫, 井上正和, 二宮剛美, 森 文子:小児急性白血病の特異免疫療法. 最新医学, 33, 1537-1542, 1978.
  Medical*Online

• 70) Skurkovich, S. V., Kisljak, N. S., Bulicheva, T. I., Makhonova, L. A., Majakova, S. A., Skorikova, A. S. and Erjemkina, E. I.:Active immunization of children suffering from acute leukemia in remission with"living"mixed leukoblast vaccine and means of enhancement of antileukemic immunity. Ann. New York Acad. Science, 277, 384-395, 1976.

• 71) Kyushu Childhood Leukemia Study Group:Treatment of acute childhood leukemia:Comparison of two methods of remission maintence. Jap. J. Clin. Oncol. 7, 27-34, 1977.

• 72) Gutterman, J. U., Hersh, E. M., Rodriguez, V., Mavligit, G. M., Reed, R., Burgess, M. A., Smith, T., Gehan, E., Bodey, G. P. and Freieich, E. J.:Chemoimmunotherapy of adult acute leukemia. Prolongation of remission in myeloblastic leukemia with BCG. Lancet, 2, 1405--1409, 1974.

• 73) Volger, W. R. and Chan, Y. K.:Prolonging remissions in myeloblastic leukemia by Tice-strain Bacillus Calmette-Guerin. Lancet, 2, 128-131, 1974.

• 74) Hewlett, J. S., Balceza K. S., Gutterman, J., Freireich, E. J., Gahan, E. A and Kennedy, A.:Remission maintenance in adult acute leukemia with and without BCG. A Southwest Oncology Group Study. in Terry, W. D. and Windhorst, D. (eds) :Immunotherapy of Cancer:Present Status of Trials in Man. Raven Press, New York, 1977, pp. 383-392.

• 75) Powles, R. L.:Immunotherapy in the management of acute leukemia, Brit, J. Haematol,. 32・ 145-149, 1976.

• 76) Reizenstein, R., Brenning, G., Engstedt, L., Franzen, S., Gahrton, G., Gullbring, B., Holm, G., Hocker, P., Hoglund, S., Hornsten, P., Tameson, S., Killander, A., Klein, E., Lantz, B., Linderman, Ch., Lockner, D., Loonnqvist, B., Mellstedt, H., Palmblad, J., Pauli, C., Skarberg, K. O., Uden, A. M., Vanky, F. and Wadman, B.:Effect of immunotherapy on survival and remission duration in acute nonlymphatic leukemia. in Terry, W. D. and Windhorst, D. (eds) :Immunotherapy of Cancer:Present Status of Trials in Man. Raven Press, New York, 1977, pp. 329-340.

• 77) Whiteside, M. G., Cauchi, M. V. and Paton, C. M.:Immunotherapy with chemotherapy in the management of remission in acute myeloblastic leukemia. Med. J. Aust., 2, 10-13, 1976.

• 78) Whittaker, J. A. and Slater A. J.:The immunotherapy of acute myelogenous leukemia usingintravenous BCG. Brit. J. Haematol., 35, 263-272, 1977.

• 79) Weiss, D. W., Stupp, Y. Many, N. and Iza K. G.:Treatment of acute myelocytic leukemia (AML) patients with MER tubercle baccilus fraction:A preliminary report. Transplantation Proc., 7, (suppl.) , 545-552, 1975.

• 80) Cuttner, J., Glidewell, O., Hollan d, J. F. and Bekesi, J. G.:Chemoimmunotherapy of acute myelocytic leukemia with MER. in Terry, W. D. and Windhorst, D. (eds) :Immunotherapy of Cancer:Present Status of Trials in Man. Raven Press, New York, 1977, pp. 405-414.

• 81) Ohno, R., Ueda, R., Imai, K., Kato, Y., Watanabe, E., Morishima, Y., Yokomaku, S., Kobayashi, M., Takeyama, H., Ezaki, K., Kawashima, M., Ohara, K., Kosaki, T. Yoshikawa, S. and Yamada, K.:A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia. Gann, 69, 179-186, 1978.

• 82) Bekesi, J. G. . Roboz, J. P. and Holland, J. F.:Therapeutic effectiveness of neuraminidase-treated tumor cells as immunogen in man and experimental animals with leukemia. Ann. New York Acad. Science, 277, 313-331, 1976.

• 83) Gee, T. S., Dowling, M. D., Cunningham, I., Oettgen, H. S., Armstrong D. and Clarkson, B. D.:Evaluation of pseudomonas aeruginosa vaccine for prolongation of remissions in adults with acute nonlymphoblastic leukemia treated with the L-12 protocol:A preliminary report. in Terry, W. D. and Windhorst, D. (eds) :Immunotherapy of Cancer:Present status of Trials in Man. Raven Press. New York, 1977, pp. 415-422.

• 84) McIntyre, O. R., Rai, K. R., Glidewell, O. and Holland, J. F.:Polyriboinosinic:polyribocytidyli. acid as an adjunct to remission maintenance therapy in acute myelogenous leukemia. in Terry, W. D. and Windhorst, D. (eds) :Immunotherapy of Cancer:Present status of Trials in Man. Raven Press, New York, 1977, pp. 423-431.

• 85) Sauter, Chr., Cavalli, F., Lindermann, J., Gmur, J. P., Berchtold, W., Alberto, P., Obrecht, P. and Senn, H. J.:Viral oncolysis:Its application in maintenance treatment of acute myelogenous leukemia. in Terry, W. D and Windhorst, D. (eds) :Immunotherapy of Cancer:Present status of Trials in Man. Raven Press, New York, 1977, pp. 355-354.

抗白血病剤の殺細胞作用

P.158 掲載の参考文献

• 1) Skipper, H. E. et al.:Experimental evaluation of potential anticancer agents. VIII. On the criteria and kinetics associated with"curability"of experimental leukemia. Cancer Chemoth. Rep. 35, 1, 1964・

• 2) Bruce, W. R.:The action of chemotherapeutic agents at the cellular level and the effects of these agents on hematopoietic and lymphomatous tissue. Canad. Cancer Conf. 7, 53, 1966.

• 3) 下山正徳・他:抗がん剤のin vitroにおける殺細胞作用について-培養 L-1210細胞を中心に-. 最新医学, 28, 1024, 1973.

• 4) Van Putten, L. M. et al.:Factors determining cell killing by chemotherapeutic agents in vivo. II melphalan, chlorambucil and nitrogen mustard. Europ. J. Cancer. 7, 11, 1971.

• 5) Van Putten, L. M.:Cell cycle specificity and therapeutic effectiveness of cytostatic agents. Cancer Chemoth. Rep. 56, 691, 1972.

• 6) Valeriote, F. A. et al.:Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents. Cancer Res. 32, 470, 1972.
  pubmed

• 7) Goldenberg, G. J. et al.:Sensitivity to nitrogen mustard as a function of transport activity and proliferation rate in L-5178 Y lymphoblasts. Cancer Res. 31, 1616・1971.

• 8) 下山正徳:抗がん剤の殺細胞作用の様式とcell-killing kineticsについて, 培養吉田肉腫細胞を中心に-2, アルキル化剤及び抗がん性抗生物質のcell-killing kineticsの分析. 日本癌治療学会誌, 10, 73, 1975.

• 9) 下山正徳・他:アルキル化剤のcell-killing kineticsについて. 最新医学, 30, 479, 1975.
  Medical*Online

• 10) 下山正徳・他:抗がん性抗生物質のcell-killing kineticsについて, Chemotherapy (日本化学療法学会誌) , 23, 2577, 1975.

• 11) 下山正徳:人がん細胞培養株の薬剤感受性度. 癌の臨床, 25, 75, 1979.

• 12) 下山正徳:抗がん剤の殺細胞作用の様式とcell-killing kineticsについて-培養吉田肉腫細胞を中心に-4. 代謝拮抗物質, Vinca alkaloidsおよびL-asparaginaseのcell-killing kineticsの分析. 日本癌治療学会誌, 10, 78, 1975.

• 13) Skipper, H. E. et al.:Implications of biochemical, cytokinetic, pharmacologic and toxicologic relationships in the design of optinal therapeutic schedules. Cancer Chemoth Rep. 54, 431, 1970.

• 14) Bhyyan, B. K. et al.:Cell-kill kinetics of several S-phase-specific drugs. Cancer Res. 33, 888, 1973.

• 15) 下山正徳:抗白血病剤のcell-killing kineticsの立場から抗白血病剤の投与はいかにあるべきか. 日本血液学会雑誌, 37, 695, 1974.

• 16) 下山正徳:抗がん剤の至適投与法. 癌の臨床, 22, 1277, 1976.

• 17) 下山正徳:制癌剤のcell-kill-kineticsと至適投与法. 癌と化学療法, 3, 1103, 1976.
  Medical*Online

• 18) 井上雄弘, 下山正徳・他:油性ブレオマイシンによる悪性リンパ腫の化学療法-油性BLMと通常の水性BLMの比較. 臨床血液, in press.

• 19) Skipper, H. E. et al.:Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytocine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemoth. Rep. 51, 125, 1967.

• 20) 近田千尋・他:N-(2'-Furanidyl) -5-Fluorouracil (FT-207) の経口投与. 癌の臨床, 19, 495, 1973.

• 21) Aoshima, M. et al:Comparative effect of vincristine and alkylating agents No. 864T on rat leukemia in relation to the distribution of drugs and leukemic cells. GANN. 64, 417, 1973.

• 22) 下山正徳・他:Cyclophosphamide及びその関連活性物質の化学療法効果3. 最大効果をあげるための投与法についての一考察. 癌と化学療法, 2, 889, 1975.

• 23) Shimoyama, M. et al.:Unique characteristics in action of Neocarzinostatin. 第36回日本癌学会総会記事, 1976.

• 24) Schneider, M.:Effect des chimiotherapies antimitotiques sur une reaction d'hypersensibilite retardee. Rev. franc. Etudes Clin. biol. 13, 877, 1968.

• 25) Aoshima, M. et al.:N4-behenoyl-1-β-D-arabinofuranosylcytosine, as a potential new antitumor agent. Cancer Res. 37, 1977.

• 26) Djerassi, I.:High-dose methotrexate and citrovorum factor rescue:Back ground and rationale. Cancer Chemoth. Rep. Part 2 6, 3, 1975.

• 27) Frei. E. III. et al.:New approaches to cancer chemotherapy with methotrexate. New Engl. J. Med. 292, 846, 1975.

• 28) Vadlamudi, S. et al.:Influence of mitotic cycle inhibitors in the antileukemic activity of cytosine arabinoside (NSC-63378) in mice bearing leukemia L-1210. Cancer Chemoth. Rep. 55, 547, 1971.

• 29) Zager, R. F. et aL:The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L-1210 murine leukemia. Cancer Res. 33, 1670, 1973.

• 30) Charbit, A. et aL:Relation between the pathological nature and the growth rate of human tumors. Europ. J. Cancer 7, 307, 1971.

• 31) 下山正徳:悪性リンパ腫の化学療法. 「血液疾患最近の進歩-高久史麿編 (金原出版) p. 267, 1978.

白血病の実験化学療法 - 動物実験モデルの予言性と化学療法の基礎

P.177 掲載の参考文献

• 1) Ehrlich, P. and Apolant, H.:Beobachtungen uber maligne Mausentumoren. Berl. Klin. Wchnschr., 42, 871-874, 1905.

• 2) Lowenthal, H. and Jahn, G.:Ubertrangungsversuche mit carcinomatoser Mause-Ascites-Flusigkeit undihr Verhalten gegen physikalische und chemische Einwirkungen. Ztschr. f, Krebsforsch., 37, 439-447, 1932.

• 3) 吉田富三, 牟田義雄, 佐々木仁一:Studien uber das "Ascites-Sarkom". Proc. Imp. Acad. Tokyo. XX, 616-618, 1944.

• 4) 吉田富三:吉田肉腫. 寧楽書房, 東京, 1949.

• 5) 吉田富三, 佐藤春郎, 有路智彦:腹水肝癌の実験的生成. 癌, 43, 128-130, 1952.

• 6) 佐藤 博:3. マウス・ラットの腹水腫瘍 b. ラットの腹水腫瘍 (1) 上皮性のもの. 実験腫瘍学 p485-499. 朝倉書店, 東京, 1966.

• 7) Chemical Target:Cancer Chem. Engin. News, 33, 5138-5142, 1955.

• 8) Goldin, A., Serpick, A. A. and Mantel, N.:A Commentary. Experimental Screening Procedures and Clinical Predictability Value. Cancer Chemoth. Rep, 50, 173-218, 1966.

• 9) 星野 章:癌化学療法の基礎 (4) , (6) 癌および白血病における実験的化学療法の予言性. 医学のあゆみ, 85, 121-128, 1973.

• 10) 星野 章:日本における制癌剤スクリーニングシステムと人癌化学療法モデル. 癌と化学療法. 1, 615-630, 1974.
  Medical*Online

• 11) Larionov, L. F.:Commentary, Methods of Screening Anticancer Drugs in the Soviet Union. Cancer Chemoth. Rep, Part 1, 54, 71-77, 1970.

• 12) Schneiderman, M. A.:Letters., On Screening Procedures, Cancer Chemoth. Rep, Part 1, 54 249-295, 1970.

• 13) Goldin, A., Carter, S. K. and Mantel, N;Letters, On Screening Procedures. Cancer Chemoth. Rep, Part, 1, 54, 295-298, 1970.

• 14) Stock, C. C.:A Developing Need for Perspective in Survey of Antitumor Data, Cancer Chemoth. Rep, Part 1, 54, 299-301, 1970.

• 15) 星野 章:抗白血病剤の併用投与はいかにあるべきか-実験化学療法の立場から-. 日本血液学会雑誌, 37, 731-739, 1974.

• 16) 星野 章:急性白血病の多剤併用療法と寛解導入. 内科シリーズNo. 6. 白血病のすべて, p252-265, 南江堂, 東京, 1972.

• 17) 星野 章:多剤併用療法, 1. 多剤併用療法の基礎. 臨床薬理学大系, 11巻B, 抗腫瘍薬, p279-298, 中山書店, 東京, 1973.

• 18) 太田和雄:癌の化学療法, -合併療法-, 癌と化学療法社, 東京, 1976.

• 19) Livingston, R. B. and Carter, S. K.:Single Agents in Cancer Chemotherapy, IFI/Plenum, New York-Washington-London, 1970.

• 20) Hibino, S.:Chemotherapy of leukemia, with special reference to mitomycin C and some other agents recently originated in Japan. Proc. VIIth International Congress of the International Society of Hematology, P 115, 1960.

• 21) 木村禧代二:白血病の化学療法. 第16回日本医学会総会学術講演集 Vol III, p540. 1963.

• 22) Freireich, E. J. and Frei, E. III:Quadruple combination therapy (VAMP) for acute lymphocytic leukemia of childhood. Proc. Am. Ass. Cancer Res., 5, 20, 1964.

• 23) Goldin, A. and Mantel, N.:The employment of combination of drugs in the chemotherapy of neoplasia. A review. Cancer Res, 17, 635-654, 1957.
  pubmed

• 24) Mantel, N.:An experimental design in combination chemotherapy. Ann. N. Y. Acad. Sci., 76, 909-931, 1958.
  pubmed

• 25) 太田和雄, 星野 章, 天羽弘行, 加藤武俊:癌化学療法における多剤併用療法"METT"に関する実験的研究. 第26回日本癌学会総会記事, p49. 1967.

• 26) 太田和雄, 星野 章・他:悪性腫瘍化学療法における多剤併用療法(METT療法) . 最新医学, 23, 631-645, 1968.

• 27) 星野 章:薬剤耐性からみた合併療法. 日本癌治療学会誌, 4 (Suppl) , 28-34. 1969.

• 28) 星野 章, 藤本修一:多剤併用療法の意義. 癌の臨床, 23, 1157-1167. 1977.

• 29) 星野 章, 加藤武俊, 天羽弘行, 太田和雄:Mitomycin C. 5-Fluorouracil, Cytosine Arbainosideの3者併用MFC療法に関する基礎的研究. Chemotherapy 18, 384-385. 1970.

• 30) 星野 章, 加藤武俊, 天羽弘行, 太田和雄:L1210 マウス白血病における Daunomycin, Cytosine Arabinoside, 6-Mercaptopurine 三者併用療法の実験的研究. 日本血液学会雑誌, 33, 781. 1970.

• 31) Ota, K., Kurita, S. and Hoshion, A.:Triple combination therapy of mitomycin C (MMC) , 5-fluorouracil (5-FU) and cytosine arabinoside (Ara-C) in treatment for human advanced cancer. Abstracts, Xth International Cancer Congress, p733, Houston, 1970.

• 32) 亀井良孝, 栗田宗次, 小川一誠, 今井邦之, 村上稔, 太田和雄:急性白血病の多剤併用療法(DCMP療法) について. 日本血液学会雑誌, 33, 784, 1970.

• 33) 藤本修一, 稲垣治郎, 堀越 昇, 倉石安庸, 星野 章, 天羽弘行, 加藤武俊, 太田和雄:Neocarzinostatin(NCS) のL1210 マウス白血病に対する効果-特に交叉耐性, 併用療法について-. 癌と化学療法, 1, 851-860, 1974.
  Medical*Online

• 34) Venditti, J. M., Humphreys, S. R., Mantel, N. and Goldin, A.:Combined treatment of advanced leukemia (L1210) in mice with amethopterin and 6-mercaptopurine. J. Natl Cancer lnst, 17, 631-638, 1956.

• 35) Hutchison, D. J., Robinson, D. L, Martin, D., Ittenson, O. L. and Dillenberg, J.:Effects of selected cancer chemotherapeutic drugs on the the survival times of mice with L1210 leukemia:Relative response of antimetabolite resistant strains. Cancer Res., 22, (No. 1, Part 2) (Suppl.) , 57-72, 1962.

• 36) Goldin, A., Venditti, J. M., Mantel, N., Kline, I. and Gang, M.:Evaluation of combination chemotherapy with three drugs. Cancer Res., 28, 950-960, 1968.
  pubmed

• 37) 星野 章:動物実験からみた併用療法の意義. 最新医学, 28, 844-849, 1973.

• 38) 星野 章:薬剤耐性, 交叉耐性からみた抗白血病剤の作用機序ならびに併用療法の基礎的研究. 日本合同癌会議シンポジウム記録, p. 23-24. 1971.

• 39) 星野 章, 小原寛治, 神谷修, 山崎健之, 藤本修一:多剤併用療法の基礎と臨床-ACNUと5-FUの併用療法について. 日本癌治療学会誌, 12, 94-95, 1977.

• 40) Fujimoto, S., Inagaki, J., Horikoshi, N. and Hoshino. A.:Combination chemotherpay of 6-thioguanine with various antitumor agents against murine leukemia L1210. GANN, 68, 543-552, 1977.

• 41) Moertel, C. G., Hanley, J. A.:Phase II-III studies in chemotherapy of advanced gastric cancer. Proc. Am. Cancer Res., 16, 260, 1975.

• 42) Moertel, C. G., Schutt, A. J., Hahn, R. G. et al:Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1, 3-cis (2-chloroethyl) -1-nitrosourea, and vincristine. J. Natl. Cancer Inst., 54, 69-71, 1975.

• 43) 星野 章, 小原寛治, 神谷 修, 名倉英一, 鬼塚俊夫, 山崎健之:進行消化器癌に対するACNU+5-FU, Me-CCNU+5-FU併用療法の比較研究. 日本癌治療学会誌, 13, 100-101, 1978.

急性白血病の病態と治療

P.232 掲載の参考文献

• 1) 木村禧代二:急性白血病細胞について. 日血全書 p. 158 丸善, 1961.

• 2) Whang, J. J., A. I. Freeman and L. F. Sinks:Treatment of acute lymphocytic leukemia by highdose methotrexate. Cancer Res. 36, 1441, 1976.

• 3) R., Ohno, M. Hirano, K. Imal, K. Koie, T. Kamiya, H. Nishiwaki, J. Ishiguro, T. Uetani, F. Sako, K. Imamura and K. Yamada:Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults. Cancer 36, 1945, 1975.

• 4) Sakano, T.:Chemotherapy of acute myelocytic leukemia of adults:A study of influence of chemotherapy on survival time. Jap. J. Clin. Oncol. 5, 113, 1975.

• 5) Gee, T. S., K. P. Yu and B. D. Clarkson:Treatment of adult acute leukemia with arabinosyl cytosine and thioguanine. Cancer 23, 1019, 1969.

• 6) Freireich, E. J:Current status of therapy for acute leukemia current concepts in the management of leukemia and lymphoma. RRCR 36, 119, 1975.

• 7) Whitecar, J. P., G. P. Bodey, E. J. Freireich, K. B. McCredie and J. S. Hart:Cyclophosphamide, Vincristine, Arabinosyl cytosine and Prednisone (COAP) combination chemotherapy for adult acute leukemia. Cancer Chemo. Rep. 56, 543, 1972.

• 8) 坂井保信:Cyclocytidine, 癌の化学療法剤. クリニックマガジン, 81, 1977.

• 9) Bernard, J., M. Weil, M. Boiron, C. Jacquillat, G. Flandrin and M. F. Genon:Acute promyelocytic leukemia:Results of treatment by Daunorubicin. Blood 41, 489, 1973.

• 10) Rosenthal, D. S. and W. C. Moloney:The treatment of acute granulocytic leukemia in adults. New Engl. J. Med. 286, 1176, 1972.

• 11) McCredie, K. B., G. P. Bodey, M. A. Burgess, J. U. Gutterman, J. P. Hester, V. Rodriguez and E. J. Freireich:The management of acute leukemia in adults. Cancer chemotherapy. Year Book Medical Publishers. 173, 1975.

• 12) 喜多嶋康一, 長尾忠美, 高橋功, 上村致信, 土岐博信, 林 久智, 陳 博明, 内藤徳郎, 新谷憲治, 中西紀男, 真田 浩:急性白血病に対するNeocarzinostatinの臨床効果-全国集計による単独投与52例, 併用投与74例の分析. 基礎と臨床, 9, 1864, 1975.

• 13) 山田一正, 平野正美, 柿沢久美, 森田昭光, 植谷忠昭, 大野竜三, 川島康子, 高橋利忠, 西脇洋, 佐光富士男, 鯉江捷夫, 神谷忠, 堀越昇, 三浦守司:l-asparaginaseの抗白血病作用. 最新医学, 25, 1064, 1972.

• 14) 山田一正・他:急性白血病における寛解導入と維持ならびに補助療法に関する究研. 日本合同癌シンポジウム記録, 26-21, 1971.

• 15) 山田一正・他:急性白血病における多剤併用療法. 最新医学, 28, 867, 1973.

• 16) 大野竜三:成人急性白血病の多剤併用療法, 日血会誌, 37, 740, 1974.

• 17) Ohno, R., Yamada, K., et al:Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults. Cancer 36, 1945, 1975.

• 18) Uzuka, Y. et al:Treatment of adult acute nonlymphocytic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy. Tohoku, J. Exp. Med. 118 (Suppl) , 217, 1976.

• 19) 厚生省がん研究助成金「白血病とその類縁疾患の腫瘍・宿主・薬剤関係における総合的治療体系の確立に関する研究」班. 第2回班会議, 東京, 1977年1月

• 20) Clarkson, B. D.:Acute myelocytic leukemia in adults. Cancer 30, 1572, 1972.
  pubmed

• 21) Growther, D., Powles, R. L. et al.:Management of adult acute myelogenous leukemia. Brit. Med. J. 1, 131, 1973.

• 22) Rosenthal, D. S., Moloney, W. C.:The treatment of acute granulocytic leukemia in adults. N. Eng. Med. 286, 1176, 1972.

• 23) Whitecar J. P., Bodey, G. P. et al.:Cyclophosphamide, vincristine, cytosine arabinoside and prednisone combination chemotherapy for acute leukemia in adults. Cancer Chemother. Rep. 56, 543, 1972.
  pubmed

• 24) McCredie, K. B. et al.:Comparative study of POMP versus COAP (PVC) in remission induction and maintenance of acute adult leukemia. Proc. Am Aasoc Cancer Res 13, 101, 1072.

• 25) 山田一正・他:急性白血病の寛解導入, 維持ならびに寛解強化療法. 白血病の化学療法-基礎と臨床-290-296, 科学評論社, 1976.

• 26) Clarkson, B. D.:Consideration of cell kinetic principles to strategy of treating leukemia. Cancer Chemotherapy 19-50, Year Book Medical Publishers, Inc. Chicago, 1974.

• 27) 三浦守司・他:急性白血病の治療, II 補助療法の進歩. 最新医学, 26, 1586, 1970.

• 28) 勝見乙平・他:急性白血病と出血. 臨床科学, 5, 192, 1969.

• 29) 大野竜三・他:急性白血病患者の重症感染症に対する抗生物質大量併用療法. 臨床血液, 14, 1141 1973

• 30) 上田龍三 ・他:持続血球分離装置 (Celltrifuge) とその臨床応用について. 最新医学, 29, 527 1974.

• 31) Graw, R. G. et al.:Normal granulocyte transfuion therapy. Treatment of septicemia due to gramnegative bacteria. The New Engl. J. Med. 292, 762, 1975.

• 32) Higby, D. J. et al:Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. New Engl. J. Med., 292, 762, 1975.

• 33) McCredie, K. B. et al.:Clinical results of granulocyte transfusion using normal donors in leukocytes:Separation and transfusion. Academic Press, pp. 287, 1975.

• 34) 山田一正・他:無菌環境下における急性白血病の化学療法-必要性と実用化について. 空気清浄, 11, 11 1973.

• 35) 植谷忠昭・他:無菌環境下における白血病の治療. 臨床血液, 15, 384, 1974.

• 36) Char, D. H., Lepourhiet, A. Leventhal, B. C. and Herberman, R. B.:Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia. Int. J. Cancer, 12, 409, 1973.

• 37) Fridman, W. H. and Kourilsky, F. M.:Stimulation of lymphocytes by autologous leukaemic cells in acute leukemia. Nature, 224, 277, 1969.
  pubmed

• 38) Leventhal, B. G., Halterman, R. H., Rosenberg, E. B. and Herberman, R. B.:Immune reactivity of leukemia patients to autologous blast cells. Cancer Res., 32, 1820, 1972.
  pubmed

• 39) Viza, D. C., Bernard-Degani, O., Bernard, C. and Harris, R. C.:Leukemia antigens. Lancet, 2, 493, 1969.

• 40) Powles, -R. L, Balchin, L. A., Hamilton-Fairley, G. and Alexander P.:Recognition of leukaemia cells as foreign before and after autoimmunization. Brit. Med. J., 1, 486, 1971.

• 41) Gutterman, J. U., Rossen, R. D., Butler, W. T., McGredie, K. B., Bodey, G. P., Freireich, E. J. and Hersh, E. M.:Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N. Eng. J. Med., 228, 169, 1973.

• 42) 大野竜三, 山田一正・他:リンパ球・自己白血病細胞混合培養法による急性白血病細胞の腫瘍特異抗原の検索. 日血会誌, 40, 177, 1977.

• 43) Davignon, L., Lemonde, P., Robillar, P. et al.:B. C. G. vaccination and leukemia mortality. Lancet, 2, 638, 1970.

• 44) Rosenthal, S. R., Crispen, R. G., Thorne, M. G., Plekarski, N. et al:BCG vaccination and leukemia mortality. J. Am. Med. Assoc., P22, 1543, 1972.

• 45) Shneiderman, M. A. and Levin, D. L.:Parallels, convergences, and departures in case-control studies and clinical trials. Cancer Res., 33, 1498, 1973.

• 46) British Medical Research Coucil:BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull. WHO, 46, 371, 1972

• 47) Comstock, G. W., Livesay, V. T. and Webster, R. G.:Leukemia and B. C. G. A controlled trial. Lancet, 2, 1062, 1971.

• 48) Comstock, G. W., Martinez, I. and Livesay, V. T.:Ffficacy of BCG vaccination in prevention of cancer., J. Nat. Cancer Inst., 54, 835, 1975.

• 49) Mathe, G.:Approaches to the immunological treatment of cancer in man. Brit. Med. J., 4, 7, 1969.

• 50) Heym, R. et al:BCG in the treatment of acute lymphoblastic leukemia. Proc. Amer. Assoc. Cancer Res., 14, 45, 1973.

• 51) Medical Research Council:Report on the treatment of acute lymphoblastic leukemia. Brit. Med. J., 4, 189, 1971.
  pubmed

• 52) Heyn, R. et al.:BCG in the treatment of acute lymphocytic leukemia. In:Immunotherapy of Cancer. Conference held in Bethesda, 27-29 0ct., 1976, Abstract 42, p. 31

• 53) Powles, R. L. et al.:Immunotherapy for acute myelogenous leukemia. Brit. J. Cancer, 28;365, 1973.
  pubmed

• 54) Freeman, C. B. et al:Active immunotherapy used alone for maintenance of patients with acutemycloid leukemia. Brit. Med. J., 4, 571, 1973.
  pubmed

• 55) Volger, V. W. &Chan, Y. K.:Prolonging remission in myeloblastic leukemia by Tice strain Bacillus Calmette Guerin. Lancet, 2, 128, 1974.

• 56) Gutterman, J. U, Hersh, E. M. et al.:Chemotherapy of adult acute leukemia. Prolongation of remission in myelocytic leukema with BCG. Lancet, 4, 1405, 1974.

• 57) Volger, V. W. et al.:A randomized clinical trial of BCG in myeloblastic leukemia conducted by the Southeastern Cancer Study Group. Abstracts, lmmunotherapy of Cancer, Present Status of Trials in Man, pp. 25, 0ct 27-29, 1976.

• 58) Whittaker, J. A. & Stater, A. J.:The Immunotherapy of acute myelogenous leukemia using intravenous BCG. pp. 33, abstracts, immunotherapy of cancer-present status of trials in man. Oct 27-29, 1976 Bethehsda.

• 59) Reizenstein, P. et al:Effect of immunotherapy on survival and remission duration in acute, non-lymphatic leukemia. ibid., pp. 23.

• 60) Peto, R.:Immunotherapy of acute myeloid leukemia. ibid., pp. 24.

• 61) Hewlett, J. S. et al.:Remission induction in adult acute leukemia by 10-day continuous intravenous infusion of Ara-C, puls oncovin and prednisone. ibid., pp. 26.

• 62) Holland, J. F. & Beckesi, J. G.:Immunotherapy of human leukemia with neuraminidase-modified cells. Med. Clin. Nerth. Amer., 60, 539, 1976.

• 63) Sokal, J. E., Aungst, C. W. and Grace, J. T.:Immunotherapy of well-controlled chronic myelocytic leukemia. NY State J. Med. 73, 1180, 1973.

• 64) Sokal, J. E., Aungst, C. W. and Snyderman, M.:Delay in progression of malignant lymphoma after BCG vaccination. N. Engl., J. Med., 291, 1226, 1974.
  pubmed

• 65) Thomas, J. W., Plenderleith, I. H., Clements, D. V. and Landi, S.:Observation in immunothrapy of lymphoma and melanomal patients. Clin. Exp. Immnunol., 21, 82, 1973.

• 66) Azuma, I., Ribi, E. E. et al.:Biologically active component from mycobacterial cell wall. I. Isolation and composition of cell wall skeleton and component p. 3. J. Natl. Cancer lnst., 52, 95, 1974.

• 67) Yamamura, Y., Azuma, I. et al.:Immunotherapy of cancer with cell wall s keleton of mycobacterium bovis-Bacilllus Calmette-Guerin:Experimental and clinical results. Ann. N. Y. Acad. Sci., 277, 209, 1976.

• 68) Yamada, K., Kawashima, K., Morishima, Y., Esaki, K., Kodera, Y. and Ohno, R.:Chemoimmunotherapy of acute myelogenous leukemia in adults with BCG cell wall skeleton. Gann Monograph on Cancer Research 21, 199, 1978.

• 69) Ohno, R. Yamada, K. et al.:Immune response of regional lymphnode to BCG cell-wall skeleton and other immunopotentiators. ibid. 109.

• 70) Sparks, F. C.:Hazards and complications of BCG immunotherapy. Clin. North. Amer. 60, 499, 1976.

• 71) 神谷修・他:骨髄移植と再生不良貧血-治療法としての検査. 1) その現状. 医学のあゆみ, 96, 569, 1961.

• 72) 山田一正, 森島泰雄, 平林憲之:骨髄移植. 臨床科学, 13, 151, 1977.

• 73) 森島泰雄, 山田一正・他:骨髄移植の臨床的研究. 移植, 13 (4) , 202, 1978.
  Medical*Online

• 74) Hirabayashi, N. and Morishima, Y.:Bone marrow transplantation for acute leukemia and aplastic anemia. Acta Haem. Jap., 40, 923, 1977.

• 75) Thomas, E. D. et al:Bone marrow transplantation. New Engl. J. Med. 292, 832, 1975.

• 76) Santos, G. W. lmmunosupression for clinical marrow transplantation Semin. Hematol. 11, 341, 1974.
  pubmed

• 77) Graw, R・G・ et al:Bone marrow transplantation following combination chemothrapy immunosuppression (B. A. C. T.) in patients with acute leukemia. Transpl. Proc. 7, 349, 1974.

• 78) Cline, M. J. et al:Bone marrow transplantation in man. Ann. Int. Med, 83, 69, 1975.

• 79) Storb, R. et aL:Methotrexate regimens for control of graft versus host disease in dogs with allogeneic marrow graft. Transplantation, 9, 240-246 (1970) .
  pubmed

• 80) 山田一正:急性白血病の長期生存例における宿主腫瘍薬剤関係について. 医学のあゆみ, 59, 613, 1966.

• 81) 植谷忠昭-日本における急性白血病長期生存例に関する研究-特に5年以上生存例について-. 日血会誌, 36, 98, 1973.

• 82) Yamada, K. et a. l:Five-year survivors with acute leukemia in Japan. Acta Haemat. Japonica 37, 335, 1974.

• 83) Burchenal, J. H.:Long-term survivors in acute leukemia and Burkitt's tumor. Cancer, 21, 595, 1968.
  pubmed

• 84) Hata, T., Sano, W., Sugawara, R., Matsuma, A., Kanamori, K., Shima, T., and Hoshi, T.:Mitomycin, a new antibiotics from streptomyces. J. Antibiotics 9:141, 1956 Wakaki, S., Marumo, H., Tomioka, K., Shimizu, G., Kato, E., Kamada, H., Kudo, S., and Fujimoto, Y.:Isolation of new fractions of antitumor mitomycins. Antibiot. Chemother 8, 228, 1958.

• 85) Kiyoji, K., Kurita, S., Ota, K.:Chemotherapy of chronic myelogenous leukemia with special reference to Mitomycin C, ProC. IInd Congr, Asian Pacific Soc. Hemat. (Menila) p. 114, 1962.

• 86) Frank, W., and Osterberg, A. E.:Mitomycin c (NSC-26980) -an evaluationof the Japanese reports Cancer Chemother Rep . 9, 114, 1960.

• 87) 全国造血器腫瘍登録調査報告第1報 (昭和47, 48年) 昭和51年3月全国造血器腫瘍登録委員会, 1976.

• 88) 全国造血器腫瘍登録調査報告第2報 (昭和49, 50年) 昭和52年12月全国造血器腫瘍登録委員会, 1977.

• 89) 坂野輝夫, 木村禧代二:白血病-診療に有用な数値表-. 日本臨牀, 32, 1786-1804, 1974.
  Medical*Online

• 90) 滝川清治:白血病(細胞) の病態生理, 診断と治療, 59, 262-272, 1971.

• 91) 滝川清治, 御供泰治, 浅川瑞穂:異常白血球のみかた. 診断と治療, 64, 209-213, 1976.

• 92) 坂野輝夫, 坂井保信:超生体染色による細胞鑑別, 臨床検査, 16, 564-565, 1972.

• 93) 滝川清治, 浅川瑞穂, 伊藤銑一:急性白血病における淋巴芽球と骨髄芽球の鑑別-細胞生化学ならびに電子顕微鏡の立場より-. 日本臨牀, 22, 2360-2373, 1964.

• 94) Kersey, J. H. et al.:Acute lymphoblastic leukemic cells with lymphocyte markers. Science, 182, 1355-1356, 1973.
  pubmed

• 95) Greaves, M. F., Owen, J. J. T. and Raff, M. C.:T and B lymphocytes, Amer. Elsevier Pub., N. Y., 1973, p. 207.

• 96) Melief, C. J. M. et al.:Some immunological properties of lymphoid cells from patients with acute lymphocytic leukemia, Clin. Eyp. Immunol. 15, 131-143, 1973.

• 97) Borella, L. and Sen, L.:T cell surface markers on lymphoblasts from acute lymphocytic leukemia, J. Immanol. 111, 1257-1260, 1973.

• 98) Shevach, E. et al:A human leukemia cell with both B and T cell surface receptors. Proc. Nat. Acad. Sci. 71, 863-866, 1974.

• 99) Frei, E. III., and Sallan, S. E.:Acute lymphoblastic leukemia:Treatment. Cancer 42, 828-838, 1978.

• 100) Gee, T. S., Hoghbin, M., Dowling, M., Jr., Cuningham, I., Middleman, M. P. and Clarkson, B. D.:Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens. Cancer 37, 1256-1264, 1976.

• 101) Mauer, A. M. and Simone, J. V.:The current status of the treatment of childhood acute lymphoblastic leukemia. Cancer Treatment Review 3, 17-41, 1976.

• 102) Five-year survivors with acute leukemia in Japan. Kawashina, K., Imai, K. and Yamada, K.:Excerpta Med. Intern. Cong. Series No. 415, 832-834, 1976.

• 103) 藤本孟男:小児急性白血病の治療. 癌と化学療法, 6, 9-20, 1979.
  Medical*Online

• 104) Sen, L. and Borella, L.:Clinical importance of lymphoblasts with T markers in childhood acute leukemia, N. Engl. J. Med. 292, 828, 1975.

• 105) Davey, F. R. and Gottlieb, A. J.:Lymphocyte surface markers in acute lymphocytic leukemia, Am. J. Chin. Pathol. 62, 818-822, 1974.

• 106) Smith, J. L et al:Characterization of malignant mediastinal lymphoid neoplasm (Sternberg's sarcoma) as thymic in origin. Lancet 1, 74-77, 1973.

• 107) 矢田純一, 月本一郎:急性リンパ性白血病とその周辺. 臨床血液, 17, 422-427, 1976.

• 108) Schwenk, H. U. and Schneider, U.:Cell cycle dependency of T cell marker on lymphoblasts. Blut. 31, 299-306, 1975.
  pubmed

• 109) Tsukimoto, I., Wong, K. Y. and Lampkin, B. C.:Surface markers and prognostic factors in acute lymphoblastic lcukemia. N. Engl. J. Med. 294, 245, 1976.
  pubmed

• 110) Hillestad, L. K.:Acute promyelocytic leukemia. Acta Med. Scandinav. 159, 189-194, 1957.

• 111) Didisheim, P. et al:Acute promyelocytic leukemia with fibrinogon and factor V. deficiencies. Blood 23, 717-728, 1964.
  pubmed

• 112) 長谷川弥人・他:急性前骨髄球性白血病. 臨床血液, 6, 191-203, 1965.

• 113) 松岡松三, 渡辺透:急性前骨髄球性白血病の30例について. 臨床血液, 15, 1-16, 1974.

• 114) 渡辺透, 服部晃:急性前骨髄球性白血病の診断とくに細胞形態と凝固線溶系について. 臨床血液, 17, 380-388, 1976.

• 115) 野村武夫:急性前骨髄球性白血病, 内科 Mook No. 5 pp. 107-113, 東京 1978.

• 116) 安藤泰彦・渡辺清明:急性前骨髄球性白血病におけるDICの原因と病態生理. 臨床血液, 17, 389-395, 1976.

• 117) Bermard, J. et al:Acute promyelocytic leukemia. Results of treatment by daunorubicin. Blood 41, 489-496, 1973.

• 118) 大西義久:急性前骨髄球性白血病の臨床病理. 臨床血液, 17, 402-408, 1976.

• 119) Reschad, H. und Schilling-Torgau, V.:Uber neue Leuktamie durch echte Ubergangsformen (Splenozytenleukamie) und ihre Bedeutung furdie Selbstandigkeit dieser Zellen. Munch med. Wochenschr. 60, 1981-1984, 1913.

• 120) Fleischman, P.:Der zweite Fall von Monozytenleukamie. Fol. Haematol. 20, 17-32, 1916.

• 121) Ewald, O.:Die Leukamische Reticuloendotheliose, Dtsch. Arch. f, Klin. Med. 142, 222-228, 1923.

• 122) Naegeli, O.:Blutkrankheiten und Blutdiagnostik. V. Afl. Springer, Berlin, 1931.

• 123) Dowhey, H.:Moroeytic leukemia and leucemic reticulo-endotheliosis. Hand book of Hematology. II, 1273-1334, 1938.

• 124) 天野重安:血液学の基確, 上巻, 丸善, 東京, 1948.

• 125) 滝川清治, 吉田照史, 山田一正:単球白血病について. 日本臨牀, 18, 2007-2023, 1960.

• 126) 平木潔, 大藤真:単球白血病. 白血全書, 5, 268-312, 丸善, 東京, 1962.

• 127) 太田宏, 内海真:単球白血病. 血液病学 (三輪史朗編) , 文光堂, 東京, 印刷中

• 128) Osserman, E. F. and Lawlor, D. P:Serum and urine lysozyme (muramidase) in momocytic and monomyelocytic leukemia. J. exp. Med. 124, 921-952, 1966.

• 129) Braunstein, H.:Esterase in leukocytes. J. Histochem. Cytoehem. 7, 202 1959.
  pubmed

• 130) Li, C. Y., Lam, K. W. L. T.:Esterases in human leukocytes. J. Histochem, Cytochem. 21, 1-12, 1973.

• 131) Yam, L. T., Li, C. Y. and Crosby, W. H.:Cytochemical identification of monocytes and granulocytes. Amer. J. Clin. Path. 55, 283-290, 1971.

• 132) van Furth, R. (ed) :Mononuclear phagocytes in immunity, infection and pathology. Blackwell Scientific Publications. Oxford, 1975.

• 133) Bradley, T. R. and Metcalf, D.:The growth of mouse bone marrow cells in vitro. Amer. J. exp. Biol. med. Sci. 44, 287-299, 1966.

• 134) Pluznik, P. H. and Sachs. L.:The cloning of normal "mast" cells in tissue culture. J. Cell Physiol. 66, 319-334, 1965.

• 135) Cline, M. J. and Golde, D. W.:A review and reevaluation of the histiocytic disorders. Amer. J Med. 55, 49-60, 1973.
  pubmed

• 136) 高久史麿:顆粒球産生の調-特にコロニー産生刺激因子(CSF) の病態生理学的意義. 医学のあゆみ, 95, 41-50, 1975.

• 137) 太田宏:単球の分化と成熟, 血液病学(三輪史朗編) , 文光堂, 東京, 印刷中

• 138) 太田宏, 安間秋清:単球増殖性疾患-myelomonocytic leukemiaと単球白血病について. 日本網内系学会誌, 19, 印刷中

• 139) Mc Kenna, R. W., Bloomfield, C. D., Dick, F., Nesbit, M. E. and Bruhning, R. D.:Acute monoblastic leukemia:Diagnosis and treatment of ten cases. Blood 46, 481-494, 1975.

• 140) Bouroncle, B. A., Wiseman, B. K. and Doan, C. A.:Leukemic reticuloendotheliosis. Blood 13, 609-630, 1958.
  pubmed

• 141) 柴田昭:細網症の臨床. 臨床血液, 15, 329-342, 1974.

• 142) Osgood, E. E.:Acute monocytic leukemia as an explanation for"hiatus leukemicus" and "myelomonocytic leukemia". Blood 33, 268, 273, 1969.

• 143) Linman, J. W.:Myelomonoeytic leukemia and its preleukemic phase. J. chron. Dis. 22, 713-716, 1970.
  pubmed

• 144) Soarni, M. I. and Linman, J. W.:Myelomopocytic leukemia:Disorderly proliferation of all marrow cells. Cancer 27, 1221-1230, 1971.

• 145) Miescher, R. A. and Farquet, J. J.:Chronic myelomonocytic leukemia in adults. Seminars in Hematol. 11, 129-139, 1974.

• 146) 千田信行, 吉武淳介:単球性白血病. 臨床血液学 (長谷川弥人, 日野志朗編) , 医学書院, 東京, 1974. p. 520-540.

• 147) Schmalzl, F., Hukn, D., Asamer, H., Abbrederis, K. and Braunsteiner, H.:Atypical (monomyelocytic) myelogeneous leukemia. Cytochemical, electron microscopic and biochemical investigations. Acta haemat, 48, 72-88, 1972.

• 148) Kass, L.:Esterase reactions in acute myelomonocytie leukemia. Amer. J. Clin. path. 67, 485-488, 1977.

• 149) Skinnider, L. F., Card, R. T. and Padmanabh, S:Chronic myelomonocytic leukemia, An ultrastructural study by transmission and scanning electron microscopy. Amer. J. clin. Path. 67, 33-346, 1977.

• 150) Sexauer, J., Kass, L. and Schnitzer, B.:Subacute myelomonocytic leukemia. Clinical, morphologicand ultrastructural studies of 10 cases. Amer. J. Med. 57, 853-861, 1974.
  pubmed

• 151) Geary, C. G., Catovsky, D. Wiltshaw, E., Milner, G. R., Scholes, M. C., van Noorden, S., Wadsworth, L. D., Muldai, S., Mac Iver, J. E. and Galton, D. A. G.:Chronic myelomonocytic leukemia. Brit. J. Haemat. 30, 289-302, 1975.

• 152) Zittoun, R.:Subacute and chronic myelomonocytic leukemia:A distinct haematological entity. Brit. J. Haemat. 32, 1-7. 1976.
  pubmed

• 153) 遠藤安行, 酒井力, 山口昭彦, 新藤徹郎, 吉田広作, 間宮繁夫, 三浦亮, 柴田昭:Chronic myelomonocytic leukemia 1例. 日内会誌, 67, 601-609, 1978.

• 154) 浅野茂隆, 千葉省三:Chronic myelomonocytic leukemia. 内科, 41, 1232-1237, 1978.

慢性白血病の病態と治療

P.272 掲載の参考文献

• 1) Nowell, P. C. and Humgerford, D. A.:A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497, 1960.

• 2) Casparson, T., Gahrton, G., Lindsten, J. and Zech, L.:Indentification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorenscence analysis. Exp. Cell Res., 63, 238-240, 1970.

• 3) Rowley, J. D.:A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluoresce and Giemsa staining. Nature, 243, 290-293, 1973.
  pubmed

• 4) Ezdinli, E. Z., Sokal, J. E. Crosswhite, L. and Sandberg, A. A.:Philadelphia-chromosome-positive and-negative chronic myelocytic leukemia. Annals lnt. Med. 72, 175-182, 1970.

• 5) 鎌田七男, 田中龍二, 内野治人:前白血病状態. 最新医学, 31, 1142-1151, 1976.
  Medical*Online

• 6) Ogawa, M., Fried, J., Sakai, Y., Strife, A. and Clarkson, B.:Studies of cellular proliferation in human leukemia. VI The proliferative activity, generation time and emergence time of neutrophilic granulocytes in chronic leukemia. Cancer, 25, 1031-1049, 1970.
  pubmed

• 7) 村上巌:3H-thymidine autoradiograph法による人白血球の回転に関する研究. (I) 好中球に関して. 日血会誌, 31, 10-27, 1968.

• 8) Gavosto, F.:Granulopoiesis and cell kinetics in chronic myeloid leukaemia. Cell Tissue Kinet., 7, 151-163, 1974.

• 9) Stryckmans, P., Debusscher, L. and Socquet, M.:Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia. Cancer Res., 36, 3034-3038, 1976.
  pubmed

• 10) Sjogren, U. and Brandt, L.:Different composition and mitotic activity of the haemopoietic tissue in bone marrow, spleen and liver in chronic myeloid leukemia. Acta Haemat., 55, 73-80, 1976.
  pubmed

• 11) 御供泰治, 神谷とし彦, 樋上昌男, 仁田正和, 仲西義裕, 滝川清治, 高本滋, 太田和雄:Flow-micro-fluorimetry(F. M. F.) による白血病細胞回転に関する研究 (第2報) -とくに慢性骨髄性白血病について-. 第39回日本血液学会総会, 1977.

• 12) Mitelman, F., Nilsson, P. G. and Brandt, L.:Brief communication:Abnormal clones resembling those seen in blast crisis arising in the spleen in chronic myelocytic leukemia. J. N. C. I., 54・1319-1321, 1975.

• 13) 太田和雄:白血病の化学療法におけるalkylating agentに関する研究. 名古屋医学, 71, 24-64, 1956.

• 14) 遠藤博志, 岩田豊, 後藤迪夫, 太田和雄:慢性骨髄性白血病の急性化に関する考察. 日血会誌, 20, 316-317, 1957.

• 15) 太田和雄, 野村聡, 今村一夫, 平光精二, 山田一正, 星野章, 神谷博彦, 木村禧代二:慢性骨髄性白血病の急性転化に関する考察, 日血会誌, 28, 440-441, 1958.

• 16) 太田和雄, 遠藤博志, 吉兼和美, 竹内清:白血病の急性増悪について-慢性骨髄性白血病の急性化に関する考察-. 診療, 11, 713-723, 1958.

• 17) 川島康平, 上田竜三, 吉川活哉, 江崎幸治, 西脇洋, 大野滝三, 今井邦之, 槌谷忠明, 山田一正:慢性骨髄性白血病の急性転化について. 臨床血液 14, 676-682, 1973.

• 18) 喜多嶋康一, 高橋功, 高橋安彦:慢性骨髄性白血病の急性転化. 内科ムック白血病, p. 131-138, 金原出版, 東京, 1978.

• 19) Lawrence, R. L., Low-Beer, B. V. A. and Brown, B. R.:Chronic myelogenous leukemia:Study of 129 cases in which treatment was with radioactive phosphorus. JAMA, 136, 672-677, 1948.

• 20) Osgood, E. E.:Treatment of chronic leukemias. Results of therapy by titrated, regularly spaced total body radioactive phosphors, or roentgen irradiation. JAMA, 150, 1372-1379, 1952・

• 21) Blackburn, E. K., King, G. M. and Swan, H. T.:Myeleran in treatment of chronic myeloid leukaemia. Brit. M. J. 1, 835-837, 1956.

• 22) Platzer, R. F.:Onset of myeloblastic leukemia. Proc. VIII International Congress of Hematology, 564-567, 1962.

• 23) 太田和雄:慢性骨髄性白血病の急性転化時の治療. 臨床血液, 10, 378-386, 1969.

• 24) 中尾喜久, 衣笠恵士, 高久史麿, 三浦恭定, 八幡義人, 倉科周介:慢性骨髄性白血病のMyleran療法に対する検討, II 急性転化について. 臨床血液, 8, 21-26, 1967.

• 25) Karanas, A. and Silver, R. T.:Characteristics of the terminal phase of chronic granulocytic leukemia. Blood, 32, 445-459, 1968.
  pubmed

• 26) Monfardini, S., Gee, T., Fried, J. and Clarkson, B.:Survival in chronic myelogenous leukemia:Influence of treatment and extent of disease at diagnosis. Cancer, 31, 492-501, 1973.
  pubmed

• 27) Vallejos, C. S., Trujillo, J. M., Cork, A., Bodey, G. P., McCredie, K. B. and Freireich, E. J., :Blastic crisis in chronic granulocytic leukemia:Experience in 39 patients. Cancer, 34, 1806-1812, 1974.
  pubmed

• 28) 太田和雄, 山田一正, 坂井保信, 棟方宏次, 木村喜代次:白血病化学療法に関する 2, 3の問題. 臨床血液, 1, 824-832, 1960.

• 29) 勝沼精蔵:血液疾患の診断及び療法 (白血球方面) . 日本内科学会雑誌, 23, 1-142, 1935.

• 30) Bernard, J. and Seligmann, M.:La transformation aigue des leucemies chroniques. Proc. VIII International Congress of Hematology, 318-326, 1962. (日比野進, 太田和雄:白血病の臨床と診断について. 最新医学, 16, 245-250, 161.)

• 31) 服部絢一:慢性白血病-急性転化時の治療. 臨床血液, 10, 370-377, 1969.

• 32) 鎌田七男:慢性骨髄性白血病における摘脾の意義とその適応. 臨床血液, 18, 1191-1202, 1977.

• 33) 遠藤博志:慢性白血病の臨床知見補遺. 名古屋医学, 77, 1570-1601, 1959.

• 34) 岡田浩佑:アルカリフォスファターゼ. 臨床血液, 9, 250-265, 1968.

• 35) 中島章, 大橋辰哉:慢性骨髄性白血病. 臨床血液学 p. 632 医学書院, 1966.

• 36) 喜多嶋康一, 石崎雅信, 長尾忠美, 高橋功, 木下日出男, 島田明人, 森脇洋司, 上村致信:慢性骨髄性白血病. 急性転化の早期診断基準早期治療に関する臨床的研究. 臨床血液, 13, 1840-1846, 1976.

• 37) 喜多嶋康一:癌の化学療法-白血病-. 日本臨牀, 33, 1840-1846, 1976.

• 38) 名尾良寛, 村上義次, 牧泰, 小幡裕, 町井彰, 片野てい子, 小島靖, 岡田寛, 高松道雄:腫瘤形成性白血病の検討. 臨床血液, 9, 414-422, 1968.

• 39) 長尾忠美, 上村致信, 土岐博信, 陳博明, 内藤徳郎, 高橋功, 喜多嶋康一:腫瘤形成性白血病に関する臨床的研究. 臨床血液, 16, 19-24, 1975.

• 40) 内田立身, 山岸司久:著明な骨髄芽球腫を伴った慢性骨髄性白血病の1例. 臨床血液, 10, 740-747, 1969.

• 41) 太田和雄, 村上巌, 三浦守司, 平光精二, 中島八良:興味ある血液型を示し骨髄性細網肉腫を発生した慢性骨髄性白血病の1例. 臨床血液, 6, 100-101, 1965.

• 42) Ota, K.:Clinical and hematological studies on the reticulum-cell-sarcoma-like tumor developing during the terminal phase of chronic myelogenous leukemia. Recent Advances in RES Research 10, 95-107, 1970. The Japan Society of RES, Nagoya.

• 43) 森崎直木, 今井三喜, 山田喜久馬:慢性白血病患者にみられた悪性骨腫瘍について. 東女医誌, 18, 557-558, 1955.

• 44) 衣笠恵士, 今村幸雄, 三輪卓爾, 来栖明, 高久史麿, 平嶋邦猛, 斉藤昌信, 朝長正徳:高度の骨破壊と肉腫様腫瘤形成を認めた慢性骨髄性白血病の1成人例. 臨床血液, 2, 240, 1961.

• 45) 衣笠恵士, 三輪卓爾:白血病の種類と染色体構成について. 日血会誌, 26, 17-22, 1963.

• 46) 藤本幸雄, 石田定, 徳田種二, 建石竜平:慢性骨髄性白血病に細網肉腫症を併発した1例. 広島医学, 17, 764-770, 1964.

• 47) 大西義久, 小泉富美朝, 北村四郎, 小黒昌夫, 塚田恒安, 速水一雄, 桜川信男:巨細胞を伴った腫瘤形成白血病の1部検例, とくに本腫瘍について. 日血会誌, 26, 411-412, 1963.

• 48) 太宰厚, 佐藤安一, 木間周男:臀部腫瘤を伴った慢性骨髄性白血病の一例. 東北医学, 68, 287, 1963.

• 49) 浅井淳平, 太田和雄:慢性骨髄性白血病に併発した左上腕部腫瘍. 医学のあゆみ, 55, 93-94, 1965.

• 50) 谷本一夫, 仁保喜之, 服部絢一, 櫃本恵:著しい巨脾を伴った腫瘤形成骨髄性白血病の1例. 臨床血液 8, 156-157, 1967.

• 51) 牧野卓磨, 富田貞雄, 堀江建, 田上正昭, 河北靖夫:上腕骨に巨大な腫瘤を形成し, 離断術を施行した慢性骨髄性白血病の2例. 臨床血液, 11, 184-185, 1970.

• 52) 星野孝, 河崎昭, 高島昭佳, 深瀬政市, 為我井道子, 井谷舜郎:末期に細胞肉腫様の組織像を示す腫瘤形成を認めた慢性骨髄性白血病の1例. 臨床血液, 11, 183-184, 1970.

• 53) 津崎文雄:慢性骨髄性白血病の経過中に骨腫瘍を併発した1例. 九血誌, 12, 82, 1962.

• 54) 戸塚忠政, 石井善一郎, 那須毅:信州大学学長故佐藤武雄先生の臨床剖検記録. 信州医誌, 8, 1-4, 1959.

• 55) 勝沼英宇, 佐藤淳, 西村恒夫, 長村重之:剖検でそれぞれ潰瘍と結節と病変を呈した慢性骨髄性白血病の2例. 臨床血液, 10, 142, 1969.

• 56) 朝長万左男, 高橋敬一, 市丸道人, 河原田正晴, 木下勝:興味ある終末像を呈したCMLの一例. 臨床血液, 11, 183, 1970.

• 57) Suchi, T.:Histopathological survey of the cases with the reticulum cell sarcoma-like tumors developed during the terminal phase of chronic myelogenous leukemia. ibid. 147-162.

• 58) Suchi, T. and Ota, K.:Clinical, cytological and histopathological studies of cases of reticulum cell sarcoma-like tumors developing during the terminal phase of chronic myelogenous leukemia. In Malignant Diseases of the Hematopoietic System. Monograph on Cancer Research 15, 97-110, University of Tokyo Press, 1973.

• 59) Fukuda, T.:Pathological investigation on reticulum cell sarcoma-like tumor developed during terminal phase of chronic myelogenous leukemia. Recent Advances in RES Research, 10, 108-120, 1970. Proceeding of the Japan Society of RES, Nagoya.

• 60) Ohnishi, Y.:Chronic granulocytic leukemia terminating in reticulum cell sarcoma-relationship between chronic graunlocytic leukemia and primary reticulum cell sarcoma of bone-ibid. 121-146,

• 61) Joseph, R. P., Zarafonetic, J. D. and Durant, J. R.:"Lymphoma" in chronic granulocytic leukemia. Amer. J. Med. Sci., 251, 417, 1966.

• 62) Kranznai, G., Keresztury, S. and Szucs, L.:Granulomatous giant cell reticulosis associated with cases of treated leukemia. J. Clin. Path., 20, 841-844, 1967.

• 63) Chabner, B. A., Haskell, C. M. and Canellos, G. P.:Destructive bone lesions in chronic granulocytic leukemia. 48, 401-410, 1969.
  pubmed

• 64) Pascoe, H. R.:Tumors composed of immature granulocytes occurring in the breast in chronic granuocytic leukemia. Cancer, 25, 697-704, 1970.
  pubmed

• 65) 若狭治毅, 高橋弘, 木村伯子, 吾妻美子, 安保徹, 熊谷勝雄, 大家清:悪性リンパ腫の病理-腫瘍細胞の特性を中心として-. 最新医学, 32, 1556-1567, 1977.
  Medical*Online

• 66) Boggs, D.:Hematopoietic stem cell theory in relation to possible lymphoblastic conversion of chronic myeloid leukemia. Blood, 44, 449-453, 1974.
  pubmed

• 67) Jenkins, D. W., Rivera, H. P. and Coltman, C. A.:Case report. Acute lymphatic leukemia followed by a clinical picture indistinguishable from chronic granulocytic leukemia in the same patient. Am., J. Med. Sci. 274, 329-333, 1972.

• 68) Beard, M. E., Durrant, J., Catovsky, D., Wiltshaw, E., Amess, J. L, , Brearly, R. L, Kirk, B., Winley, P. F. M., Greaves, M. F. and Galton, D. A. G.:Blast crisis of chronic myeloid leukemia (CML) I. Presentation simulating acute lymphoid Ieukemia (ALL) . Brit. J. Hematology, 34, 167-178, 1976.

• 69) Mauri, C., Torelli, U., Prisco, U. D., Silingardi, V., Artusi, T., and Emillia, G.:Lymphoid blastic crisis at the onset of chronic granulocytic leukemia, report of two cases. Cancer, 40, 863-870, 1977.

• 70) 小池正, 青柳愛孝, 塚田恒安, 山田康子:急性リンパ性白血病の病像で発熱したPh1陽性骨髄性白血病の1例. 第19回日本臨床血液学会総会 1977.

• 71) McCaffrey, R., Smoler, D. F. and Baltimore, D.:Terminal deoxynucleotidyl transferase activity in a case of childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci, 70, 521-525, 1973.

• 72) Gallo, R., Bhattacharyya, J. and Anderson, P.:Specific markers of chronic myelogenous leukemia (CML) cells (Ph1 chromosome) , thymic-derived cells (terminal transferase) , and type-C RNA tumor virus (reverse transcriptase) in blastic leukemia. J. Clin. Invest. 53, 26a, 1974.

• 73) Sarin, P. S. and Galls, R. C.:Terminal deoxynucleotidyl transferase in chronic myelogenous leukemia. J. Biol. Chem. 249, 8051-8053, 1974.

• 74) McCaffrey, R., Harrison, T. A., Parkman, R. and Bastimore, D.:Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes. N. E. J. M. 292, 775-780, 1975.

• 75) Barr, R. D., Sarin, P. S. and Perry, S. M.:Terminal transferase in human bone-marrow lymphoytes. Lancet, 508-511, 1976.

• 76) 佐々木龍平, 高久史麿:白血病とTerminal Transferase. 医学のあゆみ, 100, 557-562, 1977.

• 77) Srivastave, B. E. S., Khan, S. A. and Henderson, E. S.:High terminal deoxynucleotidyl transferase activity in acute myelogenous leukemia. Cancer Res., 36, 3847-3850, 1976.

• 78) 佐々木龍平, 坂本忍:造血細胞の増殖に於ける各種DNAポリメレースの役割とその臨床的意義. 第39回日本血液学会総会シンポジウム 1977.

• 79) 宮田久寿, 山田清美:慢性骨髄性白血病の急性転化時にみられた染色体異常について. 臨床血液, 11, 2, 1970.

• 80) 鎌田七男, 小熊信夫, 田中龍二:CML急性転化時の染色体異常-とくにE17の異常例について. 臨床血液, 17, 233-234, 1976.

• 81) Fossfeld, D. K. and Sandberg, A. A.:Das Philadelphia Chromosom. Klin. Wschr. 48, 1431-1441, 1970.

• 82) 阿部達生:細胞遺伝学よりみた慢性骨髄性白血病. 臨床血液, 16, 839-849, 1975.

• 83) DeGrouchy, J., de Nava, C., Cantu, J-M., Bilski-Pasquier G. and Bonsser, J.:Model for clonal evolutions:A study of chronic myelogenous leukemia. Amer. J. Human Genet. 18, 485-503, 1966.

• 84) 天羽弘行, 星野章, 栗田宗次, 小川一誠, 太田和雄:興味ある染色体異常を示した慢性骨髄性白血病2例について. 日血会誌, 33, 780, 1970.

• 85) 阿部達生, 森田益次, 三澤信一:慢性骨髄性白血病. 臨床科学, 13, 142-150, 1977.

• 86) Shaw, M. T., Borromley, R. H., Graozea, P. N. and Nordquist, R. E.:Heterogeneity of morphological, cytochemical, and cytogenetic features in the blastic phase of chronic granulocytic leukemia. Cancer, 35, 199-206, 1975.

• 87) Peterson, L. C., Bloomfield, C. D. and Brunning, R. D.:Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia, a study of 28 patients. Amer. J. Med. 60, 209-220, 1976.
  pubmed

• 88) Janossy, G., Greaved, M. F., Revesz, T., Lister, T. A., Roberts, M., Durrant, J., Kirk, B., Catovsky, D. and Beard, M. E.:Blast crisis of chronic myeloid leukemia (CML) . Brit. J. Hematology, 34, 169-192, 1976.

• 89) 大野竜三, 上田竜三, 鈴木久三, 田中正史, 江崎幸治, 川島康平, 山田一正, 吉川治哉, 社本幹博, 川部正巳:B-cellマーカーを有するリンパ芽球によるblast crisisを呈した慢性骨髄性白血病の1例. 臨床血液, 19, 166-171, 1978.

• 90) 滝川清治, 浅川瑞穂:血球の組織細胞化学. 綜合臨牀, 18, 1709-1722, 1969.

• 91) 高野康雄, 平野正美, 柿沢久美, 林清剛, 水野康, 社本幹博:急性転化時, 貧食性巨細胞の出現した慢性骨髄性白血病の1症例. 第19回日本臨床血液学会総会, 1977.

• 92) Pusey, W. A.:Report of cases treated with roentgen rays. JAMA, 82, 1489-1490, 1924.

• 93) Osgood, E. E.:Titrated, regularly spaced radioactive phosphorus or spray roentgen therapy of leukemias. A. M. A. Arch. Internal Med., 87, 329-340, 1951.

• 94) Haddow, A. and Timmis, G. M.:Myleran in chronic myeloid leukemia:Chemical contribution and biological action. Lancet, 1, 207-210, 1953.

• 95) Minot, G. R. Buckman, T. E. and Isaacs, R.:Chronic myelogenous leukemia, JAMA., 82, 14 89-1494, 1924.

• 96) Shimkin, M. B., Mettier, S. R. and Bierman, H. R.:Myelocytic leukemia:an analysis of incidence, distribution and fatality. 1910-1948, Ann. Intern. Med., 35, 194-212, 1951.
  pubmed

• 97) Reinhard, E. H., Neery, C. L and Samples, D. M.:Radioactive phosphorus in the treatment of chronic leukemias:long-term results over a period of 15 years. Ann. Intern. Med., 50, 942-958, 1959.

• 98) Haut, A., Abbott, W. S., Wintrobe, M. M. and Cartwright, G. E.:Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy. Blood, 17, 1-19, 1961.
  pubmed

• 99) Report of the Medical Research Council's working party for therapeutic trials in leukaemia:Chronic granulocytic leukaemia:Comparison of radiotherapy and busulphan therapy. Brit. Med. J. 1, 201-208, 1968.

• 100) Conrad, C. F. G.:Survival in chronic granulocytic leukemia, splenic irradiation vs busulfan. Arch Int. Med. 131, 684-685, 1973.

• 101) Monfardini, S., Gee, T., Fried, J. and Clarkson, B:Survival in chronic myelogenous leukemia:Influence of treatment and extent of disease at diagnosis. Cancer, 31, 492-501, 1973.
  pubmed

• 102) Report of the dibromomanitol cooperative study group:Survival of chronic myeloid leukaemia patients treated by dibromomannitol. Europ. J. Cancer, 9, 583-589, 1973.

• 103) Kardinal, C. G., Bateman, J. R. and Weiner, J.:Chronic granulocytic leukemia:Review of 536 cases. Arch. Intern. Med. 136, 305-313, 1976.
  pubmed

• 104) Sullivan, J. R, Hurley, T. H. and Bolton, J. H.:Treatment of chronic myeloid leukemia with repeated single doses of busulfan. Cancer Treat Rep. 61, 43-45, 1977.
  pubmed

• 105) 栗田宗次, 星野章, 小川一誠, 亀井良孝, 村上稔, 太田和雄:慢性白血病. 日本臨牀, 29, 2686-2691, 1971.
  Medical*Online

• 106) 北川中行, 厚井文一, 時岡正明, 土岐博信, 高橋功, 喜多嶋康一, 木村郁郎:CML長期生存例に関する検討-全国集計70例の解析-. 第19回日本臨床血液学会総会, 1977.

• 107) 中尾喜久, 衣笠恵士, 今村幸雄, 高久史麿, 平野真司, 佐々茂, 溝口秀昭:慢性骨髄性白血病のmyleran療法に関する研究. III. Myleran 微量療法について. 臨床血液, 8, 659-665, 1967.

• 108) 柴田昭:再び慢性骨髄性白血病について. 臨床血液, 17, 698, 1975.

• 109) Canellos. G. P., DeVita, V. T., Whang-Peng, J. and Carbone, P. P.:Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood, 38, 671-679, 1971.
  pubmed

• 110) Canellos, G. P., Wang-Peng, J., Schnipper, L. and Brown, C. H., :Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulocytic leukemia. Cancer, 30, 288-293, 1972.

• 111) Marmont, A. M. and Damasio, E. E.:The treatment of terminal metamorphosis of chronic granulocytic leukaemia with corticosteroids and vincristine. Acta Haemat. 50, 1-8, 1973.
  pubmed

• 112) Spiers, A. D. S., Costello, C., Catovsky, D., Gaston, D. A. G. and Goldman, J. M.:Chronic granulocytic leukaemia:multiple-drug chemotherapy for actue transformation. Brit. Med. J. 13, 77-80, 1974.

• 113) Vallejos, C. S., McCredie, K. B., Britin, G. M. and Freireich, E. J.:Biological effects of repeated leukapheresis of patients with chronic myelogenous leukemia. Blood, 42, 925-933, 1973.

• 114) Canellos, G. P., Dvita, V. T., Whang-Peng, J., Chabner, B. A. Schein, P. S. and Young, R. C.:Chemotherapy of the blastic phase of chronic granulocytic leukemia:Hypodiploidy and respons to therapy. Blood. 47, 1003-1009, 1976.

• 114) 坂野輝夫, 井上雄弘, 木村禧代二:慢性白血病の化学療法-特に急性転化におけるVEMP療法を中心に. 癌と化学療法, 2, 247-253, 1975.

• 115) 正岡徹:私信

• 116) Spiers, A. S. D.:In Leukemia, 3rd ed., ed. Gunz, F. & Baikie, Ag., p. 655, New York:Grune & Stratton, 1974.

• 117) Spiers, A. S. D.:The treatment of chronic granulocytic leukemia. Brit. J. Hematol. 32, 291-298, 1976.

• 118) 川島康平, 上田龍三:急性及び慢性白血病への臨床応用. 臨床血液, 18, 620-626, 1977.

• 119) Mitelman, F., Brandt, L. and Nilsson, P. G.:Cytogenetic evidence for splenic origin of blastic transformation in chronic myeloid leukemia. Scand. T. Haematol. 13, 87-90, 1974.

• 120) Spiers, A. S. D., Baikie, A. G., Gaston, D. A. G., Richards, H. G. H., Wiltshaw, E., Goldman, J. M., Catovsky, D., Spencer, J. and Peto, R.:Chronic granulocytic leukaemia:effect of elective splenectomy on the course of desease. Brit. Med. J. 1, 175-179, 1975.

• 121) Ihde, D・C・, Canellos, G. P., Shwartz, J. H. and DeVita, V. T.:Splenectomy in the chronic phase of chronic granulocytic leukemia. Eeffects in 32 patients, A. lntern. Med. 84, 17-21, 1976.

• 122) 柴田昭:慢性骨髄性白血病治療の問題点 脾摘について. 第19回日本臨床血液学会総会, 1977.

• 123) Finney, R., McDonald, G. A., Baikie, A. G. and Douglas, A. S.:Chronic granulocytic leukaemia with Ph1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia. Brit. J. Haematology, 23, 283-288, 1972.

• 124) Chervenick, P. A,. Ellis, L. D., Pan S. F., Lawson A. L.:Human leukemic cells:in vitro gowth of colonies containing the philadelphia (Ph1) chromosome. Science, 174, 1134-1136,

• 125) Clarkson, B., Dowling, M., Gee, T., Cunningham, I. Hopfan, S., Knapper, W. and Chaganti, R.:Radical therapy for chronic granulocytic leukemia (CGL) . XVI International Congress of Hematology, 1976.

• 126) Goto. T. and Clarkson, B. D.:私信

• 127) 川島康平, 緒方完治:慢性骨髄性白血病治療の問題点, 慢性骨髄性白血病根絶のための強力化学療法について. 第19回日本臨床血液学会総会, 1977.

• 128) 阿部達生:細胞遺伝学よりみた慢性骨髄性白血病. 臨床血液, 16, 839-849, 1975.

• 129) Smalley, R. V., Vogel, J., Huguley, C. M. and Miller, D.:Chronic granulocytic leukemia:Cytogenetic conversion of the bone marrow with cycle-specific chemotherapy. Blood, 50, 107-113, 1977.
  pubmed

• 130) Sokal, J. E:, Aungst, C. W. and Grace, J. T.:Immunotherapy in well-controlled chronic myelocytic leukemia. N. Y. S. J. Med. 1180-1185, 1973.

• 131) 伊勢 泰, 塙 嘉之:小児の慢性骨髄性白血病. 小児科診療, 31, 973-985, 1968.

• 132) Hardisty, R. M., Speed, D. E. and Till, M.:Granulocytic leukemia in childhood. Brit. J. Haemat. 10, 551-566, 1964.
  pubmed

• 133) 田口信行:小児の慢性白血病. 日本臨牀, 29, 2692-2696, 1971.
  Medical*Online

• 134) Virchow, R.:Die Leukamie. In Gessammelte Abhandlungen zur wissenschaftlichen Medizin. p. 190, Frankfurt. Meidinger, 1856a.

• 135) Proposed Guideline for Protocol Studies III. Chronic Lymphocytic Leukemia. Cancer Chemoth. Reports, part 3. 1, 41, 1968.

• 136) Kundrat, H.:Ueber Lympho-Sarcomatosis. VVien Klin. Wchnschr. 6, 211-234, 1893.

• 137) Rappaport, H.:Malignant lymphoma. Tumors of the hematopoietic system. in Atlas of Tumor Pathology, Sect III, Tascicle 8. Armed Forces Institute of Pathology, Washington, D. C., 1966.

• 138) Dameshek, W.:Chronic lymphocytic leukemia-an accumulative disease of immunologically incompetent lymphocyte. Blood, 29, 566, 1967.

• 139) Lukes, R. J. and Collins, R. O.:Immunologic characterization of human malignant lymphoma. Cancer, 34, 1488, 1974.

• 140) Clark, C., Rydell, R. E. and Kaplan, M. E.:Frequent association of Ig M with crystalline inclusions in chronic lymphatic leukemic lymphocytes. New Engl. J. Med. 289, 113, 1973.

• 141) Aisenberg, A. C. and Bloch, K. J.:Immunoglobulins on the surface of neoplastic lymphocytes. New Engl. J. Med. 287, 272, 1972.
  pubmed

• 142) 白石忠男, 田中英二:リンパ球の臨床. 臨床と研究, 51, 167, 1974.

• 143) Stephen, D.:Hypothesis:Differentiation of the human lymphoid system based on cell surface markers. Blood, 45, 871, 1975.

• 144) Catovsky, D. and Molt, P. J. L.:T or B lymphocytes in chronic lymphocytic leukemia. Lancet, 1, 976, 1971.

• 145) Lille, I., Desplaces, A., Aeeus, L., Saracins, R. T. and Brout, J. C.:Thymus-derived proliferating lymphocyte in chronic lymphocytic leukemia. Lancet, II, 263, 1973.

• 146) Russell, J. M. and Cochran, A. J.:Concurrent malignancy in T cell chronic lymphocytic leukemia. Lancet, 24, 1215, 1973.

• 147) Shevach, E., Edelson, R., Frank, M. et al:A human leukemic cell with both B and T cell surface reports. Proc. Nat. Acad. Sci. 71, 863, 1974.

• 148) Sandilans, G. P., Gray, K., Cooney, A., Browning, J. D. Grant, R. M., Anderson, J. R., Dagg, J. H. and Lucie, N.:Lymphocytes with T and B cell properties in a lymphoproliferative disorder. Lancet, 1, 903, 1974.

• 149) 木下研一郎, 上平 憲, 市丸道人:慢性リンパ性白血病 (CLL) とその周辺. 臨床血液, 17, 428, 1976.

• 150) 後藤達彦, 尾山 淳, 高本 滋, 小川一誠, 太田和雄, 御供泰治:末梢血リンパ球の機能に関する研究 (第3報) -大中小リンパ球におけるTB cell subpopulationについて-. 日血会誌, 38, 410. 1975.

• 151) 高月 清, 内山 卓, 佐川公矯, 淀井淳司:リンパ球系腫瘍の表面マーカー-新しい疾患概念としての 成人T細胞白血病-. 臨床血液, 17, 416, 1976.

• 152) 高月 清, 内山 卓, 佐川公矯, 淀井淳司:T 細胞白血病-白血化T細胞の機能的側面-. 臨床科学, 13, 637, 1977.

• 153) Brouet, J. C., Flandrin, G., Sasportes, M., Preud'homme, J. L, Seligmann, M.:Chronic lymphocytic leukemia of T cell origin. Immunological and clinical evaluation in eleven patients. Lancet, 2, 890, 1975.
  pubmed

• 154) Galton, D. A. G. et al.:Prolymphocytic Leukemia. Brit. J. Haemat. 27, 7, 1974.

• 155) Yodoi, J., Takatsuki, K., Aoki, N. and Masuda, T.:Chronic lymphocytic leukemia of T-cell origin. Demonstration in two cases by the use of antithymocyte membrane antiserum. Acta Haematol. Jap. 37, 289, 1974.

• 156) 野村紘一郎, 古庄弘典, 菊地博, 西岡紘一郎, 松元正, 花田修一, 加藤吉保, 橋本修治, 松元実, 柚木 一雄, 寺師慎一, 吉井紘興:成人型T細胞性白血病の肺合併症の検討. 日血会誌, 41, 174. 1978.

• 157) Russell, J. M. and Cochran, A. J.:Concurrent malignancy in T-cell chronic lymphocytic leukemia. Lancet 2, 1215, 1973.

• 158) Hansen, M. M.:Chronic lymphocytic leukemia. p. 105, Munksgaard, Copenhagen, 1973.

• 159) 小林司郎, 鎌田武信, 大植更二:肺癌を合併した慢性淋巴球性白血病の1症例. 日血会誌, 28, 681, 1965.

• 160) 本堂 克, 塩岡 誠, 亀谷正明, 清水 勝, 松友啓典, 小島峯雄:肺癌を合併したT細胞性慢性リンパ 性白血病の1例. 臨床血液, 18, 1272, 1977.

• 161) Catovsky, D. and Galton, D. A. G.:Myelomonocytic leukemia supervening on chronic lymphocytic leukemia. Lancet, 1, 478, 1971.

• 162) Roberts, P. D. and Forster, P. M.:Chronic lymphocytic leukemia associated with acute myelomonocytic leukemia. Brit. J. Haemat. 25, 203, 1973.
  pubmed

• 163) Klajman, A. et al.:Acute lymphoblastic crisis in a patient with chronic lymphatic leukemia. Acta Haemat. 54, 306, 1975.

• 164) Knospe, W. H., Loeb, V. Jr. and Huguley, C. M.:Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer, 33, 555, 1974.
  pubmed

• 165) Johnson, R. E.:Total body irradiation of chronic lymphocytic leukemia. Cancer, 37, 2691, 1976.
  pubmed

悪性リンパ腫の病態と治療

P.342 掲載の参考文献

• 1) Hodgkin, T.:On some morbid appearances of the absorbent glands and spleen. Med. chirug. Trans., London 17, 68, 1832.

• 2) Wintrobe, M. M.:Conditions chiefly affecting lymph nodes and spleen. Clinical Hematology, Lea & Febiger, Philadelphia, p. 1099, 1967.

• 3) Wilks, Sir S.:Cases of lardaceous disease and some allied affections with remarks. Guy's Hosp. Rep, 2, 103, 1856.

• 4) Virchow, R.:Weisses Blut und Milztumoren. Med. Ztg. 15, 157, 163, 1846.

• 5) Kundrat, H.:Ueber Lympho-sarkomatosis. Wien. Klin. Wschr. 6, 211, 1893.

• 6) Oberling, Ch.:Les reticulosarcomes et les reticuloendotheliosarcomes de las moelle osseuse (sarcomes d'Ewing) . Bull. Ass. franc. etude du Cancer. 17, 259, 1928.

• 7) Sternberg, C.:Zur Frage des sog. Ewing Tumor. Frank. Z. Path. 48, 525, 1935.

• 8) Virchow, R・:In"Handbook of Hematology" IV:3049, Hafner Publishing Co. New York, 1965.

• 9) Billroth, T.:Ueber die feinere Structur der medullaren Geschwulste. Virchow. Archiv , 99, 378, 1860.

• 10) Minot, G. R. and Isaags, R.:Lymphobastoma and Malignant lymphoma. JAMA 86, 1185, 1265, 1926

• 11) Preschfeld, J.:Beitrtige zur Lehre von den Lymsakomen. Dtsch. med. Wschr 17, 1175, 1893.

• 12) Paltauf, R.:Lymphosarkom (Lymphosarkomatose, Pseudoleukamie, Myelom, Chlorom) . Ergebn, allg. patn. Path. Anat. 3, 652, 1897.

• 13) Sternberg, C. ; Uber Leukosarcomatose. Wien. Klin. Wschr, 21, 475, 1908.

• 14) John, A. & Roman, B.:Uber das Lymphosarcoma. Frankf. Z. Path. 19, 1, 1916.

• 15) Ewing, J.:Endothelioma of Lymph Nodes. J. Med. Res. 28, 1, 1913-1914.
  pubmed

• 16) Komochi, W.:Ueber eine Geschwulst von eigenartigen Ban (Reticuloma S. Adenoidoma) . Virchow. Arch. Path. Anat. 250, 517, 1924.

• 17) Komochi, W.:Noch ein Fall von Reticuloma. Virchow. Arch. Path. Anat. 277, 605, 1930.

• 18) Aresu, M., Scalabrino R.:"Ipreplasie e sarcomatos" delle ghiandole linfatiche. Tumori, 1, 307, 1927.

• 19) Roulet, F.:Das primare Retothelsarkom der Lymphknoten. Virchow. Arch Path. Anat. 277, 15, 1930.

• 20) Rossle, R.:Das Retothelsarkom der Lymphdrtisen. Seine Form und Verwandtshaftan, Beitr. Path. Anat. 103, 385, 1939.

• 21) 赤崎兼義:細網内皮系統とその腫瘍. 日血会誌, 41, 1, 1952.

• 22) Brill, N. E. et al:Generalized giant lymph follicle hyperplasia of lymph nodes and spleen. JAMA 84, 668, 1925.

• 23) Symmers, D.:Giant follicular lymphadenopathology with or without splenomegaly. Arch. Path. 26, 603 1938.
  pubmed

• 24) Rappaport, H.:Tumor of the hematopoietic system. Atlas of tumor pathology. Sec. 3, Fasc. 8. Washington, D. C., Armed Forces Institute of Pathology 1966.

• 25) Lukes, R. J.:The American concept of malignant lymphoma. 最新医学, 19, 1631, 1964.

• 26) Gall, E. A. & Mallory, T・B.:Malignant lymploma. Aclinical pathologic survey of 618 cases. Amer. J Path, 18, 381, 1942.

• 27) Jackson, H., Jr. & Parker, F., Jr.:Hodgkin's disease and allied disorders. Oxford Univ. Pres, 1947.

• 28) Custer, R. P. et al・:The interrelationship of Hodgkin's disease and other lymphatic tumors. Amer. J. med. Sci 216, 625, 1948.

• 29) Berman, L.:Malignant lymphoma. Blood, 8, 195, 1953.
  pubmed

• 30) 松井敬介:淋巴肉腫. 日血全書1, 丸善, 東京, p. 345, 1962.

• 31) de Oliveira, G.:Ueber die Stellung der Retothelsarkome in System der Lymphdrusengeschwulste. Virchow Arch. Path. Anat. 298, 464, 1937.

• 32) Lukes, R. J.:The pathologic picture of the maliganat lymphomas. Prcc. Int. Conf. on Leukemia, Lympoma. Lea & Febiger, Philadelphia, p. 333, 1968.

• 33) Lukes, R. J. et al.:Hodgkin's disease;an evaluation of the significance of clincal stages and histologic findings of the basis of 377 U. S. Army. Cases from World War II.

• 34) Peters, M. V. & Middlemiss, K. C. H.:A study of Hodgkin's disease treated by irradiation. Amer. J. Roentg. 79, 114, 1958.

• 35) Symposium:Obstacles to the control of Hodgkin's disease. Rye, New York, September 13-15, 1965. Cancer Res. 6, 1045, 1966.

• 36) Rosenberg, S. A.:Report of the Commitee on the Staging of Hodgkin's Disease. Cancer Res. 26, 1310, 1966.

• 37) Tubina, M.:Position d'une classification des differentes formes cliniques de la maladie de Hodgkin. J. Radiol. Electr. (Supp.) 47, 175, 1966.

• 38) Peters, M. V., Haselback, R. and Brown, T. C.:The natural history of the lymphomas related to the clinical classifications. In Prodeedings of the International Conferences on Leukemia, Lymphoma. edited by C. J. D. Zarafonetis, Philadelphia, Leo& Febigner, p. 357, 1968.

• 39) Musshoff, K. and Boutis, L.:Beurteilung Behandlungsgrundsatze und Ergebnisse bei der Lymphogranulomatose. Strahlentherapie (Sonderb.) 69, 59, 1969.
  pubmed

• 40) Rosenberg, S. A. and Kaplan, H. S.:Hodgkin's disease and other malignant lymphomas. Calif. Med. 113, 23, 1970.
  pubmed

• 41) Carborne, P. P. et al.:Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 31, 1860, 1971.

• 42) Carborne, P. P. and De Vila, V. T.:Malignant Lymphoma. In Cancer Medicine, edited by Holland J. F. and Frei E. Lea& Febiger, Philadelphia, p. 1302. 1973.

• 43) Chabner, B. A. et al.:Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Cancer 42, 922, 1978.
  pubmed

• 44) Sweet, D. L et al.:Hodgkin's disease, problems of staging. Cancer 42, 957, 1978.
  pubmed

• 45) 木村禧代二:日本に於ける網内系腫瘍, 1. 臨床的立場から. 日網会誌, 3, 1, 1963.

• 46) 坂井保信:リンパ性細網肉腫の生存期間とそれに関係する要因について. 日網会誌, 7, 239, 1967.

• 47) Kimura, K.:Clinical studies of Hodgkin's disease in Japan. Recent advances in RES Research 11, 1, 1971.

• 48) 木村禧代二・他:悪性淋巴腫の化学療法. -淋巴肉腫を中心に-. 癌と化学療法, 1, 9, 1974.
  Medical*Online

• 49) Lukes, R. J. and Collins, R. D.:Immunologic characterization of human malignant lymphoma. Cancer 34, 1488, 1974.

• 50) Lukes, R. J. and Collins, R. D.:New approach to the classification of malignant lymphoma. Recent results. Cancer Res. 46, 18, 1974.

• 51) Lukes, R. J.:Functional classification of malignant lymphoma of Lukes and Collins in lymphoid neoplasia, 1. Classification, categorization, natural history. edited by G. Mathe, M. Seligman, M. Tuhina, S. Springer-Verlag Berlin. Heiderberg, NewYork p. 19, 1978.

• 52) Burkitt D. P.:Asarcoma involving the jaws in African children. Brit. J. Surg. 46, 218, 1958.

• 53) 久賀宣人・大星章一:リンパ肉腫の病理, 悪性リンパ腫の病態と臨床 (木村禧代二編著) . p. 67 日本評論社, 東京, 1976.

• 54) O'Conar, G. T.:Malignant lymphoma in African children. II A pathological entity. Cancer 14, 270, 1961.

• 55) Burkitt, D. P. and Wright, D. H.:Burkitt's lymphoma. Levingstone, Ediburgh and London, 1970.

• 56) 月本一郎・他:本邦における Burkitt腫瘍. 臨床血液, 14, 849, 1973.

• 57) Levin. P. H. et al:Antibodies to EBV in African patients with Burkitt lymphoma, Cancer 30, 610, 1972.

• 58) Dorfman, R. E.:Childhood lymphosarcoma in St. Louis, Missouri, clinically and histologically resembling Burkitt's tumor. Cancer 18, 418, 1965.

• 59) Burkitt, D. P.:Etiology of Burkitt's lymphoma, an alternative hypothesis to a vectored virus. J. Nate. Cancer lnst. 42, 19, 1969.

• 60) 0'Conar, G. T.:Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor. Am. J. Moed. 48 279, 1970.

• 61) 田中昇:細網症の諸相-病理, 持に悪性細網症-malignant reticulohistiocytosisについて. 最新医学, 24, 825, 1969.

• 62) Tanaka, N.:Malignant reticulohistiocytosis border line between reactive and neoplastcs. In Recent Advances in RES Research 12, 924, 1972.

• 63) 小島瑞:狭義の細網内及症. 最新医学, 19, 1767, 1964.

• 64) Fukuda, T・:Leukemic reticulosis and allied disorders. Tohoku J. Exp. Med. 87, 1, 1965.

• 65) 小川一誠, 太田和雄, 栗田宗次:悪性リンパ腫の細胞像と細胞回転, 悪性リンパ腫の病態と臨床, 木村禧代二編著, p. 15, 日本評論社, 東京, 1976.

• 66) 小川一誠・他:リンホアデノグラムの意義. 日本臨床細胞学会シンポジュム 1973.

• 67) Vitetta, E. A. et al.:Immunoglobulinreceptors revisited. Science 189, 964, 1975.
  pubmed

• 68) Sarin, P. S. et al.:Terminal deoxynucleotidyl transferase activities in human blood leukocytesand lymphoblast cell lines:high levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase. Blood 47, 11, 1976.

• 69) Tachibana, T. et al.:Immunological analysis of hemoadsorption of cultured cells derived from Burkitt's Lymphoma. Proceeding of 1st International Symposium of the Prince Takamatsu Cancer Recearch Fund. p. 433, University of Tokyo Press, Tokyo, 1971.

• 70) Ross, G. D. et al.:Specificity of human lymphocyte complement receptors. J. Exp. Med. 141, 1163, 1975.
  pubmed

• 71) Winchester, R. J. et aL:Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J. Exp. Med. 141, 924, 1975.

• 72) Scherach, A. et al:Human leukemia cell with both B and T cell surface receptors. Proc. Nat. Acag. Sci. 71, 863, 1974.

• 73) Siegal, F. P. et al.:Association of a chromosomal abnormality with lymphocytes having both T and B markers in a patient with lymphoproliferative disease. Am. J. Med. 60, 157, 1976.

• 74) Mathe, G. et al.:Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho-and reticulosarcoma (non-Hodgkin's lymphoma) . Biomedicine, 22, 177, 1975.

• 75) Order, S. E. et al.:Pathogenesis of Hodgkin's diseases. Lancet 571, 1972.
  pubmed

• 76) Leech J.:Immunoglobulin-positive Reed Sternberg cells in Hodgkin's disease. Lancet. ii, 265, 1973.

• 77) Tindle, B. et al.:"Reed-Sternberg cells"in infectious mononucleosis? Am. J. Clin. Path. 58, 607, 1972.
  pubmed

• 78) Lutzner, M. et al.:Cutaneous T-cell lymphomas:the Sezary syndrome, mycosis fungoides, and related disorders. Ann. Int. Med. 83, 534, 1975.
  pubmed

• 79) Aisenberg, A. C. et aL:Lymphocyte surface characterstics in malignant lymphoma. Am. J. Med. 58, 300, 1975.

• 80) 湊 啓輔, 下山正徳・他:白血病細胞の膜性状の検討. 医学のあゆみ, 94, 58, 1975.

• 81) 下山正徳, 湊 啓輔・他:B-cell type を示した巨大炉胞性リンパ腫の1例. 第16回日本臨床血液学会総会1974.

• 82) 湊 啓輔, 下山正徳・他:造血器腫瘍細胞とヒツジ赤血球及び IgM 抗体感作補体結合, ヒツジ赤血球との結合能. 医学のあゆみ, 13, 961, 1974.

• 83) Jaffe, E. S. et al.:Nodular lymphoma evidence for origin from follicular B lymphocytes. New. Engl. J. Med. 290, 813, 1974.
  pubmed

• 84) Fu., S. M. et aL:Occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J. Exp. Med. 142, 1334, 1975.

• 85) 下山正徳, 湊 啓輔・他:成人のT-cell型リンパ系悪性腫瘍の臨床病態生理学的特徴. 第17回日本臨床血液学会総会, 1975.

• 86) Yodoi, J. et al.:新しい白血病-adult T-cell leukemia. 日本癌学会総会記事 34, 215, 1975.

• 87) Lukes, R. J. et al.:New approaches to the classification of the lymphomata. Br. J. Cancer 31, Suppl II, 1, 1975.

• 88) Lennert, K. et al.:Cytological and functional criteria for the classification of malignant lymphoma. Br. J. Cancer, 31, Suppl II, 29, 1975.

• 89) 難波紘二, 飯島宗一:悪性リンパ腫研究の新段階, 恵性リンパ腫分類に関する国際会議の周辺. 日網内会誌 15, 135, 1976.

• 90) Pusey, W. A.:Cases of sarcoma and of Hodgkin:s disease treated by exposure to X-ray. A preliminary report. JAMA 38, 166, 1902.

• 91) Kaplan, H. S.:Evidence for tumorcidal dose level in the radiotherapy of Hodgkin's disease. Cancer Res. 26, 1225, 1966.

• 92) Gillman, A・et al・:unpublished data, 1942-43 Kamofsky D. A"The Chemotherapy of theLympherra". In Proceedings of the International Conference on Leukemia-Lymphoma, Edited by D. Zarafonetis, Lea&Febigne Philadelphia, p. 403, 1968.

• 93) Jacobson, L. O. et al.:Nitrogen-mustard therapy:Studies on the effect of methyl bis betachloroethyl amine hydrochloride on neoplastic diseases and allied disorder of the hematopoietic system. JAMA132, 263, 1968.

• 94) Goodman, M. M. et aL:Nitrogen-mustard therapy:Use of methyl bis(β-chloroethyl) -aminehydrochloride and tris(β-chloroethyl) amine for Hodgkin's disease, lymphosarcoma, leukemiaand certain allied and miscellaneous disorder. JAMA 132, 26, 1946.

• 95) Karnofsky, D. A. et al.:An evolution of methyl bis(β-chloroethyl) amine hydrochloride(nitrogen mustard) in the treatment of lymphoma, leukemia and allied diseases in approaches to tumorchemotherapy. Am. Assoc. Advancement Sc., Washington, D. C., P. 319, 1947.

• 96) 日比野進, 木村禧代二:白血病の臨床. 日血会誌, 14(補) , 261, 1952.

• 97) Clinical studies of Hodgkin's desease in Japan Recent advances in RES. Research. 11, 1, 1971

• 98) Davis, H. L. et al.:Evolution and role of single chemotherapeutic agent in adult non-Hodgkin's lymphoma, In"Recent Results in Cancer Research. Lymphoid Neoplasias II-Clinical and Therapeutic Aspect" edited by G. Mathe, M. Seligman, M. Tubina, Springer Verlag. Berlin, Heideeberg, New York pp. 129, 1978.

• 99) Skipper, H. E. et al.:Implications of biochemical cytokinetic, pharmacologic and toxicologic relationships in the design of optimal therapeutic schedules. Cancer Chemotherapy or Report 54, 431, 1970.

• 100) 木村禧代二・他:悪性淋巴腫の化学療法. 綜合臨牀, 20, 1556, 1971

• 101) Kimura, K. et al.:Chemotherapy of malignant lymphoma with special references to the effect of sequential therapy with bleomycin and vinca alkaloids, In Advances in Antimicrobial and Anti-neoplastic Chemotherapy. Urban & Schwarzanberg, Munchen, Berlin, Wien, P. 667, 1972.

• 102) 木村禧代二:ホジキン病の化学療法. 癌ﾉ臨床, 19 , 4, 1973.

• 103) 木村禧代二・他:悪性リンパ腫の化学療法-細網肉腫を中心に-. 皮膚科の臨床, 15, 特:852, 1973.

• 104) 木村禧代二・他:悪性リンパ腫の化学療法-淋巴肉腫を中心に-. 癌と化学療法, 1, 9, 1974.

• 105) Kimura, K:Clinical problems of Non-Hodgkin's lymphoma. In Topics in Hematology, edited by S. Seno, F. Takaku, S, Irino, Excerpta Medica, Amsterdam-Oxford. p. 33, 1977.

• 106) 近田千尋:悪性リンパ腫に対する化学療法の効果と腫瘍細胞の形態学的所見との相関-細網肉腫を中心に-. 癌と化学療法, 2, 53, 51.

• 107) Kimura, K.:Chemotherapy of adult malignant lymphoma with references to long term control. In Advances in Cancer chemotherapy, edited by Stephen K. Carter et al. Japan Scientific Societies Press, Tokyo University Park Press, Baltimore, P. 367, 1977.

• 108) 井深田鶴子・他:急性白血病及び悪性淋巴腫の感染症. 最新医学, 31, 1360, 1976.
  Medical*Online

• 109) 下山正徳・他:造血器腫瘍に合併した感染症の治療. 抗生物質3剤. 広域ペニシリン, セファロスポリン系アミノ配糖体系併用療法の有用性. 癌の臨床, 25, 171, 1979.

• 110) 竹中武昭・他:白血病に合併した敗血症の治療. 臨床血液, 20, 261, 1979.

• 111) 木村禧代二他:白血球輸血, 臨床看護3, 91, 1977.

• 112) 井上雄弘他:白血球(顆粒球) 輸血および血小板輸血. 内科Mook, 金原出版, 1978

• 113) 下山正徳・他:半連続血球分離装置ヘモネティクスモデル30を用いた顆粒球採取について. 臨床血液 19, 1453, 1978.

• 114) Clinical drug evaluation:Ageneral protocol for the phase II study of cancer chemotherapeutic agents in malignant solid tumors. Cancer Chemoth. Rep. 52, 650, 1968.

• 115) Bagley, C. M. et aL:Advanced lymphosarcoma:Intensive lyclical combination chemotherapy with cyclophoshamide, Vincristine and Prednisone. Ann. Interm. Med. 76, 277, 1972.

• 116) Luce, J. K. et al.:Combined cyclophosphamide, vincristine and prednisone therapy of malignant lymphoma. Cancer 28, 306, 1971.
  pubmed

• 117) Mukherji, B. et al.:Cyclic chemotherapy in lymphosarcoma. Cancer 28, 886, 1971.
  pubmed

• 118) Ziegler, J. L:Relapse patterns in Burkitt's lymphoma. Cancer Res. 32, 1267, 1972.
  pubmed

• 119) DeVita, V. T.:Advanced diffuse histiocytic lymphoma. A potentially curable disease. Results with combination chemotherapy. Lancet 1, 248, 1975.

• 120) McKelvey, E. M. et a1.:Hydroxyldaunomycin (adriamycin) combination chemotherapy in non-Hodgkin's lymphoma. Proc. Amer. Soc. Clin. Oncol. 16, 223, 1975.

• 121) Schein, P. et al.:Anew combination chemotherapy program for diffuse histiocytic (DHL) and mixed (DML) non-Hodgkins's lymphoma. Proc. Amer, Soc. Clin, Onco1. 16, 248, 1975.

• 122) Ziegler, J. L.:Relapse patterns in Burkitt's lymphoma. Cancer Res., 32, 1267, 1972.
  pubmed

• 123) McElwain, T. J. et al. ; Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl. Cancer Inst. Monogr. 36, 395, 1973.
  pubmed

• 124) Lokich, J. J. et al.:Combination chemotherapy in advanced Hodgkin's dieasse. Ann, intern. Med. 79, 376, 1973.

• 125) Lokich, J. J. et al.:New multiple-agents chemotherapy (B-DOPA) for advanced Hodgkin's disease. Cancer 38, 667, 1976.
  pubmed

• 126) Vinciguerra, V. et al.:ANew combination chemotherapy for resistant Hodgkin's disease. JAMA 237, 33, 1977.

• 127) McElwain, J. J.:Acombination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Brit of Cancer 36, 276, 1977.

• 128) 小川一誠, 太田和雄・他:悪性リンパ腫に対する多剤併用(BONP) 療法の臨床治験. 癌の臨床, 18, 525, 1972.

• 129) 林恭一, 木村郁郎・他:悪性リンパ腫既治療剤に対するAdriamycin, Vincristine, Ifosphamide, Predonisolone四者併用療法. 第20回日本臨床血液学会総会記事, p. 21, 1978.

• 130) 栗田宗次, 太田和堆・他:悪性リンパ腫のBleomycin, Vincristine, Adriamycin, prednisolone併用(BOAP) 療法. 第20回日本臨床血液学会総会記事, p. 21, 1978.

• 131) Shimoyama, M. et aL:Oil-depot type bleomycin in the treatment of malignant lymphoma in comparison with regular bleomycin. Jap. J. Clin. Oncol. 8, 111, 1978.

• 132) 竹中武昭・他:進行Non-Hodgkin's lymphomaに対するAdriamycin の治療成績. 臨床血液, 19, 1314, 1978.

• 133) Gilbert, R.:Radiotherapy ln Hodgkin's disease (malignant granulomatosis) . Amer. J. Roentgenol. Rad. Ther. 4, 198, 1939.

• 134) Kaplan H. S.:The radical radiotherapy of regionally localized Hodgkin's disease. Radiology 553, 1962.
  pubmed

• 135) Kaplan H. S.:Clinical evaluation and radiotherapeutic management of Hodgkin's dsiease and other malignant lymphoma. New Eng. J. Med. 287, 892, 1968.

• 136) Lukes R. J. &Butler, J. J.:The pathology and nomenclature of Hodgkin's disease Symposium:Obstacles to the Control of Hodgkin's Disease. Cancer Res. 26, 1063, 1966.

• 137) Rosenberg, S. A.:Hodgkin's disease. In Cancer Medicine, edited by Holland, J. F. &Frie, III. Lea & Febiger, Philadelphia, P. 1276. 1973.

• 138) 金田浩一:悪性リンパ腫の放射線療法, 悪性リンパ腫の病態と臨床. 木村禧代二編著, 日本評論社, 東京, 1976.

• 139) Fuller, L. M.:Result of intensive regional radiation therapy in the treatment of Hodgkin's disease and the malignant lymphoma of the head and neck. Amer, J. Roentgenol, 99, 340, 1967.
  pubmed

• 140) Kaplan. H. S. et al.:National Cancer Institute. Mono 9. 36, 1973.

• 141) Newell, J. et al.:Reticulum cell sarcoma. Part III､ Radiation dosage for each type. Radiology 94, 2643, 1970.

• 142) 真崎規江・他・細網肉腫の臨床病期分類と予後. 日医放誌, 33, 212, 1973.

• 143) 金田浩一・他:悪性リンパ腫の照射様式, 線量と予後. 臨床放射線, 18, 897, 1973.

• 144) Easson, E. G.:The management of Hodgkin's disease and allied disorders. Modern Trend in Radiotherapy, edited by Deelsy and Wood. Butterwork, London p. 277, 1967.

• 145) van der Verf-Messing, B.:Reticulun cell sarcoma and lymphos arcoma. Aretrospective study of potential survival in leuco-regional disease. Eur. J. Cancer. 425, 49, 1976.

• 146) Musg. hoff, K. et al.:On the question of the tumorcidal dose in Non-Hodgkin's lymphomas. I"Recent Results in Cancer Research. -Lymphoid neoplasias-clinical therapeutic aspects. "Edited by Mate G. et al., Springer-Verlag, Berlin, Heidelberg, New York pp. 203 1978

• 147) Cox, J. D. et al.:Irradiation in the local control of malignant lymphoreticular tumor (Non-Hodgkins lymphoma) . Radiology 112, 179, 1974.
  pubmed

• 148) Smithers, D.:Hodgkins disease. Churchill Livingstone, Edinburgh & Lonpon 1977.

• 149) Gelhorn, A.:End results in Iymphosarcoma and Hodgkin's disease. Proceedings of Third National Cancer. Conference p. 862, 1957.

• 150) Rosenberg, S. A. et al.:Lymphosarcoma; A review of 1, 269 cases. Medicine 40, 31, 1961.

骨髄腫の病態と治療

P.373 掲載の参考文献

• 1) Osseman, E. F. and Isobe, T.:Plasma cell dyscrasias, Hematology, Williams, W. J., Beutler, E., Erslev, A. J. and Rundles, R. W. ed. pp. 950-956, Mc Graw-Hill, New York 1972.

• 2) Waldenstr6m, J.:Diagnosis and treatment of multiple myeloma. Grune & Stratten, New Yorks, 1970.

• 3) 柴田寿彦, 池田靖, 磯部敬, 太田宏, 新美守彦, 小野三郎:メルファラン大量投与により長期生存した多発性骨髄腫の一症例. 臨床血液, 14, 619-625, 1973.

• 4) Isobe, T., Ikeda, Y., Shibata, T., Nihmi, M. and Ohta. H:Detection of solitary plasmacytoma by 99mTc pertechnetate in a patient with monoclonal gammaglobulin. Acta Haemat Jap. 39, 109-110, 1976.

• 5) Carbone, P. P:Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am. J. Med. 42, 937-948, 1967.
  pubmed

• 6) Costa, G. et al. (The Acute Leukemia Group B and Eastern Cooperative Oncology Group) :Melphalan and prednisolone:an effective combination for the treatment of multiple myeloma. Am. J. Med. 54, 589-599, 1973.

• 7) Dollin, S, and Dewar, J. P.:Extramedullary plasmacytoma. Am. J. Path. 32, 82-100, 1956.

• 8) 橋本美智雄, 橋本紀三:多発性骨髄腫の病理, 第一編, 多発性骨髄腫剖検例54例の骨髄ならびに骨所見. 九州血液同好会誌, 12, 84-149, 1962.

• 9) Isobe, T., lkeda, Y., Imura, H. and Ohta, H.:Plasma cell leukemia. A clinical study of 13 cases, with a demonstration of small-sized plasma cells. Acta Haematol. Jap. 40, 529-540, 1977.

• 10) Shimoyama. M. and Mikami, H.:Some clinical characteristics of reticulum cell sarcoma and lymphoblastic lymphosarcoma with reference to leukemic transformation. Recent Advances in RES Research 12, 166-182. 1972.

• 11) 天野重安:形質細胞に就て. 日血会誌, 9, 25-30, 1946.

• 12) Rohr, K:Das Menschliche Knochenmark, 3(vollig umgarbeitete) Auflage, Georg Thieme. Stuttgart 1960.

• 13) Douglas, S., D.:Cells involved in immune responses. Basic & clinical immunology., Fudenberg, H. H, et al, ed., Lange Medical publications, USA. 1976.

• 14) 池田靖, 太田宏, 竹中武昭, 高橋順也, 伊藤銑一, 水野晴光:骨に打ち抜き像を認めた原発性マクログロブリン血症の1例. 臨床血液, 13, 864-872, 1972.

• 15) Isobe. T., Horimatsu, T., lkeda, Y. and Ohta, H.:Macroglobulinemia:Its polymorphisln of clinical manifestations. Acta. Haematol. Jap. 42, 16-23, 1979.

• 16) 磯部敬:アミロイドーシス・骨髄腫のすべて(三好和夫編) , pp. 189-198. 南江堂, 1978.

• 17) Isobe, T., Ikeda, Y. and Ohta, H.:Monoclonal immunoglobulin and its related abnormalties in cases of plasma cell dyscrasia. Nagoya J. Med. Sci, 39, 15-19, 1977.

• 18) Isobe, T., lkeda, Y., Ohta, H. and Imura. H.:IgD myeloma-A clinical study of g cases. Acta Haematol. Jap. 39, 319-328, 1976,

• 19) Bergel, F, and Stock, J. A.:Cytotoxic alpha amino acids and peptides. Br. Emp. Cancer Campaign Annual Rep. 31. 6-11, 1953.

• 20) Larionov, L. F., Shkodinskaja, E. N., Troosheikina, V. I, Khokhlov, A. S., Vasina, O. S. and Novikova, M. A.:Studies on the antitumor activity of p-di-(2-chloroethyl) aminophenyl alanine (sarcolysin) ､ Lancet, I (269) , 169-171, 1955.

• 21) Blokhin, N., Larionov, L. F., Perevodchikava, N. 1., Chebotreva, L. and Merkuleva, N.:Clinical experiences with sarcolysin in neoplastic diseases. Ann. N. Y. Acad Sci. 68, 1128-1132. 1958.

• 22) Bergsagel, P. E., Sprague, C. C. Austin, C. and Griflfith, K. M.:Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV L-phenylalanine mustard (NSC-8806) . Cancer Chemother. Rep. 21, 87-99, 1962.

• 23) 太田宏, 池田靖, 柴田寿彦, 服部宏己, 安間秋靖:メルファラン(melphalan) による多発性骨髄腫の治療. 臨床血液, 13, 811-819, 1972.

• 24) Alexanian, R., Bonnet, J., Gehan, E., Haut, A., Hewlett, J., Lane, M., Monto, R. and Wilson, H.:Combination chemotherapy for multiple myeloma. Cancer 30, 382-389, 1972.

• 25) 山崎健之, 植谷忠昭:多発性骨髄腫の治療. 臨床血液, 10, 404-413, 1969.

• 26) McArther, J. R., Wintrobe, M. M. ad Cartwright, G. E.:Melphalan and myeloma. Ann. Intern. Med 72, 665-670. 1970.

• 27) George, R. P., Poth, J. L, Gordon, D. and Schrier, S. L.:Multiple myeloma-aintermittent combination chemotherapy compared to continuous therapy. Cancer 29, 1665-1670, 1972.

• 28) Costa, G., Engle, R. L., Schilling, A., Carbone, P., Kochwa, S., Nachman, R. L. and Glidewell, 0. J.:An effective combination for the treatment of multiple myeloma. Am. J. Med. 54. 589-599, 1973.

• 29) 今村幸雄:多発性骨髄腫の診断(1) . 臨床科学, 7, 913-926, 1971.

• 30) Osgood, E. E.:The survival time of patients with plasmacytic myeloma. Cancer Chemother Rep. 9, 1-10, 1960.
  pubmed

• 31) Midwest Cooperative Chemotherapy Group:Multiple myeloma. JAMA 188, 741-745, 1964.
  pubmed

• 32) Bergsagel, D. E., Griffith, K. M., Haut. A. and Stuckey, W. J. Jr.:The treatment of multiple myeloma. Adv. Cancer Res. 10, 311, 1967.

• 33) Hoogstraten, B., Sheehe, P. R. Cuttner, J., Cooper, T., Kyle, R. A., Oberfield, R. A., Townsend, S. R., Harley, J. B., Hayes, D. M., Costa, G. and Holland, J. F.:Melphalan in multiple myeloma. Blood 30, 74-83, 1967.
  pubmed

• 34) Hoogstraten, B., Costa, J., Cuttner, J., Forcier, T., Leone, L. A., Harley, J. R. and Glidewell, 0. J.:Intermittent melphalan therapy in multiple myeloma. JAMA 209, 251-253 1969.

• 35) Alexanian, R., Bergsagel, D. E., Migliore, P. J., Vaughn, W. K and Howe, C. D.:Melphalan therapy for plasma cell myeloma. Blood 31, 1-10, 1968.
  pubmed

• 36) Alexanian, R., Haut, A., Khan, A. V., Lane, M., Mc Kelvey, E. M., Migliore, P. J. Stuckey, W. J., Jr. and Wilson, H. E.:Treatment for multiple myeloma, JAMA 208, 1680-1685, 1969.

• 37) Rivers, S. L. and Patno, M. E.:Cyclophosphamide vs melphalan in treatment of plasma cell myeloma. JAMA 207, 1328-1334, 1969.
  pubmed

• 38) Medical Research Council:Myelomatosis:Comparison of melphalan and cyclophosphamide therapy. Br. Med. J. 1, 640-641, 1971.

• 39) Farhangi, M. and Osserman, E. F.:The treatment of lnultiple myeloma. Seminar Hematol. 10, 149-161, 1973.

• 40) Hansen, O. P., J essen, P. and Videbaek, A.:Prognosis of myelomatosis on treatment with prednisone and cytostatics. Scand. J. Haemat. 10, 282-290, 1973.

• 41) 坂井保信:多発性骨髄腫の化学療法. 第19回日本医学会総会会誌, 508-510, 1975.

• 42) Bergsagel, D. E., Migliore, P. J., and Griffith, K. H.:Myeloma proteins and the clinical responseto melphalan therapy. Science 148, 376-377, 1965.

• 43) Osserman, E. F.:Melphalan and antigenic type of Bence-Jones proteins in myeloma. Science 149, 564, 1965.

• 44) Bergsagel, D. E. and Pruzanski, W.:Treatment of plasma cell myeloma with cytotoxic agents. Arch. lntern. Med. 135, 172-176, 1975.
  pubmed

• 45) Galton, D. A. G.:Treatment of myelomatosis M. R. C. trial. Br. Med. J. 2, 323-324, 1971.

• 46) Medical Research Council:Report on the first myelomatosis trial. Part I. Analysis of presenting features of prognostic importance. Br. J. Haemat, 24, 123-139, 1973.

• 47) Holland, T. F.:Epidemic acute leukemia. New Eng. J. Med. 283, 1165-1166, 1970.

• 48) Ohta, H., lkeda, Y., Shibata, T. and Hirabayashi, N.:Acase of multiple myeloma terminating with acute myelomonocytic leukemia after long-term melphalan therapy. Acta Haematol. Jap. 37, 49-57, 1974.

• 49) Bergsagel, D. E., Cowan, D. H. and Hasselback, R.:Plasma cell myeloma:Response of melphalan resistant patients of high dose intermittent cyclophosphamide, Canad. Med. Assoc. J. 107, 851-855, 1972.
  pubmed

• 50) Osserman, E. F.:Monocytic and monomyelocytic leukemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma. Br. Med. J. 2, 327, 1971.
  pubmed

• 51) Rosner, F. and GrOnwald, H.:Multiple myeloma terminating in acute leukemia. Am. J. Med . 57, 927-939, 1974.

• 52) Salmon, S. E.:Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Seminar Hematol. 10, 135-147, 1973.

• 53) Hobbs, J. R.:Growth rates and response to treatment in human myelomatosis. Br. J. Haematol. 16, 607-617, 1969.
  pubmed

• 54) Alberts, D. S. and Golde, D. W.:DNA synthesis in multiple myeloma cells following cell cyclenon specific chemotherapy. Cancer Res. 34, 2911-2914, 1974.

• 55) Lee, B. J., Sahakian, G., Clarkson, B. D. and Klakoff, J. H.:Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU. Cancer 33, 533-538, 1974.

• 56) Azam, L. and Delmore, I. W.:Combination therapy for myelomatosis. Br. Med. J. 4, 560-564, 1974.

• 57) Case, D. C., Lee, B. J. and Clarkson, B. D.:Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU:M-2 protocol. Amer. J. Med. 63, 897-903, 1977.

• 58) Alexanian, R., Salmon, S., Bonnet, J., Gehan, E., Haut, A. and Weick, J.:Combination therapy for multiple myeloma. Cancer. 40, 2765-2771, 1977.
  pubmed

真性多血症

P.390 掲載の参考文献

• 1) Vaquez, H. M.:Sur une forme speciale de cyanose saccompagnant d'hyperglobulie excessive et persistante, Compt. Rend. Soc. Biol., 4, 384-388, 1892.

• 2) Osler, W.:Chronic cyanosis with polycythemia and enlarged spleen; a new clinical entity, Am. J. Med. Sci., 126, 187-201, 1903.

• 3) Gaisbock, F.:Die Bedeutung der Blutdruckmessung fur die arztliche Praxis, Deutsh. Arch. Klin. Med., 83, 363-409, 1905.

• 4) Minot, G. R., Buckman, T. E.:Erythremia (Polycythemia rubra vera) :the development of anemia:the relation to leukemia; consideration of the basal metabolism in blood formation and destruction and fragility of the red cells, Am. J. Med. Sci., 166, 469-489, 1923.

• 5) Dameshek, W.:Some speculations on the myeloproliferative syndromes, Blood, 6, 372-375, 1951.
  pubmed

• 6) Reissmann, K. R.:Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia, Blood, 5, 372-380, 1950.
  pubmed

• 7) Erslev, A. J.:Humoral regulation of red cell production, Blood, 8, 349-357, 1953.

• 8) Fried, W.:Erythropoietin, Arch. Intern. Med., 131, 929-938, 1973.
  pubmed

• 9) Adamson, J. W.:The erythropoietin hematocrit relationship in normal and polycythemic man:Implications of marrow regulation, Blood, 32, 597-608, 1968.
  pubmed

• 10) Krantz, S. B.:Response of polycythemia vera marrow to erythropoietin in vitro, J. Lab. Clin. Med., 71, 997-1012, 1968.

• 11) Gurney, C. W.:Polycythemia vera and some possible pathogenetic mechanisms, Ann. Rev,. Med., 16, 169-186, 1965.
  pubmed

• 12) Adamson, J. W., Fialkow, p J., Murphy, S., Prchal, J. F., Steinmann, L.:Polycythemia vera:stem-cell and probable clonal origin of the disease, Nem Engl. J. Med., 295, 913-916, 1976.

• 13) Ward, H. P., Vautrin, R., Kurnick, J.:Presence of a myeloproliferative factor in patients with polycythemia vera and agnogenic myeloid metaplasia, I. Expansion of the erthropoietin-responsive stem cell compartment, Proc. Soc. Exp. Biol. Med., 147, 305-308, 1974.

• 14) Zanjani, E. D.:Hematopoietic factors in polycythemia vera, Semin. Hemat., 13, 1-12, 1976.
  pubmed

• 15) Dameshek, W.:Stress erythrocytosis, Blood, 8, 282-284, 1953.
  pubmed

• 16) Russell, R. P., Conley, C. L:Benign polycythemia:Gaisb6ck's syndrome, Arch. lntern. Med., 114, 734-740, 1964.
  pubmed

• 17) Brown, S. M., Gilbert, H. S., Krauss, S., Wasserman, L. R.:Spurious (relative) polycythemia:Anonexistent disease, Am. J. Med., 50, 200-207, 1971.
  pubmed

• 18) Weinreb, N. J., Shih, C.:Spurious polycythemia, Semin. Hemat., 12, 397-407, 1975.
  pubmed

• 19) Donati, R. M., Mccarthy, J. M, Lange, R. D., Gallagher, N. I.:Erythrocythemia and neoplastic tumors, Ann. Intern. Med., 58, 47-55, 1963.
  pubmed

• 20) Waldmann, T. A., Rosse, W. F., Swarm, R, L.:The erythropoiesis-stimulating factors produced by tumors, Ann. N. Y. Acad. Sci., 49, 509-515, 1968.

• 21) Hammond, D., Winnick, S.:Paraneoplastic erythrocytosis and ectopic erythropoietin, Ann. N. Y. Acad. Sci., 230, 219-227, 1974.
  pubmed

• 22) Charache, S., Weatherall, D. J., Cleg9, J. B:Polycythemia associated with a hemoglobinopathy, J. Clin. Invest., 45, 813-822, 1966.

• 23) Hamilton, H. B., Iuchi, I., Miyaji, T., Shibata, S.:Hemoglobin Hiroshima(β143 histidine-》aspartic acid) :a newly identified fast moving beta chain variant associated with increased oxygen affinity and compensatory erythremia, J. Clin. Invest., 48, 525-535, 1969.

• 24) Stephens, A. D.:Polycythaemia and high affinity haemoglobins, Brit. J. Haemat., 36, 153-159, 1977.
  pubmed

• 25) Modan, B.:An epidemiological study of polycythemia vera, Blood, 26, 657-667, 1965.
  pubmed

• 26) Modan, B., Kaliner, H., Zemer, D., Yoran, C.:Anote on the increased risk of polycythemia vera in Jews, Blood, 37, 172-176, 1971.

• 27) Silverstein, M. N., Lanier, A. P.:Polycythemia vera, 1935-1969, an epidemologic survey in Rochester, Minnesota, Mayo. Clin. Proc., 46, 751-753, 1971.

• 28) 日比野進, 山崎健之, 栗田宗次:多血症. 日血全書, 5, 647-689, 丸善, 1962.

• 29) Berlin, N. I.:Diagnosis and classifcation of the polycythemias, Semin. Hemat., 12, 339-351, 1975.

• 30) Wasserman, L. R.:Polycythemia vera-its course and treatment:relation to myeloid metapasia and leukemia, Bull. N. Y. Acad. Med., 30, 343-375, 1954.
  pubmed

• 31) Chievitz, E., Thiede, T.:Complications and causes of death in polycythemia vera, Acta. Med. Scand., 172, 513-523, 1962.
  pubmed

• 32) Stroebel, C. F., Law, W. M. l Polycythemia vera, Med. Clin. N. Am., 40, 1045-1060, 1956.

• 33) Robert, B. E, Miles, D. W., Woods, C. G.:Polycythaemia vera and myelosclerosis:Abone marrow study, Brit. J. Haemat., 16, 75-85, 1969.

• 34) Van Dyke, D., Anger, H. O.:Patterns of marrow hypertrophy and atrophy in man, J. Nucl. Med., 6, 109-120, 1965.

• 35) Kay, H. E. M., Lawler, S. D., Millard, R. E.:The chromosomes in polycythemia vera, Brit. J. Haemat., 12; 507-527, 1966.

• 36) Reeves, B. R., Lobb, D. S., Lawler, S. D.:Identity of the abnormal F-group chromosome associated with polycythemia vera, Huonangenetik, 14, 159-161, 1972.
  pubmed

• 37) Shiraishi, Y., Hayata, I., Sakurai, M., Sandberg, A. A.:Chromosomes and causation of human cancer and leukemia, XII. Banding analysis of abnormal chromosomes in polycythemia vera, Cancer, 36, 199-202, 1975.
  pubmed

• 38) Wurster-Hill, D., Whang-Peng, J., McIntyre, O. R, Hsu, L. Y. F., Hirshhorn, K., Modan, B., Pisciotta, A. V., Pierre, R., Balcerzak, S. P., Weinfeld, A., Murphy, J:Cytogenetic studies in polycythemia vera, Semin. Hemat., 13, 13-32, 1976.

• 39) Gilbert, H. S., Krauss, S., Pasternack, B., Herbert, V., Wasserman, L. R.:Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease, value in differential diagnosis and as indications of disease activity, Ann. Intern. Med., 71, 719-729, 1969.

• 40) Cutler, S. J., Ederer, F.:Maximum utilization of the life table method in analyzing survival, J. Chron. Dis., 8, 699-712, 1958.
  pubmed

• 41) 厚生省大臣官房統計調査部編:第12回生命表. 厚生統計協会, 1970.

• 42) Osgood, E. E.:Polycythemia vera:age relationships and survival, Blood, 26, 243-256, 1965.
  pubmed

• 43) Halnan, K. E., Russell, M. H.:Polycythemla vera, comparison of survival and causes of death in patlents managed with and without radiotherapy, Lancet, 2, 760-763, 1965.

• 44) Lawrence, J. H., Winchell, H. S., Donald, W. G.:Leukemia in polycythemia vera, relationship to splenic myeloid metaplasia and therapeutic radiation dose, Ann. Intern. Med., 70, 763-771. 1969.

• 45) Silverstein, M. N.:Postpolycythemia myeloid metaplasia, Arch. Intern. Med., 134, 113-115, 1974.
  pubmed

• 46) Perkins, J., Israels, M. C. G., Wilkinson, J. F.:Polycythemia vera, clinical studies on a series of 127patients managed without radiation therapy, Quart. J. Med., 33, 499-518, 1964.

• 47) Arthur, K.:Radioactive phosphorus in the treatment of polycythemia, areview of ten years'experience, Clin. Radiol., 18, 287-291, 1967､

• 48) Campbel1, A., Emery, E. W., Godlee, J. N., Prankerd, T. A. J.:Diagnosis and treatment of primary polycythemia, Lancet, 1, 1074-1077, 1970.

• 49) Tubiana, M., Flamant, R., Attie, E., Hayat, M.:Astudy of hematological complications occurring in patients with polycythemia vera treated with 32P, Blood, 32, 536-548, 31968.

• 50) Watkins, P. J., Fairley, G. H., Scott, R. B.:Treatment of polycythemia vera, Brit. Med J., 2, 664-666, 1967.
  pubmed

• 51) Modan, B., Lilienfeld, A. M.:Polycythemia vera and leukemia, a study of 1222 patients, Medicine, 44, 305-344, 1965.
  pubmed

• 52) Osgood, E. E.:The case of P32 in treatment of polycythemia vera, Blood, 32, 492-499, 1968.

• 53) Landaw, S. A.:Acute leukemia in polycythemia vera, Semin. Hemat., 13, 33-48, 1976.
  pubmed

• 54) Adamson, J. W.:Familial polycythemia, Semin. Hemat., 12, 383-396, 1975.
  pubmed

• 55) 小宮悦造編:日本人の正常血液像, 南山堂. 1962.

• 56) Wasserman, L. R.:The management of polycythemia vera, Brit. J. Haemat., 21, 371-376, 1971.
  pubmed

• 57) Loeb, V.:Treatment of polycythemia vera, Clin. Haemat., 4, 441-456, 1975.
  pubmed

• 58) Wasserman, L R.:The treatment of polycythemia vera, Semin. Hemat., 13, 57-78, 1976.
  pubmed

• 59) Gilbert, H. S.:Problems relating to control of polycythemia vera:the use of alkylating agents, Blood, 32, 500-505, 1968.

• 60) Klein, H., J acobson, L. O.:Management of the polycythemias, polycythemia, theory and management, ed. Klein, H., C. C. Thomas Pub., Springfield, 209-237, 1973.

• 61) Szur, L, Lewis, S. M., Goodden, A. W. G.:Polycythaemia vera and its treatment with radioactive phosphorus, a review of 90 cases, Quart. J. Med., 28, 397-421, 1959.

• 62) Dameshek, W., Baldini, M.:The Di Guglielmo syndrome, Blood, 13, 192-194, 1958.
  pubmed

• 63) Dameg. hek, W.:Sideroblastic anaemia:Is this a malignancy? Brit. J. Haemat., 11, 52-58, 1965.

• 64) Dameshek, W.:Foreword and a propos al for considering Paroxysmal nocturnal hemoglobinuria (PNH) as a"candidate" myeloproliferative disorder, Blood, 33, 263-264, 1969.